Pesticide-inactivating heterocyclic derivatives having sulfur-containing substituents

By developing new heterocyclic derivatives containing sulfur substituents, the problems of insufficient insecticidal activity and threats to non-target arthropods in the prior art are solved, and effective control of insects and safety to bees are achieved. Excellent biological activity and environmental friendliness.

CN115023426BActive Publication Date: 2024-11-12SYNGENTA CROP PROTECITON AG
View PDF 57 Cites 0 Cited by

Patent Information

Application Number
CN202180011423.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-01-06
Filing Date
2021-01-06
Publication Date
2024-11-12
Estimated Expiration
2041-01-06

AI Technical Summary

Technical Problem

The existing pest-killing active heterocyclic derivatives fail to effectively play insecticidal roles and pose a potential threat to non-target arthropods such as bees.

Method used

A new class of heterocyclic derivatives containing sulfur substituents was developed, with specific compounds having formula I and their agrochemically acceptable salts, stereoisomers, enantiomers, tautomers, The body and N-oxide are prepared by oxidation reactions and are used as active ingredients for insecticidal, acaricidal, nematodeic or molluscicidal animals.

Benefits of technology

These compounds show superior biological activity, especially effective in protecting plants against insects, and show favorable safety for non-target arthropods such as bees, with higher biological activity and improved physical-chemical properties, enhancing biological Degradability and environmentally friendly.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115023426B_ABST
    Figure CN115023426B_ABST
Patent Text Reader

Abstract

Compounds of formula (I) wherein the substituents are as defined in claim 1. In addition, the invention relates to agrochemical compositions comprising compounds of formula (I), the preparation of these compositions, and the use of said compounds or compositions in agriculture or horticulture for combating, preventing or controlling animal pests, including arthropods and in particular insects, nematodes, molluscs or representatives of the order Acarina. #imgabs0#
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to pesticidally active, in particular insecticidal, heterocyclic derivatives containing a sulphur substituent, to processes for their preparation, to compositions comprising those compounds, and to their use for controlling animal pests, including arthropods and in particular insects or representatives of the order Acarina.

[0002] Heterocyclic benzoannulated dihydropyrrolone and phthalimide derivatives with sulfur-containing substituents have been described in the literature, for example, in J. Org. Chem. [Journal of Organic Chemistry] 2003, 62, 8240 and Bull. Chem. Soc. Chim. Belg. [Bulletin of the Belgian Chemical Society] 1997, 106, 151. However, the compounds mentioned in these references are not described as exerting pesticidal effects. Pesticide-active heterocyclic derivatives with sulfur-containing substituents have been described, for example, in WO 2012 / 012086848, WO 2013 / 018928, and WO 2020 / 171077.

[0003] It has now been found, surprisingly, that certain novel pesticidally active derivatives having sulphur-containing substituents have advantageous properties as pesticides.

[0004] The present invention therefore provides compounds of formula I,

[0005]

[0006] in

[0007] G1 and G2 are independently CH or N;

[0008] R2 is C1-C6 haloalkyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C6 haloalkoxy or C1-C4 haloalkylsulfonyloxy;

[0009] Q is a group selected from the group consisting of: formula Qa and Qb

[0010]

[0011] wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring;

[0012] And among them,

[0013] X is S, SO or SO2;

[0014] R1 is C1-C4 alkyl or C3-C6 cycloalkyl-C1-C4 alkyl;

[0015] R3, R4, R5 and R6 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, C3-C6 cyanocycloalkylC1-C4 alkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, -N(R7)2, or -N(R7)C(=O)R8; and

[0016] R7 and R8 are independently hydrogen, C1-C4 alkyl, C1-C6 haloalkyl, or C3-C6 cycloalkyl.

[0017] The present invention also provides agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compound of formula I.

[0018] Compounds of formula I with at least one basic center can form acid addition salts, for example, with strong inorganic acids (such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrous acid, phosphoric acid or hydrohalic acids), strong organic carboxylic acids (such as unsubstituted or, for example, halogen-substituted C1-C4-alkanecarboxylic acids, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid), or organic sulfonic acids (such as unsubstituted or, for example, halogen-substituted C1-C4-alkanesulfonic acids or arylsulfonic acids, for example methanesulfonic acid or p-toluenesulfonic acid). Compounds of formula I having at least one acidic group can, for example, form salts with bases, for example mineral salts, such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts; or with ammonia or organic amines (for example morpholine, piperidine, pyrrolidine, mono-, di- or tri-lower alkylamines, for example ethylamine, diethylamine, triethylamine or dimethylpropylamine, or mono-, di- or trihydroxy-lower alkylamines, for example monoethanolamine, diethanolamine or triethanolamine).

[0019] In each case, the compounds of formula (I) according to the invention are in free form, in oxidized form, such as N-oxides, or in salt form (eg in the form of agronomically usable salts).

[0020] N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen-containing heteroaromatic compounds. They are described, for example, by A. Albini and S. Pietra in 1991 in the book "Heterocyclic N-oxides", published by CRC Press, Boca Raton.

[0021] The compounds of formula I according to the invention also include hydrates which may be formed during salt formation.

[0022] When substituents are indicated as themselves being further substituted, this means that they carry one or more identical or different substituents, for example one to four substituents. Typically, there are no more than three such optional substituents at the same time. Preferably, there are no more than two such substituents (that is, the group is substituted by one or two indicated substituents) at the same time. When additional substituents are larger groups such as cycloalkyl or phenyl, it is most preferred that there is only one such optional substituent. When a group is indicated as being substituted, for example alkyl, this includes those groups that are a part of other groups, for example the alkyl in alkylthio.

[0023] As used herein, the term "C1-C n “Alkyl” refers to a saturated straight or branched chain hydrocarbon radical having 1 to n carbon atoms, attached via any carbon atom, such as any of the following: methyl, ethyl, n-propyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, n-pentyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, or 1-ethyl-2-methylpropyl.

[0024] As used herein, the term "C1-C n“Haloalkyl” refers to straight-chain or branched saturated alkyl groups (as mentioned above) having 1 to n carbon atoms, attached via any carbon atom, wherein some or all of the hydrogen atoms in these groups may be replaced by fluorine, chlorine, bromine and / or iodine, i.e., for example, any of the following: chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2,2-difluoropropyl, 2,3-difluoropropyl The term "Ci-C2-fluoroalkyl" shall mean a C1-C2-alkyl radical having 1, 2, 3, 4, or 5 fluorine atoms, such as difluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl, or pentafluoroethyl.

[0025] As used herein, the term "C1-C n "Alkoxy" refers to a straight-chain or branched saturated alkyl group (as mentioned above) having 1 to n carbon atoms, which is attached via an oxygen atom, i.e., for example, any of the following: methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy or 1,1-dimethylethoxy.

[0026] As used herein, the term "C1-C n "Haloalkoxy" refers to the C1-C nAlkoxy, which is partially or fully substituted by fluorine, chlorine, bromine and / or iodine, i.e., for example, any one of the following: chloromethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, 2,2,3,3,3-pentafluoropropoxy, heptafluoropropoxy, 1-(fluoromethyl)-2-fluoroethoxy, 1-(chloromethyl)-2-chloroethoxy, 1-(bromomethyl)-2-bromoethoxy, 4-fluorobutoxy, 4-chlorobutoxy, or 4-bromobutoxy.

[0027] As used herein, the term "C1-C n "Haloalkylsulfanyl" refers to the C1-C n Alkylthio, which is partially or fully substituted by fluorine, chlorine, bromine and / or iodine, i.e., for example, any one of the following: fluoromethylthio, difluoromethylthio, trifluoromethylthio, chlorodifluoromethylthio, bromodifluoromethylthio, 2-fluoroethylthio, 2-chloroethylthio, 2-bromoethylthio, 2-iodoethylthio, 2,2-difluoroethylthio, 2,2,2-trifluoroethylthio, 2,2,2-trichloroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, pentafluoroethylthio, 2-fluoropropylthio , 3-fluoropropylthio, 2-chloropropylthio, 3-chloropropylthio, 2-bromopropylthio, 3-bromopropylthio, 2,2-difluoropropylthio, 2,3-difluoropropylthio, 2,3-dichloropropylthio, 3,3,3-trifluoropropylthio, 3,3,3-trichloropropylthio, 2,2,3,3,3-pentafluoropropylthio, heptafluoropropylthio, 1-(fluoromethyl)-2-fluoroethylthio, 1-(chloromethyl)-2-chloroethylthio, 1-(bromomethyl)-2-bromoethylthio, 4-fluorobutylthio, 4-chlorobutylthio, or 4-bromobutylthio.

[0028] The term "C1-C n "Haloalkylsulfinyl" and "C1-C n "Haloalkylsulfonyl" refers to the above groups, but wherein the sulfur is in oxidation state 1 or 2, respectively.

[0029] As used herein, the term "C1-C n"Cyanoalkyl" refers to a straight-chain or branched saturated alkyl group having 1 to n carbon atoms (as mentioned above) which is substituted by a cyano group, for example, cyanomethylene, cyanoethylene, 1,1-dimethylcyanomethyl, cyanomethyl, cyanoethyl, cyanoisopropyl and 1-dimethylcyanomethyl.

[0030] The term "C1-C n "Cyanoalkoxy" refers to the above groups attached via an oxygen atom.

[0031] As used herein, in terms such as "C3-C n The suffix "-C1-C n Alkyl" (wherein n is an integer from 1 to 6) refers to a C3-C n A cycloalkyl-substituted straight-chain or branched saturated alkyl group. n Cycloalkyl-C1-C n An example of an alkyl group is, for example, cyclopropylmethyl.

[0032] As used herein, the term "C3-C6 cycloalkyl" refers to a 3-6 membered cycloalkyl group such as cyclopropane, cyclobutane, cyclopropane, cyclopentane and cyclohexane.

[0033] Halogen is typically fluorine, chlorine, bromine or iodine. This also applies accordingly to halogen in combination with other meanings, such as haloalkyl.

[0034] As listed below, certain embodiments according to the present invention are provided.

[0035] Example 1 provides a compound of formula I as defined above, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.

[0036] Embodiment 2 provides a compound according to embodiment 1, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, wherein Q is Qa and preferred values ​​for R2, G1, G2, X, R1, R3, R4, R7 and R8 are as listed below.

[0037] Example 3 provides a compound according to Example 1, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, wherein Q is Qb and preferred values ​​for R2, G1, G2, X, R1, R5, R6, R7 and R8 are as listed below.

[0038] With respect to Examples 1-3, preferred values ​​for R2, G1, G2, X, R1, R3, R4, R5, R6, R7, and R8, in any combination thereof, are listed below:

[0039] Preferably, R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy.

[0040] More preferably, R2 is a C1-C2 fluoroalkyl group, a C1-C2 fluoroalkylsulfanyl group, a C1-C2 fluoroalkylsulfinyl group, a C1-C2 fluoroalkylsulfonyl group, a C1-C2 fluoroalkoxy group or a C1-C2 fluoroalkylsulfonyloxy group.

[0041] Even more preferably, R2 is -CF3, -CF2CF3, -SCF3, -SOCF3, -SO2CF3, -OCHF2, -OCF3 or -OSO2CF3.

[0042] Most preferably, R2 is -CF3, -OCHF2, -OCF3 or -SO2CF3.

[0043] Preferably, G1 is N and G2 is CH, or G1 is CH and G2 is N.

[0044] It is also preferred when both G1 and G2 are N.

[0045] It is also preferred when both G1 and G2 are CH.

[0046] Most preferably, G1 is N and G2 is CH.

[0047] Preferably, X is S or SO2.

[0048] Most preferably, X is SO2.

[0049] Preferably, R1 is C1-C4 alkyl or cyclopropyl-C1-C4 alkyl.

[0050] More preferably, R1 is ethyl or cyclopropylmethyl.

[0051] Most preferably, R1 is ethyl.

[0052] Preferably, R3 and R4 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8.

[0053] More preferably, R3 and R4 are independently of each other hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0054] Even more preferably, R3 and R4 are independently of one another hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy or -NHC(O)CH3.

[0055] Most preferably, R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3; or

[0056] R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0057] Most preferably, R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy or -NHC(O)CH3; or

[0058] R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy or -NHC(O)CH3.

[0059] Also preferred is when one of R3 or R4 is hydrogen and the other of R3 or R4 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy and -NHC(O)CH3.

[0060] Preferably, R5 and R6 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8.

[0061] More preferably, R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0062] Even more preferably, R5 and R6 are independently of each other hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy or -NHC(O)CH3.

[0063] Most preferably, R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3; or

[0064] R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0065] Most preferably, R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy or -NHC(O)CH3; or

[0066] R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy or -NHC(O)CH3.

[0067] Also preferred is when one of R5 or R6 is hydrogen and the other of R5 or R6 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy and -NHC(O)CH3.

[0068] Preferably, R7 and R8 are independently of each other hydrogen or C1-C4 alkyl.

[0069] More preferably, R7 and R8 are independently hydrogen or methyl.

[0070] Most preferably, R7 is hydrogen or methyl, and R8 is methyl.

[0071] Most preferably, R7 is hydrogen and R8 is methyl.

[0072] As described below, further embodiments according to the present invention are provided.

[0073] A preferred group of compounds having formula I is represented by compounds having formula I-1

[0074]

[0075] wherein R2, G1, G2, X, R1, R3, R4, R7 and R8 are as defined above in Formula I.

[0076] In a preferred group of compounds having formula I-1, R1 is C1-C4 alkyl or cyclopropyl-C1-C4 alkyl; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; R3 and R4 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0077] In another preferred group of compounds having formula I-1, R1 is ethyl or cyclopropylmethyl; X is S or SO2; R2 is C1-C2 fluoroalkyl, C1-C2 fluoroalkylsulfanyl, C1-C2 fluoroalkylsulfinyl, C1-C2 fluoroalkylsulfonyl, C1-C2 fluoroalkoxy or C1-C2 fluoroalkylsulfonyloxy; and R3 and R4 are independently of each other hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0078] In another preferred group of compounds having formula I-1, R1 is ethyl; X is SO2; R2 is -CF3, -CF2CF3, -SCF3, -SOCF3, -SO2CF3, -OCHF2, -OCF3 or -OSO2CF3; and R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3. Also preferred is when one of R3 or R4 is hydrogen and the other of R3 or R4 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy and -NHC(O)CH3.

[0079] In another preferred group of compounds having formula I-1, R1 is ethyl; X is SO2; R2 is -CF3, -SO2CF3, -OCHF2, or -OCF3; and R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy or -NHC(O)CH3.

[0080] A preferred group of compounds according to this embodiment are compounds of formula (I-1a), which are compounds of formula (I-1), or any preferred embodiment of compounds of formula (I-1), wherein R2 is -CF3, -OCHF2, -OCF3 or -SO2CF3, preferably R2 is -CF3; X is S or SO2; preferably, X is SO2; and R1 is ethyl or cyclopropylmethyl; preferably, R1 is ethyl.

[0081] Another group of preferred compounds according to this embodiment are compounds of formula (I-1b), which are compounds of formula (I-1), or any preferred embodiment of compounds of formula (I-1), wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3; or wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0082] Another group of preferred compounds according to this embodiment are compounds of formula (I-1b-1), which are compounds of formula (I-1), or any preferred embodiment of compounds of formula (I-1), wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy or wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0083] Another group of preferred compounds according to this embodiment are compounds of formula (I-1c), which are compounds of formula (I-1), or any preferred embodiment of compounds of formula (I-1), wherein G1 is N and G2 is CH.

[0084] A preferred group of compounds according to this embodiment are compounds of formula (I-1d), which are compounds of formula (I-1), or any preferred embodiment of compounds of formula (I-1), wherein G1 is CH and G2 is N.

[0085] Another group of preferred compounds according to this embodiment are compounds of formula (I-1e), which are compounds of formula (I-1), or any preferred embodiment of compounds of formula (I-1), wherein G1 and G2 are both N.

[0086] Another group of preferred compounds according to this embodiment are compounds of formula (I-1f), which are compounds of formula (I-1), or any preferred embodiment of compounds of formula (I-1), wherein G1 and G2 are both CH.

[0087] The present invention also provides agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compound of formula 1-1.

[0088] Another preferred group of compounds having formula I is represented by compounds having formula I-2

[0089]

[0090] wherein R2, G1, G2, X, R1, R5, R6, R7 and R8 are as defined above in Formula I.

[0091] In a preferred group of compounds having formula I-2, R1 is C1-C4 alkyl or cyclopropyl-C1-C4 alkyl; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; R5 and R6 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0092] In another preferred group of compounds having formula I-2, R1 is ethyl or cyclopropylmethyl; X is S or SO2; R2 is C1-C2 fluoroalkyl, C1-C2 fluoroalkylsulfanyl, C1-C2 fluoroalkylsulfinyl, C1-C2 fluoroalkylsulfonyl, C1-C2 fluoroalkoxy or C1-C2 fluoroalkylsulfonyloxy; and R5 and R6 are independently of each other hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0093] In another preferred group of compounds having formula I-2, R1 is ethyl; X is SO2; R2 is -CF3, -CF2CF3, -SCF3, -SOCF3, -SO2CF3, -OCHF2, -OCF3 or -OSO2CF3; and R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0094] In another preferred group of compounds of formula I-2, R1 is ethyl; X is SO2; R2 is -CF3, -SO2CF3, -OCHF2, or -OCF3; and R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, or -NHC(O)CH3. Also preferred are when one of R5 or R6 is hydrogen and the other of R5 or R6 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, and -NHC(O)CH3.

[0095] A preferred group of compounds according to this embodiment are compounds of formula (I-2a), which are compounds of formula (I-2), or any preferred embodiment of compounds of formula (I-2), wherein R2 is -CF3, -OCHF2, -OCF3 or -SO2CF3, preferably R2 is -CF3; X is S or SO2; preferably, X is SO2; and R1 is ethyl or cyclopropylmethyl; preferably, R1 is ethyl.

[0096] Another group of preferred compounds according to this embodiment are compounds of formula (I-2b), which are compounds of formula (I-2), or any preferred embodiment of compounds of formula (I-2), wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3; or wherein R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0097] Another group of preferred compounds according to this embodiment are compounds of formula (I-2b-1), which are compounds of formula (I-2), or any preferred embodiment of compounds of formula (I-2), wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy or wherein R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0098] Another group of preferred compounds according to this embodiment are compounds of formula (I-2c), which are compounds of formula (I-2), or any preferred embodiment of compounds of formula (I-2), wherein G1 is N and G2 is CH.

[0099] A preferred group of compounds according to this embodiment are compounds of formula (I-2d), which are compounds of formula (I-2), or any preferred embodiment of compounds of formula (I-2), wherein G1 is CH and G2 is N.

[0100] Another group of preferred compounds according to this embodiment are compounds of formula (I-2e), which are compounds of formula (I-2), or any preferred embodiment of compounds of formula (I-2), wherein G1 and G2 are both N.

[0101] Another group of preferred compounds according to this embodiment are compounds of formula (I-2f), which are compounds of formula (I-2), or any preferred embodiment of compounds of formula (I-2), wherein G1 and G2 are both CH.

[0102] The present invention also provides agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compound of formula 1-2.

[0103] Another preferred group of compounds having formula I is represented by compounds having formula I-3

[0104]

[0105] wherein Q is a group selected from the group consisting of: formula Qa and Qb

[0106]

[0107] wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring; and

[0108] R2, X, R1, R3, R4, R5, R6, R7 and R8 are as defined above in Formula I.

[0109] In a preferred group of compounds having formula I-3, R1 is C1-C4 alkyl or cyclopropyl-C1-C4 alkyl; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; and X is S or SO2.

[0110] In another preferred group of compounds having formula I-3, R1 is ethyl or cyclopropylmethyl; R2 is C1-C2 fluoroalkyl, C1-C2 fluoroalkylsulfanyl, C1-C2 fluoroalkylsulfinyl, C1-C2 fluoroalkylsulfonyl, C1-C2 fluoroalkoxy or C1-C2 fluoroalkylsulfonyloxy; and X is S or SO2.

[0111] In another preferred group of compounds having formula I-3, R1 is ethyl; X is SO2; and R2 is -CF3, -CF2CF3, -SCF3, -SOCF3, -SO2CF3, -OCHF2, -OCF3 or -OSO2CF3.

[0112] In another preferred group of compounds having formula I-3, R1 is ethyl; X is SO2; and R2 is -CF3, -SO2CF3, -OCHF2, or -OCF3.

[0113] One group of preferred compounds according to this embodiment are compounds of formula (I-3a), which are compounds of formula (I-3), or any preferred embodiment of compounds of formula (I-3), wherein Q is Qa.

[0114] In a preferred group of compounds having formula I-3a, R3 and R4 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0115] In another preferred group of compounds having formula I-3a, R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0116] In another preferred group of compounds of formula I-3a, R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, or -NHC(O)CH3. Also preferred are when one of R3 or R4 is hydrogen and the other of R3 or R4 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, and -NHC(O)CH3.

[0117] Another preferred group of compounds of formula I-3a is that wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C( O)CH3; or those compounds wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0118] Another preferred group of compounds having formula I-3a are those wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0119] Another group of preferred compounds according to this embodiment are compounds of formula (I-3b), which are compounds of formula (I-3), or any preferred embodiment of compounds of formula (I-3), wherein Q is Qb.

[0120] In a preferred group of compounds having formula I-3b, R5 and R6 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0121] In another preferred group of compounds having formula I-3b, R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0122] In another preferred group of compounds of formula I-3b, R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, or -NHC(O)CH3. Also preferred are when one of R5 or R6 is hydrogen and the other of R5 or R6 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, and -NHC(O)CH3.

[0123] Another preferred group of compounds of formula I-3b is that wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C( O)CH3; or those compounds wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0124] Another preferred group of compounds having formula I-3b are those wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or wherein R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0125] An outstanding group of compounds of formula I-3b are compounds of formula (I-3b-2) wherein:

[0126] R2 is -CF3, -OCHF2, -OCF3 or -SO2CF3; preferably, R2 is -CF3;

[0127] X is S or SO2; preferably, X is SO2;

[0128] R1 is ethyl or cyclopropylmethyl; preferably, R1 is ethyl; and

[0129] R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3, or -NCH3C(O)CH3; or wherein R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3, or -NCH3C(O)CH3.

[0130] Another outstanding group of compounds of formula I-3b-2 are those wherein:

[0131] R5 is hydrogen; and

[0132] R6 is methyl, trifluoromethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, cyano, methoxy, isopropoxy, 2,2,2-trifluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3; preferably, R6 is trifluoromethyl.

[0133] Another outstanding group of compounds of formula I-3b-2 are those wherein:

[0134] R5 is hydrogen; and

[0135] R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy or -NHC(O)CH3; preferably, R6 is trifluoromethyl.

[0136] The present invention also provides agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compound of formula I-3.

[0137] Another preferred group of compounds having formula I is represented by compounds having formula I-4

[0138]

[0139] wherein Q is a group selected from the group consisting of: formula Qa and Qb

[0140]

[0141] wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring; and

[0142] R2, X, R1, R3, R4, R5, R6, R7 and R8 are as defined above in Formula I.

[0143] In a preferred group of compounds having formula I-4, R1 is C1-C4 alkyl or cyclopropyl-C1-C4 alkyl; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; and X is S or SO2.

[0144] In another preferred group of compounds having formula I-4, R1 is ethyl or cyclopropylmethyl; R2 is C1-C2 fluoroalkyl, C1-C2 fluoroalkylsulfanyl, C1-C2 fluoroalkylsulfinyl, C1-C2 fluoroalkylsulfonyl, C1-C2 fluoroalkoxy or C1-C2 fluoroalkylsulfonyloxy; and X is S or SO2.

[0145] In another preferred group of compounds having formula I-4, R1 is ethyl; X is SO2; and R2 is -CF3, -CF2CF3, -SCF3, -SOCF3, -SO2CF3, -OCHF2, -OCF3 or -OSO2CF3.

[0146] In another preferred group of compounds having formula I-4, R1 is ethyl; X is SO2; and R2 is -CF3, -SO2CF3, -OCHF2, or -OCF3.

[0147] One group of preferred compounds according to this embodiment are compounds of formula (I-4a), which are compounds of formula (I-4), or any preferred embodiment of compounds of formula (I-4), wherein Q is Qa.

[0148] In a preferred group of compounds having formula I-4a, R3 and R4 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0149] In another preferred group of compounds having formula I-4a, R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0150] In another preferred group of compounds of formula I-4a, R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, or -NHC(O)CH3. Also preferred are when one of R3 or R4 is hydrogen and the other of R3 or R4 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, and -NHC(O)CH3.

[0151] Another preferred group of compounds of formula I-4a is that wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C( O)CH3; or those compounds wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0152] Another preferred group of compounds having formula I-4a are those wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0153] An outstanding group of compounds of formula I-4a are compounds of formula (I-4a-2) wherein:

[0154] R2 is -CF3 or -SO2CF3; preferably, R2 is -CF3;

[0155] X is S or SO2; preferably, X is SO2;

[0156] R1 is ethyl or cyclopropylmethyl; preferably, R1 is ethyl; and

[0157] R4 is hydrogen and R3 is hydrogen, methyl, trifluoromethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, cyano, methoxy, isopropoxy, 2,2,2-trifluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3; preferably, R3 is trifluoromethyl; or

[0158] R3 is hydrogen and R4 is methyl, trifluoromethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, cyano, methoxy, isopropyloxy, 2,2,2-trifluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3; preferably, R4 is trifluoromethyl or 1-cyanocyclopropyl.

[0159] An outstanding group of compounds of formula I-4a-2 are those wherein:

[0160] R3 is hydrogen; and

[0161] R4 is trifluoromethyl or 1-cyanocyclopropyl.

[0162] Another outstanding group of compounds of formula I-4a-2 are those wherein:

[0163] R4 is hydrogen and R3 is trifluoromethyl.

[0164] Another outstanding group of compounds of formula I-4a are compounds of formula (I-4a-3) wherein:

[0165] R2 is -CF3, -OCHF2, -OCF3 or -SO2CF3; preferably, R2 is -CF3;

[0166] X is S or SO2; preferably, X is SO2;

[0167] R1 is ethyl; and

[0168] R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; preferably, R3 is bromo, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or

[0169] R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy or -NHC(O)CH3; preferably, R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, methoxy, or 2,2,2-trifluoroethoxy.

[0170] An outstanding group of compounds of formula I-4a-3 are those wherein:

[0171] R2 is -CF3;

[0172] X is SO2;

[0173] R3 is hydrogen; and

[0174] R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, methoxy or 2,2,2-trifluoroethoxy.

[0175] Another outstanding group of compounds of formula I-4a-3 are those wherein:

[0176] R2 is -CF3;

[0177] X is SO2;

[0178] R4 is hydrogen; and

[0179] R3 is bromo, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy or -NHC(O)CH3.

[0180] Another group of preferred compounds according to this embodiment are compounds of formula (I-4b), which are compounds of formula (I-4), or any preferred embodiment of compounds of formula (I-4), wherein Q is Qb.

[0181] In a preferred group of compounds having formula I-4b, R5 and R6 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0182] In another preferred group of compounds having formula I-4b, R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0183] In another preferred group of compounds of formula I-4b, R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, or -NHC(O)CH3. Also preferred are when one of R5 or R6 is hydrogen and the other of R5 or R6 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, and -NHC(O)CH3.

[0184] Another preferred group of compounds of formula I-4b is that wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C( O)CH3; or those compounds wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0185] Another preferred group of compounds having formula I-4b are those wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or wherein R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0186] The present invention also provides agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compound of formula I-4.

[0187] Another preferred group of compounds having formula I is represented by compounds having formula I-5

[0188]

[0189] wherein Q is a group selected from the group consisting of: formula Qa and Qb

[0190]

[0191] wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring; and

[0192] R2, X, R1, R3, R4, R5, R6, R7 and R8 are as defined above in Formula I.

[0193] In a preferred group of compounds having formula I-5, R1 is C1-C4 alkyl or cyclopropyl-C1-C4 alkyl; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; and X is S or SO2.

[0194] In another preferred group of compounds having formula I-5, R1 is ethyl or cyclopropylmethyl; R2 is C1-C2 fluoroalkyl, C1-C2 fluoroalkylsulfanyl, C1-C2 fluoroalkylsulfinyl, C1-C2 fluoroalkylsulfonyl, C1-C2 fluoroalkoxy or C1-C2 fluoroalkylsulfonyloxy; and X is S or SO2.

[0195] In another preferred group of compounds having formula I-5, R1 is ethyl; X is SO2; and R2 is -CF3, -CF2CF3, -SCF3, -SOCF3, -SO2CF3, -OCHF2, -OCF3 or -OSO2CF3.

[0196] In another preferred group of compounds having formula I-5, R1 is ethyl; X is SO2; and R2 is -CF3, -SO2CF3, -OCHF2, or -OCF3.

[0197] One group of preferred compounds according to this embodiment are compounds of formula (I-5a), which are compounds of formula (I-5), or any preferred embodiment of compounds of formula (I-5), wherein Q is Qa.

[0198] In a preferred group of compounds having formula I-5a, R3 and R4 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0199] In another preferred group of compounds having formula I-5a, R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0200] In another preferred group of compounds of formula I-5a, R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, or -NHC(O)CH3. Also preferred are when one of R3 or R4 is hydrogen and the other of R3 or R4 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, and -NHC(O)CH3.

[0201] Another preferred group of compounds of formula I-5a is that wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C( O)CH3; or those compounds wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0202] Another preferred group of compounds having formula I-5a are those wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0203] An outstanding group of compounds of formula I-5a are compounds of formula (I-5a-2) wherein:

[0204] R2 is -CF3, -OCHF2, -OCF3 or -SO2CF3;

[0205] X is S or SO2; preferably, X is SO2;

[0206] R1 is ethyl; and

[0207] R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; preferably, R3 is bromo, trifluoromethyl, 1,1-difluoroethyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethoxy, or methoxy; or

[0208] R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy or -NHC(O)CH3; preferably, R4 is trifluoromethyl, 1-cyanocyclopropyl, or 2,2,2-trifluoroethoxy.

[0209] An outstanding group of compounds of formula I-5a-2 are those wherein:

[0210] X is SO2;

[0211] R3 is hydrogen; and

[0212] R4 is trifluoromethyl, 1-cyanocyclopropyl, or 2,2,2-trifluoroethoxy.

[0213] Another outstanding group of compounds of formula I-5a-2 are those wherein:

[0214] X is SO2;

[0215] R4 is hydrogen; and

[0216] R3 is bromo, trifluoromethyl, 1,1-difluoroethyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethoxy or methoxy.

[0217] Another group of preferred compounds according to this embodiment are compounds of formula (I-5b), which are compounds of formula (I-5), or any preferred embodiment of compounds of formula (I-5), wherein Q is Qb.

[0218] In a preferred group of compounds having formula I-5b, R5 and R6 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0219] In another preferred group of compounds having formula I-5b, R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0220] In another preferred group of compounds of formula I-5b, R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, or -NHC(O)CH3. Also preferred are when one of R5 or R6 is hydrogen and the other of R5 or R6 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, and -NHC(O)CH3.

[0221] Another preferred group of compounds of formula I-5b is that wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C( O)CH3; or those compounds wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0222] Another preferred group of compounds having formula I-5b are those wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or wherein R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0223] The present invention also provides agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compound of formula 1-5.

[0224] Another preferred group of compounds having formula I is represented by compounds having formula I-6

[0225]

[0226] wherein Q is a group selected from the group consisting of: formula Qa and Qb

[0227]

[0228] wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring; and

[0229] R2, X, R1, R3, R4, R5, R6, R7 and R8 are as defined above in Formula I.

[0230] In a preferred group of compounds having formula I-6, R1 is C1-C4 alkyl or cyclopropyl-C1-C4 alkyl; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; and X is S or SO2.

[0231] In another preferred group of compounds having formula I-6, R1 is ethyl or cyclopropylmethyl; R2 is C1-C2 fluoroalkyl, C1-C2 fluoroalkylsulfanyl, C1-C2 fluoroalkylsulfinyl, C1-C2 fluoroalkylsulfonyl, C1-C2 fluoroalkoxy or C1-C2 fluoroalkylsulfonyloxy; and X is S or SO2.

[0232] In another preferred group of compounds having formula I-6, R1 is ethyl; X is SO2; and R2 is -CF3, -CF2CF3, -SCF3, -SOCF3, -SO2CF3, -OCHF2, -OCF3 or -OSO2CF3.

[0233] In another preferred group of compounds having formula I-6, R1 is ethyl; X is SO2; and R2 is -CF3, -SO2CF3, -OCHF2, or -OCF3.

[0234] One group of preferred compounds according to this embodiment are compounds of formula (I-6a), which are compounds of formula (I-6), or any preferred embodiment of compounds of formula (I-6), wherein Q is Qa.

[0235] In a preferred group of compounds having formula I-6a, R3 and R4 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0236] In another preferred group of compounds having formula I-6a, R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0237] In another preferred group of compounds of formula I-6a, R3 and R4 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, or -NHC(O)CH3. Also preferred are when one of R3 or R4 is hydrogen and the other of R3 or R4 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, and -NHC(O)CH3.

[0238] Another preferred group of compounds of formula I-6a is that wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C( O)CH3; or those compounds wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0239] Another preferred group of compounds having formula I-6a are those wherein R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0240] Another group of preferred compounds according to this embodiment are compounds of formula (I-6b), which are compounds of formula (I-6), or any preferred embodiment of compounds of formula (I-6), wherein Q is Qb.

[0241] In a preferred group of compounds having formula I-6b, R5 and R6 are independently hydrogen, halogen, C1-C4 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl monosubstituted by cyano, C1-C6 cyanoalkyl, C1-C6 cyanoalkoxy, cyano, C1-C4 alkoxy, C1-C6 haloalkoxy, or -N(R7)C(=O)R8; and R7 and R8 are independently hydrogen or C1-C4 alkyl.

[0242] In another preferred group of compounds having formula I-6b, R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, cyano, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0243] In another preferred group of compounds of formula I-6b, R5 and R6 are independently hydrogen, bromo, methyl, trifluoromethyl, difluoroethyl, cyclopropyl, cyanocyclopropyl, cyanoisopropyl, cyanoisopropoxy, methoxy, isopropoxy, difluoromethoxy, trifluoroethoxy, difluoroethoxy, or -NHC(O)CH3. Also preferred are when one of R5 or R6 is hydrogen and the other of R5 or R6 is selected from bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, and -NHC(O)CH3.

[0244] Another preferred group of compounds of formula I-6b is that wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropyloxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C( O)CH3; or those compounds wherein R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, cyano, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, -NHC(O)CH3 or -NCH3C(O)CH3.

[0245] Another preferred group of compounds having formula I-6b are those wherein R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or wherein R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3.

[0246] The present invention also provides agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compound of formula 1-6.

[0247] The compounds according to the present invention may have any number of benefits, including, among others, favorable levels of biological activity for protecting plants against insects or superior properties for use as agrochemical active ingredients (e.g., higher biological activity, favorable activity spectrum, increased safety, improved physico-chemical properties, or increased biodegradability or environmental profile). In particular, it has been unexpectedly discovered that certain compounds of formula (I) may exhibit favorable safety profiles relative to non-target arthropods, particularly pollinators such as honey bees, solitary bees, and bumblebees. Most particularly, relative to the Italian honey bee (Apis mellifera).

[0248] In another aspect, the present invention provides a composition comprising an insecticidal, acaricidal, nematicidal or molluscicidal effective amount of a compound of formula (I) as defined in any one of the Examples (above) under compounds of formula (I), (I-1), (I-2), (I-3), (I-4), (I-5) and (I-6), or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, and optionally, an adjuvant or diluent.

[0249] In another aspect the present invention provides a method for combating and controlling insects, acarids, nematodes or molluscs, which method comprises applying to the pest, the locus of the pest, or a plant susceptible to attack by the pest an insecticidally, acaridically, nematicidally or molluscicidally effective amount of a compound of formula (I) as defined in any one of the Examples (above) under compounds of formula (I), (I-1), (I-2), (I-3), (I-4), (I-5) and (I-6), or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, or a composition as defined above.

[0250] In yet another aspect, the present invention provides a method for protecting plant propagation material from attack by insects, acarids, nematodes or molluscs, said method comprising treating said propagation material or the locus where said propagation material is planted with a composition as defined above.

[0251] The method for preparing the compound of formula I according to the present invention is carried out in principle by methods known to those skilled in the art. More specifically, and as described in schemes A and B, there is a subgroup of the compound of formula I (wherein X is SO (sulfoxide) and / or SO2 (sulfone)) can be obtained by means of the oxidation reaction of the corresponding sulfide compound (wherein X is S) with formula I, and the oxidation reaction is related to reagents such as m-chloroperbenzoic acid (mCPBA), hydrogen peroxide, potassium persulfate (oxone), sodium periodate, sodium hypochlorite or tert-butyl hypochlorite (except other oxidants). The oxidation reaction is typically carried out in the presence of a solvent. The example of the solvent for the reaction includes aliphatic halogenated hydrocarbons, such as dichloromethane and chloroform; Alcohol, such as methanol and ethanol; Acetic acid; Water; And mixtures thereof. The amount of the oxidant used in the reaction is generally 1 to 3 mol, preferably 1 to 1.2 mol, relative to 1 mol of the sulfide compound I to produce the sulfoxide compound I, and preferably 2 to 2.2 mol relative to 1 mol of the sulfide compound I to produce the sulfone compound I. Such oxidation reactions are disclosed, for example, in WO 2013 / 018928.

[0252] Plan A

[0253]

[0254] The chemical process previously described in Scheme A for obtaining compounds of formula I-Qa-a2 and I-Qa-a3 (wherein G1, G2, R1, R2, R3 and R4 are as defined in Formula I) from compounds of formula I-Qa-a1 can be similarly applied to prepare compounds of formula I-Qb-b2 and I-Qb-b3 (wherein G1, G2, R1, R2, R5 and R6 are as defined in Formula I) from compounds of formula I-Qb-b1 (Scheme B).

[0255] Plan B

[0256]

[0257] Compounds of formula I (wherein R1, G1, G2 and Q are as defined above in formula I) can be prepared by the following (Scheme 1)

[0258] Option 1:

[0259]

[0260] By reacting a compound of formula VII, wherein R2, G1 and G2 are as defined above in formula I, with a compound of formula VIII, wherein Q is as defined above in formula I, and wherein LG3 is a halogen (or a pseudohalogen leaving group, such as triflate), in the presence of a base, such as sodium carbonate, potassium carbonate or cesium carbonate, or sodium hydride, in a suitable solvent, such as, for example, tetrahydrofuran, dioxane, N,N-dimethylformamide, N,N-dimethylacetamide or acetonitrile, at a temperature between 0°C and 150°C, optionally under microwave irradiation.

[0261] Alternatively, compounds of formula I (wherein R2, G1, G2 and Q are as defined above in formula I) can be prepared by heating in the presence of a base (such as sodium carbonate, potassium carbonate or cesium carbonate, or potassium tert-butoxide), in the presence of a metal catalyst, or a copper catalyst (such as copper(I) iodide), optionally in the presence of a ligand (such as a diamine ligand (such as N,N′-dimethylethylenediamine or trans-cyclohexyldiamine) or dibenzylideneacetone (dba), or 1,10-phenanthroline), at a temperature between 30° C. and 180° C., optionally under microwave irradiation, or in the presence of a palladium catalyst (such as palladium(II) acetate, bis(dibenzylideneacetone)palladium(0) (Pd(dba)2) or tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3 (optionally in the form of a chloroform adduct) or a palladium precatalyst (such as tert-BuBrettPhos Pd G3[(2-di-tert-butylphosphino-3,6-dimethoxy-2′,4′,6′-triisopropyl-1,1′-biphenyl)-2-(2′-amino-1,1′-biphenyl)]methanesulfonate palladium(II) or BrettPhos Pd G3 [(2-di-cyclohexylphosphino-3,6-dimethoxy-2′,4′,6′-triisopropyl-1,1′-biphenyl)-2-(2′-amino-1,1′-biphenyl)] methanesulfonate palladium (II)))) and optionally in the presence of a ligand (e.g., SPhos, t-BuBrettPhos or Xantphos), at a temperature between 60°C and 120°C, optionally under microwave irradiation, a compound of formula VII (wherein R2, G1 and G2 are as defined above in formula I) is reacted with a compound of formula VIII (wherein Q is as defined above in formula I, and wherein LG3 is a halogen (or a pseudohalogen leaving group, such as trifluoromethanesulfonate), preferably bromine or iodine). The above reaction can be carried out in the presence of a solvent (such as toluene, N,N-dimethylformamide DMF, N-methylpyrrolidone NMP, dimethyl sulfoxide DMSO, dioxane, tetrahydrofuran THF) and is described in the literature, for example, WO 2012031004, WO 2009042907 and Synthetic Communications 2011, 41: 67-72.

[0262] Alternatively, compounds of formula I, wherein R2, G1, G2 and Q are as defined above in formula I, can be prepared by reacting a compound of formula VI, wherein R2, G1 and G2 are as defined above in formula I, and LG2 is a leaving group (e.g., bromine Br, chlorine Cl or iodine I (preferably bromine)), and R is C1-C6 alkyl, benzyl or phenyl) with a compound of formula IX, wherein Q is as defined above in formula I, in the presence of a base such as sodium carbonate, potassium carbonate or cesium carbonate, or sodium hydride, or N,N-diisopropylethylamine or potassium tert-butoxide KOtBu, and in the presence of a solvent such as ethanol, methanol, dioxane, toluene, acetonitrile, DMF, N,N-dimethylacetamide DMA, DMSO, or THF, at a temperature between 0°C and 150°C, optionally under microwave irradiation (Scheme 1). Such reactions proceed via nucleophilic substitution and subsequent cyclization and are also reported in the literature, for example in WO2009042907.

[0263] Alternatively, compounds of formula I, wherein R2, G1, G2 and Q are as defined above in formula I, can be prepared by cyclizing compounds of formula X, wherein R2, G1, G2 and Q are as defined in formula I, for example, in the presence of phosphorus oxychloride (other amide coupling reagents such as thionyl chloride SOCl2, HATU or EDCI can also be used), optionally in the presence of a base such as triethylamine, pyridine or Huning's base, optionally in the presence of a solvent or diluent such as toluene or xylene, at temperatures between 0°C and 180°C, preferably between 20°C and 120°C (Scheme 1).

[0264] Compounds of formula I (wherein R2, G1, G2 and Q are as defined above in formula I) can also be prepared by the following (Scheme 2)

[0265] Option 2:

[0266]

[0267] By cyclizing a compound of formula Xa (wherein R2, G1, G2 and Q are as defined above in formula I and wherein X0 is halogen, preferably chlorine, or X0 is X) in the presence of a base (such as triethylamine, N,N-diisopropyl-ethylamine or pyridine), optionally in the presence of a catalyst (such as 4-dimethylaminopyridine DMAP), in an inert solvent (such as dichloromethane, tetrahydrofuran, dioxane, N,N-dimethylformamide, N,N-dimethylacetamide, acetonitrile, ethyl acetate or toluene) at a temperature between 0°C and 50°C. 01 or X 02 Certain bases (such as pyridine and triethylamine) can be successfully used as both base and solvent.

[0268] Compounds of formula Xa (wherein R2, G1, G2 and Q are as defined above in formula I, and wherein X0 is halogen, preferably chlorine, or X0 is X 01 or X 02 ) can be prepared by activating a compound of formula X (wherein R2, G1, G2 and Q are as defined above in formula I) by methods known to those skilled in the art and described, for example, in Tetrahedron, 2005, 61(46), 10827-10852. Preference is given to forming an activated species Xa (wherein R2, G1, G2 and Q are as defined above in formula I and wherein X0 is halogen, preferably chlorine). For example, compound Xa (wherein X0 is halogen, preferably chlorine) is formed by treating X with, for example, oxalyl chloride (COCl) 2 or thionyl chloride SOCl 2 in an inert solvent (such as dichloromethane CH2Cl2 or tetrahydrofuran THF) in the presence of a catalytic amount of N,N-dimethylformamide DMF at a temperature between 20°C and 100°C (preferably about 25°C). Alternatively, treatment of a compound of formula X with, for example, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide EDC or dicyclohexylcarbodiimide DCC at a temperature between 50° C. and 180° C., optionally in the presence of a base such as triethylamine, in an inert solvent such as pyridine or tetrahydrofuran (THF) will yield an activated species Xa (wherein X0 is X 01 or X 02 ).

[0269] Compounds of formula VII, wherein R2, G1 and G2 are as defined above in formula I, can be prepared by reacting compounds of formula VI, wherein R2, G1 and G2 are as defined above in formula I, and LG2 is a leaving group such as Br, Cl or I (preferably bromine) and R is C1-C6 alkyl, benzyl or phenyl, with ammonia or an ammonia surrogate such as NH4OH in the presence of a solvent such as ethanol, methanol, dioxane, toluene, DMF, DMA, DMSO and THF at temperatures between 0°C and 150°C, optionally under microwave irradiation (Scheme 1).

[0270] Compounds of formula X (wherein R2, G1, G2 and Q are as defined above in formula I) can be prepared by nucleophilic substitution reaction of a compound of formula VI (wherein R2, G1 and G2 are as defined above in formula I, and LG2 is a leaving group (e.g., Br, Cl or I (preferably bromo)), and R is C1-C6 alkyl, benzyl or phenyl) with an amino compound of formula IX (wherein Q is as defined above in formula I) under the conditions described above, followed by in situ hydrolysis of the formed intermediate ester of formula XVII (wherein R2, G1, G2 and Q are as defined above in formula I, and wherein R is C1-C6 alkyl, benzyl or phenyl) (Scheme 1).

[0271]

[0272] The unhydrolyzed ester compound of formula XVII generated in situ can be isolated and can also be converted via saponification in the presence of a suitable base (e.g., sodium hydroxide, NaOH, lithium hydroxide, LiOH, or barium hydroxide, Ba(OH)2) in the presence of a solvent such as ethanol, methanol, dioxane, tetrahydrofuran, or water (or mixtures thereof) to form a carboxylic acid of formula X. Alternatively, Clapico-type conditions (e.g., heating substrate XVII in the presence of sodium chloride or lithium chloride in N-methylpyrrolidone or aqueous dimethyl sulfoxide, DMSO, optionally under microwave irradiation) can also be used to convert the compound of formula XVII to the compound of formula X. The direct conversion of the compound of formula VI to the compound of formula X can be carried out in the presence of a base (e.g., sodium hydride, KOtBu, butyllithium, or lithium diisopropylamide, in particular) and in the presence of a solvent such as dioxane, DMF, DMA, DMSO, or THF at temperatures between -30°C and 150°C.

[0273] The above reaction for preparing a compound of formula X can also be carried out by reacting a compound of formula VI with a compound of formula IXa (wherein Q is as defined above in formula I and PG is an amino protecting group, such as tert-butoxycarbonyl (BOC)) under similar conditions as described above (for preparing a compound of formula X by reacting a compound of formula VI with a compound of formula IX), followed by deprotection of the amino protecting group PG. Deprotection of amino protecting groups is well known to those skilled in the art, and for example, the BOC protecting group can be removed in the presence of an acid (such as hydrochloric acid or trifluoroacetic acid), optionally in the presence of an inert solvent (such as dichloromethane, tetrahydrofuran, dioxane, or trifluorotoluene) at a temperature between 0°C and 70°C. This method for forming a compound of formula X (and I) from compounds of formula VI and IXa is detailed in Scheme 2a and reflects the specific case where the group PG of IXa is tert-butoxycarbonyl (BOC), defining a compound of formula XIX, where Q is as defined above in formula I.

[0274] Option 2a (The previously mentioned substituent definitions still apply) :

[0275]

[0276] A compound of formula VI and a compound of formula XIX are reacted in the presence of a base such as sodium carbonate, potassium carbonate or cesium carbonate, or sodium hydride, or N,N-diisopropylethylamine or potassium tert-butoxide KOtBu, in the presence of a solvent such as ethanol, methanol, dioxane, toluene, acetonitrile, DMF, N,N-dimethylacetamide DMA, DMSO, or THF at a temperature between 0° C. and 150° C., optionally under microwave irradiation, to give a compound of formula XVIIa.

[0277] Removal of the tert-butoxycarbonyl (BOC) group in a compound of formula XVIIa mediated by an acid (e.g., hydrochloric acid or trifluoroacetic acid) at a temperature between 0° C. and 70° C., optionally in the presence of an inert solvent (e.g., dichloromethane, tetrahydrofuran, dioxane, or trifluorotoluene), produces a compound of formula XVII. The compound of formula XVII is saponified in the presence of a suitable base (e.g., sodium hydroxide, NaOH, lithium hydroxide, LiOH, or barium hydroxide, Ba(OH) 2) in the presence of a solvent (e.g., ethanol, methanol, dioxane, tetrahydrofuran, or water (or mixtures thereof)) to form a carboxylic acid of formula X (alternatively, Krapcho-type conditions as described above may be used). For example, the cyclization of a compound of formula X to a compound of formula I is achieved in the presence of phosphorus oxychloride (other amide coupling reagents such as thionyl chloride SOCl2, HATU or EDCI may also be used), optionally in the presence of a base such as triethylamine, pyridine or Huning's base, optionally in the presence of a solvent or diluent such as toluene or xylene, at temperatures between 0°C and 180°C, preferably between 20°C and 120°C.

[0278] Alternatively, direct cyclization of compounds having formula XVII to compounds having formula I can be achieved under the conditions mentioned in Scheme 6 below.

[0279] A subgroup of compounds having Formula I, wherein G1, G2, and R2 are as defined in Formula I and wherein Q is defined as Qa, wherein R3, R4, X, and R1 are as defined in Formula I, can be defined as compounds having Formula I-Qa (Scheme 2b). Similarly, a subgroup of reactants having Formula IXa, wherein PG is a tert-butoxycarbonyl (BOC) group, and wherein Q is defined as Qa, wherein R3, R4, X, and R1 are as defined in Formula I, can be defined as compounds having Formula XIX-Qa.

[0280] Option 2b:

[0281]

[0282] The chemical processes previously described in Schemes 1, 2 and 2a for obtaining compounds of formula I from compounds of formula VI and compounds of formula IXa via compounds of formula X can be applied analogously to the preparation of compounds of formula I-Qa from compounds of formula VI and compounds of formula XIXa-Qa via compounds of formula X-Qa (Scheme 2b), wherein all previously mentioned substituent definitions remain valid.

[0283] Compounds of formula VI, wherein R2, G1 and G2 are as defined above in formula I, and LG2 is a halogen leaving group (e.g., bromine Br, chlorine Cl or iodine I (preferably bromine)), and R is C1-C6 alkyl, benzyl or phenyl) are known (see the preparation description disclosed in WO 20 / 174094) or can be prepared by methods known to those skilled in the art.

[0284] For example, compounds of formula VI (wherein R2, G1 and G2 are as defined above in formula I, and LG2 is a leaving group (e.g., Br, Cl or I (preferably bromine)), and R is C1-C6 alkyl, benzyl or phenyl) can be prepared by free radical-initiated benzyl halogenation of compounds of formula V (wherein R2, G1 and G2 are as defined above in formula I, and R is C1-C6 alkyl, benzyl or phenyl). Such reactions are well known to those skilled in the art and can be carried out in the presence of an electrophilic halogenating agent (such as Br2, NBS, Cl2, NIS, in particular), and in the presence of a free radical initiator (e.g., AIBN (azobisisobutyronitrile), benzoyl peroxide) or under photochemical conditions, and in the presence of a solvent (such as toluene, xylene, acetonitrile, hexane, dichloroethane or carbon tetrachloride) at a temperature ranging from 20°C to the boiling point of the reaction mixture. Such reactions are known under the name Wohl-Ziegler bromination and are reported in the literature, for example in Synthesis 2015, 47: 1280-1290 and J. Am. Chem. Soc. 1963, 85(3): 354-355.

[0285] Compounds of formula V, wherein R2, G1 and G2 are as defined above in formula I, and R is C1-C6 alkyl, benzyl or phenyl, can be prepared by a Suzuki reaction (Scheme 1), which involves, for example, reacting a compound of formula IV, wherein R2, G1 and G2 are as defined above in formula I, and LG1 is a halogen Br, Cl, I (preferably Cl), and R is C1-C6 alkyl, benzyl or phenyl, with trimethylboroxine or potassium methyltrifluoroborate and other methylboronic acid equivalents. The reaction can be catalyzed by a palladium-based catalyst such as tetrakis(triphenylphosphine)palladium(0), (1,1'bis(diphenylphosphino)ferrocene)dichloro-palladium-dichloromethane (1:1 complex) or chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (XPhos palladacycle complex) in the presence of a base such as sodium carbonate, tripotassium phosphate or cesium fluoride in a solvent or solvent mixture such as, for example, dioxane, acetonitrile, N,N-dimethylformamide, a mixture of 1,2-dimethoxyethane and water or a mixture of dioxane / water or a mixture of toluene / water, preferably under an inert atmosphere. The reaction temperature can preferably be in the range from room temperature to the boiling point of the reaction mixture, or the reaction can be carried out under microwave irradiation. Such Suzuki reactions are well known to those skilled in the art and have been reviewed, for example, in J. Organomet. Chem. 1999, 576: 147-168.

[0286] Compounds of formula IV, wherein R2, G1 and G2 are as defined above in formula I, and LG1 is halogen Br, Cl, I (preferably Cl), and R is C1-C6 alkyl, benzyl or phenyl, can be prepared by reacting compounds of formula III, wherein R2, G1 and G2 are as defined above in formula I, and LG1 is halogen Br, Cl, I (preferably Cl), and ROH, wherein R is C1-C6 alkyl, benzyl or phenyl, in the presence of an acid catalyst, such as sulfuric acid or a Lewis acid, such as, for example, Sc(OTf)3 or FeCl3 (Scheme 1). Such reactions are well known to those skilled in the art and are known by the name Fischer esterification and are reported in the literature, for example, in J. Org. Chem. 2006, 71: 3332-3334, Chem. Commun. 1997, 351-352 and Synthesis 2008, 3407-3410. Such esterification reactions can also be carried out by reacting a compound of formula III with TMSCHN2 to form a compound of formula IV (wherein R2, G1 and G2 are as defined above in formula I, and LG1 is a halogen Br, Cl, I (preferably Cl), and wherein R is methyl) and are reported in Angew. Chem. Int. Ed. 2007, 46: 7075.

[0287] Compounds of formula III, wherein R2, G1 and G2 are as defined above in formula I, and LG1 is halogen Br, Cl, I (preferably Cl), can be prepared by metallization of compounds of formula II, wherein R2, G1 and G2 are as defined above in formula I, and LG1 is halogen Br, Cl, I (preferably Cl), with a suitable base, and subsequently reacted with carbon dioxide (Scheme 1). Such metallization reactions can be carried out using a base, such as, for example, an organolithium compound, such as lithium tetramethylpiperidinium, lithium diisopropylamide, or sec-BuLi, at temperatures ranging from -78°C to 40°C, in the presence of a solvent, such as THF, DMPU, dioxane, or 2-methyltetrahydrofuran. Such reactions are reported in the literature, for example, in Tetrahedron 2004, 60(51): 11869-11874.

[0288] Alternatively, compounds of formula I (wherein G1, G2, R2 and Q are as defined above in formula I) can be prepared by following Scheme 3 by subjecting compounds of formula X (wherein G1, G2, R2 and Q are as defined above in formula I) to an amidation reaction.

[0289] Option 3:

[0290]

[0291] The reaction details of the conversion of a compound of formula X (wherein G1, G2, R2 and Q are as defined in formula I) to a compound of formula I (wherein G1, G2, R2 and Q are as defined above in formula I) are illustrated in Scheme 4 and follow the methods and conditions already described in Scheme 2 above.

[0292] Option 4:

[0293]

[0294] Compounds of formula X can be prepared by reacting a compound of formula XII (wherein G1, G2 and R2 are as defined above in formula I) with a compound of formula IX (wherein Q is as defined above in formula I) under reductive amination conditions (see Scheme 4). The reaction can be carried out in the presence of a reducing agent (especially sodium cyanoborohydride or sodium triacetoxyborohydride), and optionally in the presence of an acid (especially trifluoroacetic acid, formic acid or acetic acid), and at a temperature ranging from 0°C to the boiling point of the reaction mixture. The reaction can be carried out in the presence of an inert solvent (such as ethanol, methanol, dioxane or tetrahydrofuran). Such reactions involving the two-step conversion of compounds of formula XII to compounds of formula I have been described in the literature, for example, in Bioorganic & Medicinal Chemistry Letters 2016, 26: 5947-5950.

[0295] Compounds of formula XII, wherein G1, G2 and R2 are as defined above in formula I, can be prepared from compounds of formula XI, wherein G1, G2 and R2 are as defined above in formula I, and LG2 is chlorine, bromine or iodine (preferably bromine), and R is C1-C6 alkyl, benzyl or phenyl, by hydrolysis. The reaction can be carried out under alkaline conditions using a metal hydroxide, for example aqueous sodium hydroxide, in the presence of a solvent such as dioxane, tetrahydrofuran or water, and at a temperature ranging from 20°C to 150°C, as reported in Synlett [Synthesis Letters] 1992, (6), 531-533, or under acidic aqueous conditions, for example using acetic acid, hydrochloric acid or sulfuric acid, in the presence of a solvent such as water, dioxane, or a halogenated solvent such as dichloroethane, as reported in Tetrahedron [Tetrahedron] 2006, 62: 9589-9602. Compounds of formula XI (wherein G1, G2 and R2 are as defined above in formula I, and LG2 is chloro, bromo or iodo (preferably bromo), and R is C1-C6 alkyl, benzyl or phenyl) can be prepared from compounds of formula V (wherein G1, G2 and R2 are as defined above in formula I, and R is C1-C6 alkyl, benzyl or phenyl) by methods and conditions similar to those described in Scheme 1 for converting compounds of formula V to compounds of formula VI.

[0296] Alternatively, compounds of formula I (wherein G1, G2, R2 and Q are as defined above in formula I) can be prepared by

[0297] Option 5:

[0298]

[0299] From the compound of formula XV (wherein G1, G2, R2 and Q are as defined above in formula I) by selective reduction of the carbonyl functional group (Scheme 5). The reaction can be carried out in the presence of a reducing agent (e.g., NaBH4, LiAlH4, palladium on carbon) in the presence of hydrogen, or in the presence of a combination of two reducing agents (e.g., NaBH4, followed by triethylsilane). Such reactions have been described, for example, in US 20100160303 A1.

[0300] Compounds of formula XV (wherein G1, G2, R2 and Q are as defined above in formula I) can be prepared from compounds of formula XIV (wherein G1, G2, R2 and Q are as defined above in formula I and R is C1-C6 alkyl, benzyl or phenyl) by a hydrolysis reaction and subsequent cyclization reaction as described in Scheme 1 for converting a compound of formula X to a compound of formula I.

[0301] Compounds of formula XIV (wherein G1, G2, R2 and Q are as defined above in formula I, and R is C1-C6 alkyl, benzyl or phenyl) can be prepared by reacting compounds of formula XIII (wherein R2, G1 and G2 are as defined above in formula I, and R is C1-C6 alkyl, benzyl or phenyl) with compounds of formula IX (wherein Q is as defined above in formula I) under amidation reaction conditions as already described in Scheme 1.

[0302] Compounds of formula XIII (wherein R2, G1 and G2 are as described above in formula I, and R is C1-C6 alkyl, benzyl or phenyl) can be prepared by oxidation of the benzyl group of compounds of formula V (wherein R2, G1 and G2 are as described above in formula I, and R is C1-C6 alkyl, benzyl or phenyl). The reaction can be carried out in the presence of an oxidizing agent (such as KMNO4, nBu4MnO4, or K2S2O8) in the presence of oxygen, or under photochemical conditions in the presence of oxygen, and at a temperature ranging from 20°C to the boiling point of the reaction mixture. The reaction is carried out in the presence of an inert solvent (such as acetonitrile, ethyl acetate, DMSO or dichloroethane). Reactions of this type are known in the literature, for example in Synthesis 2017, 49: 4007-4016, Synthesis 2006, 1757-1759 and IOSR Journal of Applied Chemistry 2014, 7: 16-27.

[0303] Alternatively, a compound of formula I (wherein R2, G1, G2 and Q are as defined above in formula I),

[0304] Option 6:

[0305]

[0306] Can be prepared by cyclization reaction of compound (wherein R2, G1, G2 and Q are as defined above in formula I, and R is C1-C6 alkyl, benzyl or phenyl) of formula XVII (Scheme 6). This reaction can be in the presence of base (especially such as potassium tert-butoxide, lithium diisopropylamide or sodium hydride), and at a temperature ranging from -20 DEG C to the boiling point of the reaction mixture, and in the presence of inert solvent (such as tetrahydrofuran, dioxane, DMA, DMSO or DMF). Such reaction is reported in, for example, Synlett [Synthesis Express] 2006 (4): 591-594.

[0307] Compounds of formula XVII (wherein R2, G1, G2 and Q are as defined above in formula I and R is C1-C6 alkyl, benzyl or phenyl) can be prepared by reacting compounds of formula XVI (wherein R2, G1 and G2 are as defined above in formula I and R is C1-C6 alkyl, benzyl or phenyl) with compounds of formula IX (wherein Q is as defined above in formula I) under Mitsunobu conditions. Such reactions are well known to those skilled in the art and can be carried out in the presence of a phosphine reagent (especially triphenylphosphine, tributylphosphine or polymer-supported triphenylphosphine) and in the presence of an azodicarboxylate reagent (such as diethyl azodicarboxylate or diisopropyl azodicarboxylate) and in the presence of an inert solvent (such as acetonitrile, dichloromethane, tetrahydrofuran or toluene) at temperatures ranging from 0°C to 100°C. Such reactions are reported, for example, in Synthesis 1981(1):1-28.

[0308] Compounds of formula XVI (wherein R2, G1 and G2 are as defined above in formula I, and R is C1-C6 alkyl, benzyl or phenyl) can be prepared by reacting compounds of formula XIII (wherein R2, G1 and G2 are as defined above in formula I, and R is C1-C6 alkyl, benzyl or phenyl) with a reducing agent, such as, for example, a metal hydride, such as lithium aluminum hydride, DIBAL-H, or a borane, especially diborane or a borane tetrahydrofuran complex, in the presence of an inert solvent, such as tetrahydrofuran or dioxane, at a temperature ranging from 0° C. to 150° C. Such reactions have been reported, for example, in Tetrahedron Letters 1982, 23: 2475-2478.

[0309] Compounds having formula XVII-Qa-1

[0310]

[0311] in

[0312] R2, G1, G2, R3, R4, R1 and X are as defined above in Formula I, and R a is hydrogen, C1-C6 alkyl, benzyl or phenyl) is novel and has been developed in particular for the preparation of compounds of formula I according to the present invention and therefore represents another object of the present invention. The preferences and preferred embodiments of the substituents of the compounds of formula I are also valid for the compounds of formula XVII-Qa-1. Preferably, Ra is hydrogen or C1-C6 alkyl; even more preferably, Ra is hydrogen, methyl or ethyl; most preferably, Ra is hydrogen.

[0313] Compounds of formula IX (wherein Q is as defined above in formula I) can be prepared by

[0314] Option 7:

[0315]

[0316] Compounds of formula XIX, wherein Q is as defined above in formula I, are subjected to a deprotection reaction (BOC group removal) (Scheme 7). The reaction can be carried out in the presence of an acid, such as, in particular, trifluoroacetic acid, hydrochloric acid or sulfuric acid, under the conditions already described above.

[0317] Compounds of formula XIX (wherein Q is as defined above in formula I) can be prepared by reacting a compound of formula XVIII (wherein Q is as defined above in formula I) with an organic azide in the presence of a suitable base and t-butyl alcohol t-BuOH, in the presence of a coupling agent, optionally in the presence of a Lewis acid, and in the presence of an inert solvent at a temperature between 50°C and the boiling point of the reaction mixture. The reaction can be carried out in the presence of a coupling agent such as T3P, or by activating the carboxylic acid with SOCl2 or oxalyl chloride or other coupling agents as described in Scheme 2 for converting compounds of formula X to compounds of formula Xa. Examples of organic azides include TMSN3, sodium azide or tosyl azide, and suitable solvents can be toluene, xylene, THF or acetonitrile. Examples of suitable Lewis acids can include, among others, Zn(OTf)2, Sc(OTf)2 or Cu(OTf)2.

[0318] Compounds of formula XIX can also be prepared by reacting compounds of formula XVIII with diphenylphosphoryl azide in the presence of an organic base, such as, in particular, triethylamine or diisopropylethylamine, in the presence of tert-butyl alcohol, t-BuOH, and an inert solvent, such as, for example, a halogenated solvent, such as dichloromethane, dichloroethane, or a cyclic ether, such as, in particular, tetrahydrofuran, at a temperature ranging from 50° C. to the boiling point of the reaction mixture. Such reactions for converting carboxylic acids into BOC-protected amines are well known to those skilled in the art under the name Curtius reaction and are reported, for example, in Org. Lett. 2005, 7: 4107-4110; J. Med. Chem. 2006, 49(12): 3614-3627; J. Am. Chem. Soc. 1972, 94(17): 6203-6205.

[0319] Compounds of formula IX (wherein Q is as defined above in formula I) can also be prepared from compounds of formula XX (wherein Q is as defined above in formula I) by a Hofmann rearrangement reaction. The reaction can be carried out in the presence of a base (e.g., a metal hydroxide such as aqueous sodium hydroxide or potassium hydroxide, or an organic base such as DBU (1,8-diazabicyclo(5.4.0)undec-7-ene)) and in the presence of an electrophilic halogenating agent such as chlorine, bromine, or N-bromosuccinimide, and at a temperature ranging from 20°C to the boiling point of the reaction mixture. This type of reaction is known by the name Hofmann rearrangement and is reported in the literature, for example, in Chem. Ber. 1881, 14: 2725.

[0320] Compounds of formula XX (wherein Q is as defined above in formula I) can be prepared by reacting compounds of formula XVIII (wherein Q is as defined above in formula I) with ammonia (e.g., NH4OH, NH3, or other ammonia surrogates) in the presence of a carboxylic acid activating agent as described in Scheme 2 above.

[0321] A subgroup of compounds of formula XIX (wherein Q is Qa, wherein R3, R4, X and R1 are as defined in formula I) can be defined as compounds of formula XIX-Qa. Such compounds of formula XIX-Qa

[0322]

[0323] in

[0324] R3, R4, R1 and X are as defined above in formula I, are novel, have been developed in particular for the preparation of compounds of formula I according to the present invention, and therefore represent another object of the present invention. The preferences and preferred embodiments of the substituents of the compounds of formula I are also valid for the compounds of formula XIX-Qa. Most preferably, X is SO2, R1 is ethyl and R3 / R4 are as described in Table Q.

[0325] A subgroup of compounds of formula XVIII (wherein Q is Qa, wherein R3, R4, X and R1 are as defined in formula I) can be defined as compounds of formula XVIII-a (Scheme 8). Such compounds of formula XVIII-a are known in the literature, or they can be prepared by the following Scheme 8 using similar methods and conditions described in, for example, WO 2017 / 061497, WO 2018 / 052136, WO 2019 / 201921, WO 2019 / 175046, WO 2019 / 068572.

[0326] Option 8:

[0327]

[0328] A subgroup of compounds of formula XVIII (wherein Q is Qb, wherein R5, R6, X and R1 are as defined in formula I) can be defined as compounds of formula XVIII-b (Scheme 9). Such compounds of formula XVIII-b are known in the literature, or they can be prepared by the following Scheme 9 using analogous methods and conditions as described, for example, in WO 2016 / 142327, WO 2017 / 001311, Organic & Biomolecular Chemistry 2016, 14(3):895-904, Future Medicinal Chemistry 2017, 9(5):443-468, J. Org. Chem. 1975, 40(21), 3037-3045 and Bioorganic Chemistry 2017, 72:102-115.

[0329] Option 9:

[0330]

[0331] A subset of compounds having Formula I (wherein G1, G2 and R2 are as defined above in Formula I, and wherein Q is defined as Qa, wherein R3, R4, X and R1 are as defined in Formula I) can be defined as compounds having Formula I-Qa (Scheme 10).

[0332] Option 10:

[0333]

[0334] (a) Suzuki reaction: Pd catalyst (e.g., Pd(PPh3)4 or Pd(dppf)Cl2), base (e.g., Na2CO3), solvent (e.g., 1,2-dimethoxyethane / water), 25°C-180b.

[0335] (b) Cyanidation: cyaniding agent (e.g., NaCN, Zn(CN)2, K4[Fe(CN)6]), Pd catalyst (e.g., Pd(PPh3)4 or Pd(dppf)Cl2), base (e.g., Na2CO3), solvent (e.g., 1,2-dimethoxyethane / water), 25°C-180°C.

[0336] (c) CN bond formation: optional base (e.g., K2CO3 or Cs2CO3), optional presence of copper or palladium catalyst, optional additive (e.g., N,N'-dimethylethylenediamine), optional ligand (e.g., Xantphos), solvent (e.g., dioxane, pyridine or N,N-dimethylformamide DMF), 25°C-180°C.

[0337] In the specific case of Scheme 10 when R3 is -N(R7)COR8 (wherein R7 and R8 are as defined in Formula I), then compounds of formula I-Qa (wherein X is SO or SO2) can be prepared from compounds of formula XXXIIIa-1 (wherein R1, R2, G1, G2 and R4 are as defined in Formula I and wherein X is SO or SO2, and wherein Xb is a leaving group such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), or an aryl sulfonate or alkyl sulfonate (such as triflate)) by reaction with a reagent R3-H(XXXIIaa) (equivalent to HN(R7)COR8, wherein R7 and R8 are as defined in Formula I) (CN bond formation). This reaction is carried out in the presence of a base (such as potassium carbonate, cesium carbonate, sodium hydroxide), in an inert solvent (such as toluene, dimethylformamide DMF, N-methylpyrrolidone NMP, dimethyl sulfoxide DMSO, dioxane, tetrahydrofuran THF, etc.), optionally in the presence of a catalyst (such as palladium (II) acetate, bis (dibenzylideneacetone) palladium (0) (Pd (dba) 2) or tris (dibenzylidene-acetone) dipalladium (0) (Pd2 (dba) 3), optionally in the form of a chloroform adduct), or in the presence of a palladium precatalyst (such as tert-BuBrettPhos Pd G3 [(2-di-tert-butylphosphino-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl)-2-(2'-amino-1,1'-biphenyl)] methanesulfonate palladium (II) or BrettPhos Pd G3[(2-di-cyclohexylphosphino-3,6-dimethoxy-2′,4′,6′-triisopropyl-1,1′-diphenyl)-2-(2′-amino-1,1′-biphenyl)]methanesulfonatepalladium(II)), and optionally in the presence of a ligand (e.g. SPhos, t-BuBrettPhos or Xantphos), at a temperature between 60°C and 120°C, optionally under microwave irradiation.

[0338] In the specific case of Scheme 10 when R3 is -N(R7)2 (wherein R7 is as defined in Formula I), then compounds of formula I-Qa (wherein X is SO or SO2) can be prepared from compounds of formula XXXIIIa-1 (wherein R1, R2, G1, G2 and R4 are as defined in Formula I and wherein X is SO or SO2, and wherein Xb is a leaving group such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), or an aryl sulfonate or an alkyl sulfonate (such as trifluoromethanesulfonate)) by reaction with a reagent R3-H(XXXIIaa) (equivalent to HN(R7)2, wherein R7 is as defined in Formula I), or a salt thereof such as a hydrohalide salt, preferably a hydrochloride or hydrobromide salt, or a trifluoroacetate salt, or any other equivalent salt (CN bond formation). Such a reaction is usually carried out in an inert solvent (such as alcohol, amide, ester, ether, nitrile and water, particularly preferably methanol, ethanol, 2,2,2-trifluoroethanol, propanol, isopropanol, N,N-dimethylformamide, N,N-dimethylacetamide, dioxane, tetrahydrofuran, dimethoxyethane, acetonitrile, ethyl acetate, toluene, water or a mixture thereof) at a temperature between 0° C. and 150° C., optionally under microwave irradiation or under pressure using an autoclave, optionally in the presence of a copper catalyst (such as copper powder, copper (I) iodide or copper sulfate (optionally in the form of a hydrate) or a mixture thereof), optionally in the presence of a ligand (such as a diamine ligand (for example, N,N′-dimethylethylenediamine or trans-cyclohexyldiamine) or dibenzylideneacetone (dba) or 1,10-phenanthroline), and optionally in the presence of a base (such as potassium phosphate).

[0339] The reagents HN(R7)2 or HN(R7)COR8 (wherein R7 and R8 are as defined in formula I) are known, commercially available or can be prepared by methods known to those skilled in the art.

[0340] Alternatively, compounds of formula I-Qa (wherein X is SO or SO2) can be prepared by a Suzuki reaction involving, for example, reacting a compound of formula XXXIIIa-1 (wherein R1, R2, G1, G2 and R4 are as defined in formula I, and wherein X is SO or SO2, and wherein X b is a leaving group such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), or an arylsulfonate or alkylsulfonate (such as trifluoromethanesulfonate)) and a compound of formula (XXXII) wherein R3 is as defined in formula I, and wherein Y b1 It can be a boron-derived functional group such as B(OH)2 or B(OR b1 )2, where R b1 It can be a C1-C4 alkyl group, or two groups OR b1The reaction can be catalyzed by a palladium-based catalyst (e.g., tetrakis(triphenylphosphine)palladium(0), (1,1'-bis(diphenylphosphino)ferrocene)dichloro-palladium-dichloromethane (1:1 complex) or chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (XPhos palladacycle complex)) in the presence of a base (e.g., sodium carbonate, tripotassium phosphate or cesium fluoride) in a solvent or solvent mixture (e.g., dioxane, acetonitrile, N,N-dimethylformamide, a mixture of 1,2-dimethoxyethane and water or a mixture of dioxane / water or a mixture of toluene / water), preferably under an inert atmosphere. The reaction temperature may preferably be in the range of from room temperature to the boiling point of the reaction mixture, or the reaction may be carried out under microwave irradiation. Such Suzuki reactions are well known to those skilled in the art and have been reviewed in, for example, J. Organomet. Chem. 576, 1999, 147-168.

[0341] When R3 is cyano, it has the formula IQ a Compounds of formula XXXIIIa-1 (wherein R1, R2, G1, G2 and R4 are as defined in formula I, and wherein X is SO or SO2, and wherein X is SO or SO2) can be obtained by reaction with M-CN XXXIIa (wherein M is a metal coordinated to cyanide). bThe cyaniding agent can be prepared by using a leaving group such as chlorine, bromine or iodine (preferably chlorine or bromine), or an arylsulfonate or alkylsulfonate (such as trifluoromethanesulfonate). Examples of cyaniding agents include NaCN, Zn(CN)2, potassium ferrocyanide. The reaction can be catalyzed by a palladium-based catalyst such as tetrakis(triphenylphosphine)palladium(0), (1,1'bis(diphenylphosphino)ferrocene)dichloro-palladium-dichloromethane (1:1 complex) or chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (XPhos palladacycle complex) in the presence of a base such as sodium carbonate, tripotassium phosphate or cesium fluoride in a solvent or solvent mixture such as, for example, dioxane, acetonitrile, N,N-dimethylformamide, a mixture of 1,2-dimethoxyethane and water or a mixture of dioxane / water or a mixture of toluene / water, preferably under an inert atmosphere. The reaction temperature can preferably be in the range from room temperature to the boiling point of the reaction mixture, or the reaction can be carried out under microwave irradiation. Such reactions are well known to those skilled in the art and are described in Org. Lett. 2011, 13: 648-651, J. Org. Chem. 2017, 82: 7040-7044.

[0342] A compound of formula XXXIa-1 (wherein R1, R2, G1, G2 and R4 are as defined in formula I, and wherein X is S, and wherein X b Oxidation of a leaving group such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), or an arylsulfonate or alkylsulfonate (such as triflate) to a compound having XXXIIIa-1 (wherein X is SO or SO2) with a suitable oxidizing agent can be achieved under the conditions already described above.

[0343] A large number of compounds of formula (XXXII), (XXXIIa) and (XXXIIaa) are commercially available or can be prepared by one skilled in the art.

[0344] Alternatively, compounds of formula I-Qa, wherein X is SO or SO2, can be prepared from compounds of formula XXXIa-1, wherein X is S (sulfide), by involving the same chemical process as described above but by changing the order of the steps (i.e., by running the sequence XXXIa-1 (X is S) to I-Qa (X is S) via Suzuki reaction, cyanation reaction, or CN bond formation, followed by an oxidation step to form I-Qa (X is SO or SO2)).

[0345] A subset of compounds having Formula I (wherein G1, G2 and R2 are as defined above in Formula I, and wherein Q is defined as Qa, wherein R3, R4, X and R1 are as defined in Formula I) can be defined as compounds having Formula I-Qa (Scheme 11).

[0346] Option 11:

[0347]

[0348] (a) Suzuki reaction: Pd catalyst (e.g., Pd(PPh3)4 or Pd(dppf)Cl2), base (e.g., Na2CO3), solvent (e.g., 1,2-dimethoxyethane / water), 25°C-180°C.

[0349] (b) Cyanidation: cyaniding agent (e.g., NaCN, Zn(CN)2, K4[Fe(CN)6]), Pd catalyst (e.g., Pd(PPh3)4 or Pd(dppf)Cl2), base (e.g., Na2CO3), solvent (e.g., 1,2-dimethoxyethane / water), 25°C-180°C.

[0350] (c) CN bond formation: optional base (e.g., K2CO3 or Cs2CO3), optional presence of copper or palladium catalyst, optional additive (e.g., N,N'-dimethylethylenediamine), optional ligand (e.g., Xantphos), solvent (e.g., dioxane, pyridine or N,N-dimethylformamide DMF), 25°C-180°C.

[0351] The chemical process previously described in Scheme 10 for obtaining compounds of formula I-Qa from compounds of formula XXXIa-1 can be analogously applied to the preparation of compounds of formula I-Qa from compounds of formula XXXIa-2 (Scheme 11), wherein all substituent definitions mentioned previously remain valid.

[0352] A subset of compounds having Formula I, wherein G1, G2, and R2 are as defined above in Formula I, and wherein Q is defined as Qb, wherein R5, R6, X, and R1 are as defined in Formula I, can be defined as compounds having Formula I-Qb (Scheme 12).

[0353] Option 12:

[0354]

[0355] (a) Suzuki reaction: Pd catalyst (e.g., Pd(PPh3)4 or Pd(dppf)Cl2), base (e.g., Na2CO3), solvent (e.g., 1,2-dimethoxyethane / water), 25°C-180°C.

[0356] (b) Cyanidation: cyaniding agent (e.g., NaCN, Zn(CN)2, K4[Fe(CN)6]), Pd catalyst (e.g., Pd(PPh3)4 or Pd(dppf)Cl2), base (e.g., Na2CO3), solvent (e.g., 1,2-dimethoxyethane / water), 25°C-180°C.

[0357] (c) CN bond formation: optional base (e.g., K2CO3 or Cs2CO3), optional presence of copper or palladium catalyst, optional additive (e.g., N,N'-dimethylethylenediamine), optional ligand (e.g., Xantphos), solvent (e.g., dioxane, pyridine or N,N-dimethylformamide DMF), 25°C-180°C.

[0358] The chemical process previously described in Scheme 10 for obtaining compounds of Formula I-Qa from compounds of Formula XXXIa-1 can be analogously applied to prepare compounds of Formula I-Qb from compounds of Formula XXXIVb-1 (Scheme 12), wherein all substituent definitions mentioned previously remain valid.

[0359] A subset of compounds having Formula I (wherein G1, G2 and R2 are as defined above in Formula I, and wherein Q is defined as Qb, wherein R5, R6, X and R1 are as defined in Formula I) can be defined as compounds having Formula I-Qb (Scheme 13).

[0360] Option 13:

[0361]

[0362] (a) Suzuki reaction: Pd catalyst (e.g., Pd(PPh3)4 or Pd(dppf)Cl2), base (e.g., Na2CO3), solvent (e.g., 1,2-dimethoxyethane / water), 25°C-180°C.

[0363] (b) Cyanidation: cyaniding agent (e.g., NaCN, Zn(CN)2, K4[Fe(CN)6]), Pd catalyst (e.g., Pd(PPh3)4 or Pd(dppf)Cl2), base (e.g., Na2CO3), solvent (e.g., 1,2-dimethoxyethane / water), 25°C-180°C.

[0364] (c) CN bond formation: optional base (e.g., K2CO3 or Cs2CO3), optional presence of copper or palladium catalyst, optional additive (e.g., N,N'-dimethylethylenediamine), optional ligand (e.g., Xantphos), solvent (e.g., dioxane, pyridine or N,N-dimethylformamide DMF), 25°C-180°C.

[0365] The chemical process previously described in Scheme 11 to obtain compounds of Formula I-Qa from compounds of Formula XXXIa-2 can be similarly applied to prepare compounds of Formula I-Qb from compounds of Formula XXXIVb-2 (Scheme 13), wherein all substituent definitions mentioned previously remain valid.

[0366] A subgroup of compounds of formula I wherein G1, G2 and R2 are as defined in formula I and wherein Q is defined as Qa, wherein R4, X and R1 are as defined in formula I, and wherein R3 is C1-C4 alkoxy or C1-C6 haloalkoxy can be defined as compounds of formula I-Qa-O3 wherein Ry is C1-C4 alkyl or C1-C6 haloalkyl (Scheme 14). Similarly, a subgroup of compounds of formula I wherein G1, G2 and R2 are as defined in formula I and wherein Q is defined as Qa, wherein R4, X and R1 are as defined in formula I, and wherein R3 is 1-cyano-1-methyl-ethoxy can be defined as compounds of formula I-Qa-O5.

[0367] Option 14:

[0368]

[0369] Compounds of formula I-Qa-O3 (wherein R4, X, R1, G1, G2 and R2 are as defined in formula I and wherein Ry is C1-C4 alkyl or C1-C6 haloalkyl) can be prepared by, for example, 18 / 197315, in the presence of a base (such as sodium hydride, potassium carbonate, or cesium carbonate), in an inert solvent (such as dioxane, tetrahydrofuran, N,N-dimethylformamide or acetonitrile), at a temperature between 0°C and 120°C, preferably between 20°C and 80°C, a compound of formula I-Qa-O2 (wherein R4, X, R1, G1, G2 and R2 are as defined in formula I) is reacted with an alkylating agent of formula Ry-LG4 (wherein Ry is C1-C4 alkyl or C1-C6 haloalkyl and LG4 is halogen, preferably iodine, bromine or chlorine (or a pseudohalogen leaving group, such as trifluoromethanesulfonate)). It is known to those skilled in the art that when performing difluoromethylation to generate a compound of formula I-Qa-O3 (wherein Ry is CHF2), sodium 2-chloro-2,2-difluoroacetate (etc.) can be used instead of an alkylating agent of formula Ry-LG4 as the difluoromethylating agent.

[0370] Compounds of formula I-Qa-O2, wherein R4, X, R1, G1, G2 and R2 are as defined in formula I, can be prepared by ether cleavage (O-demethylation) of compounds of formula I-Qa-O1, wherein R4, X, R1, G1, G2 and R2 are as defined in formula I, in the presence of hydrogen bromide or hydrogen iodide in acetic acid, or concentrated hydrobromic acid or hydroiodic acid, or alternatively in the presence of a Lewis acid such as boron tribromide BBr3, in an inert solvent such as pentane, hexane or dichloromethane, and at a temperature between -80°C and 40°C, preferably between -20°C and 30°C.

[0371] Compounds of formula I-Qa-O1, wherein R4, X, R1, G1, G2, and R2 are as defined in formula I, represent a subgroup of compounds of formula I, wherein R4, X, R1, G1, G2, and R2 are as defined in formula I, and wherein R3 is -OCH3. Such compounds of formula I-Qa-O1 can be prepared by the methods described above.

[0372] Reagents of formula Ry-LG4, wherein Ry is C1-C4 alkyl or C1-C6 haloalkyl and LG4 is halogen, preferably iodine, bromine or chlorine (or a pseudohalogen leaving group such as trifluoromethanesulfonate), and alternatives thereof such as sodium 2-chloro-2,2-difluoroacetate are known, commercially available or can be prepared by methods known to those skilled in the art.

[0373] Compounds of formula I-Qa-O5, wherein R4, X, R1, G1, G2 and R2 are as defined in formula I, can be prepared by reacting compounds of formula I-Qa-O4, wherein R4, X, R1, G1, G2 and R2 are as defined in formula I, with a dehydrating agent, such as trifluoroacetic acid, trifluoroacetic anhydride, phosphorus pentoxide, thionyl chloride or phosphorus oxychloride, under dehydrating conditions as described, for example, in WO 20 / 084075, optionally in the presence of a base, such as triethylamine or pyridine, in a suitable solvent, such as, for example, dichloromethane, tetrahydrofuran, dioxane or N,N-dimethylformamide, at temperatures between 0°C and 180°C, preferably between 5°C and 80°C (Scheme 14).

[0374] Compounds of formula I-Qa-O4, wherein R4, X, R1, G1, G2 and R2 are as defined in formula I, can be prepared by reacting compounds of formula I-Qa-O2, wherein R4, X, R1, G1, G2 and R2 are as defined in formula I, with a reagent of formula XXXVI, wherein LG5 is a halogen leaving group, such as iodine, bromine or chlorine, preferably bromine, in the presence of a base, such as, for example, lithium hydroxide, sodium hydroxide or potassium hydroxide, sodium hydride, potassium carbonate or cesium carbonate, in a suitable solvent, such as acetone, dioxane, acetonitrile, N,N-dimethylformamide or N,N-dimethylacetamide, at a temperature between -10°C and 100°C, preferably between 0°C and 80°C.

[0375] Reagents of formula XXXVI, wherein LG5 is a halogen leaving group such as iodine, bromine or chlorine (preferably bromine), are known, commercially available or can be prepared by methods known to those skilled in the art.

[0376] Similar considerations as shown in Scheme 14 can be applied when the substituents at positions R3 and R4 are reversed to obtain isomeric compounds of formula I-Qa-O6 and I-Qa-O7,

[0377]

[0378] All substituent definitions mentioned previously therein remain valid.

[0379] The reactants may be reacted in the presence of a base. Examples of suitable bases are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkali metal or alkaline earth metal alkylsilylamides, alkylamines, alkylenediamines, free or N-alkylated saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxide, and carbocyclic amines. Examples that may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU).

[0380] These reactants can react with each other as is, i.e. without adding solvents or diluents. However, in most cases, it is advantageous to add inert solvents or diluents or mixtures thereof. If the reaction is carried out in the presence of a base, the base used in excess (e.g., triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline) can also serve as a solvent or diluent.

[0381] These reactions are advantageously carried out in a temperature range of from about -80°C to about +140°C, preferably from about -30°C to about +100°C, in many cases in a range between ambient temperature and about +80°C.

[0382] A compound of formula I can be converted into another compound of formula I in a manner known per se by replacing one or more substituents of the starting compound of formula I with further or additional substituent(s) according to the invention in a conventional manner and by subsequent modification of the compound by reactions such as oxidation, alkylation, reduction, acylation and other methods known to those skilled in the art.

[0383] Depending on the reaction conditions and starting materials chosen as appropriate in the respective case, it is possible, for example, to replace only one substituent with another substituent according to the invention in one reaction step or to replace several substituents with other substituents according to the invention in one and the same reaction step.

[0384] Salts of compounds of formula I can be prepared in a manner known per se. Thus, for example, acid addition salts of compounds of formula I are obtained by treatment with a suitable acid or a suitable ion exchanger reagent, and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.

[0385] Salts of compounds of the formula I can be converted in a customary manner into the free compounds I, acid addition salts (for example by treatment with suitable basic compounds or with suitable ion exchange reagents) and salts with bases (for example by treatment with suitable acids or with suitable ion exchange reagents).

[0386] Salts of compounds of the formula I can be converted in a manner known per se into other salts, acid addition salts of compounds of the formula I, for example into other acid addition salts, for example by treating salts of inorganic acids (such as hydrochlorides) with suitable metal salts of the acid (such as sodium, barium or silver salts, for example with silver acetate) in a suitable solvent in which the inorganic salt formed (such as silver chloride) is insoluble and therefore precipitates from the reaction mixture.

[0387] Depending on the procedure or reaction conditions, those compounds of the formula I which have salt-forming properties can be obtained in free form or in the form of salts.

[0388] Depending on the number of asymmetric carbon atoms present in the molecule, the absolute and relative configuration and / or on the configuration of non-aromatic double bonds present in the molecule, the compounds of the formula I and, where appropriate, their tautomers (in each case in free form or in salt form) may be present in the form of one of the possible isomers or as a mixture of these, for example in the form of pure isomers, such as enantiomers and / or diastereomers, or as isomer mixtures, such as enantiomeric mixtures, for example racemates, diastereomeric mixtures or racemic mixtures; the present invention relates to the pure isomers and also to all possible isomer mixtures, and the above and below are to be understood as such in each case, even if stereochemical details are not explicitly mentioned in each case.

[0389] Diastereomeric mixtures or racemic mixtures of compounds of formula I in free form or in salt form, the acquisition of which may depend on the starting materials and procedures chosen, can be separated in a known manner into the pure diastereomers or racemates on the basis of the physicochemical differences of the components, for example, by fractional crystallization, distillation and / or chromatography.

[0390] Enantiomeric mixtures obtainable in an analogous manner (e.g., racemates) can be resolved into the optical antipodes by known methods, for example, by recrystallization from optically active solvents; by chromatography on chiral adsorbents, for example, high performance liquid chromatography (HPLC) on acetylcellulose; by cleavage with specific immobilized enzymes with the aid of suitable microorganisms; by forming inclusion compounds, for example, using chiral crown ethers, in which only one enantiomer is complexed; or by conversion into diastereomeric salts, for example, by reacting the basic end product racemate with an optically active acid (e.g., a carboxylic acid, for example, camphoric acid, tartaric acid or malic acid, or a sulfonic acid, for example, camphorsulfonic acid) and separating the diastereomeric mixtures obtainable in this way, for example, by fractional crystallization on the basis of their different solubilities, thereby obtaining the diastereomers from which the desired enantiomer can be freed by the action of suitable reagents, for example, basic reagents.

[0391] Pure diastereomers or enantiomers can be obtained according to the invention not only by separation of the appropriate isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the method according to the invention with starting materials having the appropriate stereochemistry.

[0392] N-oxides can be prepared by reacting a compound of formula I with a suitable oxidizing agent (e.g. H O / urea adduct) in the presence of an anhydride (e.g. trifluoroacetic anhydride). Such oxidations are known from the literature, for example from J. Med. Chem., 32 (12), 2561-73, 1989 or WO 2000 / 15615.

[0393] If the individual components have different biological activities, it is advantageous to isolate or synthesize the biologically more effective isomers, such as enantiomers or diastereomers or isomer mixtures, such as enantiomeric mixtures or diastereomeric mixtures, in each case.

[0394] If appropriate, the compounds of formula I and, where appropriate, their tautomers (in each case in free form or in salt form) can also be obtained in the form of hydrates and / or include other solvents, such as those which can be used for crystallization of compounds present in solid form.

[0395] The compounds according to the following Tables A-1 to A-12, B-1 to B-12, C-1 to C-18, D-1 to D-18, E-1 to E-12, F-1 to F-12, G-1 to G-18, and H-1 to H-18 can be prepared according to the methods described above. The following examples are intended to illustrate the present invention and show preferred compounds of formula I.

[0396] The following Tables A-1 to A-12 show specific compounds of the present invention.

[0397]

[0398] Table A-1 provides 17 compounds A-1.001 to A-1.017 of formula Ia-Qa, wherein G1 is N, G2 is N, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0399] Table Y : Definition of substituents of R3:

[0400]

[0401] Table A-2 provides 17 compounds A-2.001 to A-2.017 of formula Ia-Qa, wherein G1 is N, G2 is N, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0402] Table A-3 provides 17 compounds A-3.001 to A-3.017 of formula Ia-Qa, wherein G1 is N, G2 is N, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0403] Table A-4 provides 17 compounds A-4.001 to A-4.017 of formula Ia-Qa, wherein G1 is N, G2 is CH, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0404] Table A-5 provides 17 compounds A-5.001 to A-5.017 of formula Ia-Qa, wherein G1 is N, G2 is CH, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0405] Table A-6 provides 17 compounds A-6.001 to A-6.017 of formula Ia-Qa, wherein G1 is N, G2 is CH, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0406] Table A-7 provides 17 compounds A-7.001 to A-7.017 of formula Ia-Qa, wherein G1 is CH, G2 is N, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0407] Table A-8 provides 17 compounds A-8.001 to A-8.017 of formula Ia-Qa, wherein G1 is CH, G2 is N, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0408] Table A-9 provides 17 compounds A-9.001 to A-9.017 of formula Ia-Qa, wherein G1 is CH, G2 is N, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0409] Table A-10 provides 17 compounds A-10.001 to A-10.017 of formula Ia-Qa, wherein G1 is CH, G2 is CH, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0410] Table A-11 provides 17 compounds A-11.001 to A-11.017 of formula Ia-Qa, wherein G1 is CH, G2 is CH, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0411] Table A-12 provides 17 compounds A-12.001 to A-12.017 of formula Ia-Qa, wherein G1 is CH, G2 is CH, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0412] Tables B-1 to B-12 below show additional specific compounds of the present invention.

[0413]

[0414] Table B-1 provides 17 compounds B-1.001 to B-1.017 of formula Ib-Qa, wherein G1 is N, G2 is N, R1 is ethyl, X is S and R4 is as defined in Table Z.

[0415] Table Z : Definition of substituents of R4:

[0416]

[0417] Table B-2 provides 17 compounds B-2.001 to B-2.017 of formula Ib-Qa, wherein G1 is N, G2 is N, R1 is ethyl, X is SO and R4 is as defined in Table Z.

[0418] Table B-3 provides 17 compounds B-3.001 to B-3.017 of formula Ib-Qa, wherein G1 is N, G2 is N, R1 is ethyl, X is SO2 and R4 is as defined in Table Z.

[0419] Table B-4 provides 17 compounds B-4.001 to B-4.017 of formula Ib-Qa, wherein G1 is N, G2 is CH, R1 is ethyl, X is S and R4 is as defined in Table Z.

[0420] Table B-5 provides 17 compounds B-5.001 to B-5.017 of formula Ib-Qa, wherein G1 is N, G2 is CH, R1 is ethyl, X is SO and R4 is as defined in Table Z.

[0421] Table B-6 provides 17 compounds B-6.001 to B-6.017 of formula Ib-Qa, wherein G1 is N, G2 is CH, R1 is ethyl, X is SO2 and R4 is as defined in Table Z.

[0422] Table B-7 provides 17 compounds B-7.001 to B-7.017 of formula Ib-Qa, wherein G1 is CH, G2 is N, R1 is ethyl, X is S and R4 is as defined in Table Z.

[0423] Table B-8 provides 17 compounds B-8.001 to B-8.017 of formula Ib-Qa, wherein G1 is CH, G2 is N, R1 is ethyl, X is SO and R4 is as defined in Table Z.

[0424] Table B-9 provides 17 compounds B-9.001 to B-9.017 of formula Ib-Qa, wherein G1 is CH, G2 is N, R1 is ethyl, X is SO2 and R4 is as defined in Table Z.

[0425] Table B-10 provides 17 compounds B-10.001 to B-10.017 of formula Ia-Qa, wherein G1 is CH, G2 is CH, R1 is ethyl, X is S and R4 is as defined in Table Z.

[0426] Table B-11 provides 17 compounds B-11.001 to B-11.017 of formula Ib-Qa, wherein G1 is CH, G2 is CH, R1 is ethyl, X is SO and R4 is as defined in Table Z.

[0427] Table B-12 provides 17 compounds B-12.001 to B-12.017 of formula Ib-Qa, wherein G1 is CH, G2 is CH, R1 is ethyl, X is SO2 and R4 is as defined in Table Z.

[0428] Tables C-1 to C-18 below show additional specific compounds of the present invention.

[0429]

[0430] Table C-1 provides 17 compounds C-1.001 to C-1.017 of formula Ic-Qa, wherein R2 is SCF3, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0431] Table C-2 provides 17 compounds C-2.001 to C-2.017 of formula Ic-Qa, wherein R2 is SCF3, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0432] Table C-3 provides 17 compounds C-3.001 to C-3.017 of formula Ic-Qa, wherein R2 is SCF3, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0433] Table C-4 provides 17 compounds C-4.001 to C-4.017 of formula Ic-Qa, wherein R2 is SOCF3, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0434] Table C-5 provides 17 compounds C-5.001 to C-5.017 of formula Ic-Qa, wherein R2 is SOCF3, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0435] Table C-6 provides 17 compounds C-6.001 to C-6.017 of formula Ic-Qa, wherein R2 is SOCF3, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0436] Table C-7 provides 17 compounds C-7.001 to C-7.017 of formula Ic-Qa, wherein R2 is SO2CF3, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0437] Table C-8 provides 17 compounds C-8.001 to C-8.017 of formula Ic-Qa, wherein R2 is SO2CF3, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0438] Table C-9 provides 17 compounds C-9.001 to C-9.017 of formula Ic-Qa, wherein R2 is SO2CF3, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0439] Table C-10 provides 17 compounds C-10.001 to C-10.017 of formula Ic-Qa, wherein R2 is OSO2CF3, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0440] Table C-11 provides 17 compounds C-11.001 to C-11.017 of formula Ic-Qa, wherein R2 is OSO2CF3, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0441] Table C-12 provides 17 compounds C-12.001 to C-12.017 of formula Ic-Qa, wherein R2 is OSO2CF3, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0442] Table C-13 provides 17 compounds C-13.001 to C-13.017 of formula Ic-Qa, wherein R2 is OCF3, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0443] Table C-14 provides 17 compounds C-14.001 to C-14.017 of formula Ic-Qa, wherein R2 is OCF3, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0444] Table C-15 provides 17 compounds C-15.001 to C-15.017 of formula Ic-Qa, wherein R2 is OCF3, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0445] Table C-16 provides 17 compounds C-16.001 to C-16.017 of formula Ic-Qa, wherein R2 is OCHF2, R1 is ethyl, X is S and R3 is as defined in Table Y.

[0446] Table C-17 provides 17 compounds C-17.001 to C-17.017 of formula Ic-Qa, wherein R2 is OCHF2, R1 is ethyl, X is SO and R3 is as defined in Table Y.

[0447] Table C-18 provides 17 compounds C-18.001 to C-18.017 of formula Ic-Qa, wherein R2 is OCHF2, R1 is ethyl, X is SO2 and R3 is as defined in Table Y.

[0448] Tables D-1 to D-18 below present additional specific compounds of the present invention.

[0449]

[0450] Table D-1 provides 17 compounds D-1.001 to D-1.017 of formula Id-Qa, wherein R1 is ethyl, X is S, R2 is SCF3 and R4 is as defined in Table Z.

[0451] Table D-2 provides 17 compounds D-2.001 to D-2.017 of formula Id-Qa, wherein R1 is ethyl, X is S, R2 is SOCF3 and R4 is as defined in Table Z.

[0452] Table D-3 provides 17 compounds D-3.001 to D-3.017 of formula Id-Qa, wherein R1 is ethyl, X is S, R2 is SO2CF3 and R4 is as defined in Table Z.

[0453] Table D-4 provides 17 compounds D-4.001 to D-4.017 of formula Id-Qa, wherein R1 is ethyl, X is S, R2 is OSO2CF3 and R4 is as defined in Table Z.

[0454] Table D-5 provides 17 compounds D-5.001 to D-5.017 of formula Id-Qa, wherein R1 is ethyl, X is S, R2 is OCF3 and R4 is as defined in Table Z.

[0455] Table D-6 provides 17 compounds D-6.001 to D-6.017 of formula Id-Qa, wherein R1 is ethyl, X is SO, R2 is SCF3, and R4 is as defined in Table Z.

[0456] Table D-7 provides 17 compounds D-7.001 to D-7.017 of formula Id-Qa, wherein R1 is ethyl, X is SO, R2 is SOCF3, and R4 is as defined in Table Z.

[0457] Table D-8 provides 17 compounds D-8.001 to D-8.017 of formula Id-Qa, wherein R1 is ethyl, X is SO, R2 is SO2CF3 and R4 is as defined in Table Z.

[0458] Table D-9 provides 17 compounds D-9.001 to D-9.017 of formula Id-Qa, wherein R1 is ethyl, X is SO, R2 is OSO2CF3 and R4 is as defined in Table Z.

[0459] Table D-10 provides 17 compounds D-10.001 to D-10.017 of formula Id-Qa, wherein R1 is ethyl, X is SO, R2 is OCF3 and R4 is as defined in Table Z.

[0460] Table D-11 provides 17 compounds D-11.001 to D-11.017 of formula Id-Qa, wherein R1 is ethyl, X is SO2, R2 is SCF3 and R4 is as defined in Table Z.

[0461] Table D-12 provides 17 compounds D-12.001 to D-12.017 of formula Id-Qa, wherein R1 is ethyl, X is SO2, R2 is SOCF3 and R4 is as defined in Table Z.

[0462] Table D-13 provides 17 compounds D-13.001 to D-13.017 of formula Id-Qa, wherein R1 is ethyl, X is SO2, R2 is SO2CF3 and R4 is as defined in Table Z.

[0463] Table D-14 provides 17 compounds D-14.001 to D-14.017 of formula Id-Qa, wherein R1 is ethyl, X is SO2, R2 is OSO2CF3 and R4 is as defined in Table Z.

[0464] Table D-15 provides 17 compounds D-15.001 to D-15.017 of formula Id-Qa, wherein R1 is ethyl, X is SO2, R2 is OCF3 and R4 is as defined in Table Z.

[0465] Table D-16 provides 17 compounds D-16.001 to D-16.017 of formula Id-Qa, wherein R1 is ethyl, X is S, R2 is OCHF2, and R4 is as defined in Table Z.

[0466] Table D-17 provides 17 compounds D-17.001 to D-17.017 of formula Id-Qa, wherein R1 is ethyl, X is SO, R2 is OCHF2, and R4 is as defined in Table Z.

[0467] Table D-18 provides 17 compounds D-18.001 to D-18.017 of formula Id-Qa, wherein R1 is ethyl, X is SO2, R2 is OCHF2 and R4 is as defined in Table Z.

[0468] Tables E-1 to E-12 below present additional specific compounds of the present invention.

[0469]

[0470] Table E-1 provides 17 compounds E-1.001 to E-1.017 of formula Ia-Qb, wherein X is S, R1 is ethyl, G1 is N, G2 is N and R5 is as defined in Table V.

[0471] Table V : Definition of substituents of R5:

[0472]

[0473] Table E-2 provides 17 compounds E-2.001 to E-2.017 of formula Ia-Qb, wherein X is S, R1 is ethyl, G1 is N, G2 is CH and R5 is as defined in Table V.

[0474] Table E-3 provides 17 compounds E-3.001 to E-3.017 of formula Ia-Qb, wherein X is S, R1 is ethyl, G1 is CH, G2 is N and R5 is as defined in Table V.

[0475] Table E-4 provides 17 compounds E-4.001 to E-4.017 of formula Ia-Qb, wherein X is S, R1 is ethyl, G1 is CH, G2 is CH and R5 is as defined in Table V.

[0476] Table E-5 provides 17 compounds E-5.001 to E-5.017 of formula Ia-Qb, wherein X is SO, R1 is ethyl, G1 is N, G2 is N, and R5 is as defined in Table V.

[0477] Table E-6 provides 17 compounds E-6.001 to E-6.017 of formula Ia-Qb, wherein X is SO, R1 is ethyl, G1 is N, G2 is CH and R5 is as defined in Table V.

[0478] Table E-7 provides 17 compounds E-7.001 to E-7.017 of formula Ia-Qb, wherein X is SO, R1 is ethyl, G1 is CH, G2 is N and R5 is as defined in Table V.

[0479] Table E-8 provides 17 compounds E-8.001 to E-8.017 of formula Ia-Qb, wherein X is SO, R1 is ethyl, G1 is CH, G2 is CH and R5 is as defined in Table V.

[0480] Table E-9 provides 17 compounds E-9.001 to E-9.017 of formula Ia-Qb, wherein X is SO2, R1 is ethyl, G1 is N, G2 is N and R5 is as defined in Table V.

[0481] Table E-10 provides 17 compounds E-10.001 to E-10.017 of formula Ia-Qb, wherein X is SO2, R1 is ethyl, G1 is N, G2 is CH and R5 is as defined in Table V.

[0482] Table E-11 provides 17 compounds E-11.001 to E-11.017 of formula Ia-Qb, wherein X is SO2, R1 is ethyl, G1 is CH, G2 is N and R5 is as defined in Table V.

[0483] Table E-12 provides 17 compounds E-12.001 to E-12.017 of formula Ia-Qb, wherein X is SO2, R1 is ethyl, G1 is CH, G2 is CH and R5 is as defined in Table V.

[0484] Tables F-1 to F-12 below present additional specific compounds of the present invention.

[0485]

[0486] Table F-1 provides 17 compounds F-1.001 to F-1.017 of formula Ib-Qb, wherein X is S, R1 is ethyl, G1 is N, G2 is N and R6 is as defined in Table W.

[0487] Table W : Definition of substituents for R6:

[0488]

[0489] Table F-2 provides 17 compounds F-2.001 to F-2.017 of formula Ib-Qb, wherein X is S, R1 is ethyl, G1 is N, G2 is CH and R6 is as defined in Table W.

[0490] Table F-3 provides 17 compounds F-3.001 to F-3.017 of formula Ib-Qb, wherein X is S, R1 is ethyl, G1 is CH, G2 is N and R6 is as defined in Table W.

[0491] Table F-4 provides 17 compounds F-4.001 to F-4.017 of formula Ib-Qb, wherein X is S, R1 is ethyl, G1 is CH, G2 is CH and R6 is as defined in Table W.

[0492] Table F-5 provides 17 compounds F-5.001 to F-5.017 of formula Ib-Qb, wherein X is SO, R1 is ethyl, G1 is N, G2 is N and R6 is as defined in Table W.

[0493] Table F-6 provides 17 compounds F-6.001 to F-6.017 of formula Ib-Qb, wherein X is SO, R1 is ethyl, G1 is N, G2 is CH and R6 is as defined in Table W.

[0494] Table F-7 provides 17 compounds F-7.001 to F-7.017 of formula Ib-Qb, wherein X is SO, R1 is ethyl, G1 is CH, G2 is N and R6 is as defined in Table W.

[0495] Table F-8 provides 17 compounds F-8.001 to F-8.017 of formula Ib-Qb, wherein X is SO, R1 is ethyl, G1 is CH, G2 is CH and R6 is as defined in Table W.

[0496] Table F-9 provides 17 compounds F-9.001 to F-9.017 of formula Ib-Qb, wherein X is SO2, R1 is ethyl, G1 is N, G2 is N and R6 is as defined in Table W.

[0497] Table F-10 provides 17 compounds F-10.001 to F-10.017 of formula Ib-Qb, wherein X is SO2, R1 is ethyl, G1 is N, G2 is CH and R6 is as defined in Table W.

[0498] Table F-11 provides 17 compounds F-11.001 to F-11.017 of formula Ib-Qb, wherein X is SO2, R1 is ethyl, G1 is CH, G2 is N and R6 is as defined in Table W.

[0499] Table F-12 provides 17 compounds F-12.001 to F-12.017 of formula Ib-Qb, wherein X is SO2, R1 is ethyl, G1 is CH, G2 is CH and R6 is as defined in Table W.

[0500] Tables G-1 to G-18 below present additional specific compounds of the present invention.

[0501]

[0502] Table G-1 provides 17 compounds G-1.001 to G-1.017 of formula Ic-Qb, wherein X is S, R1 is ethyl, R2 is SCF3 and R5 is as defined in Table V.

[0503] Table G-2 provides 17 compounds G-2.001 to G-2.017 of formula Ic-Qb, wherein X is S, R1 is ethyl, R2 is SOCF3 and R5 is as defined in Table V.

[0504] Table G-3 provides 17 compounds G-3.001 to G-3.017 of formula Ic-Qb, wherein X is S, R1 is ethyl, R2 is SO2CF3 and R5 is as defined in Table V.

[0505] Table G-4 provides 17 compounds G-4.001 to G-4.017 of formula Ic-Qb, wherein X is S, R1 is ethyl, R2 is OSO2CF3 and R5 is as defined in Table V.

[0506] Table G-5 provides 17 compounds G-5.001 to G-5.017 of formula Ic-Qb, wherein X is S, R1 is ethyl, R2 is OCF3 and R5 is as defined in Table V.

[0507] Table G-6 provides 17 compounds G-6.001 to G-6.017 of formula Ic-Qb, wherein X is SO, R1 is ethyl, R2 is SCF3 and R5 is as defined in Table V.

[0508] Table G-7 provides 17 compounds G-7.001 to G-7.017 of formula Ic-Qb, wherein X is SO, R1 is ethyl, R2 is SOCF3 and R5 is as defined in Table V.

[0509] Table G-8 provides 17 compounds G-8.001 to G-8.017 of formula Ic-Qb, wherein X is SO, R1 is ethyl, R2 is SO2CF3 and R5 is as defined in Table V.

[0510] Table G-9 provides 17 compounds G-9.001 to G-9.017 of formula Ic-Qb, wherein X is SO, R1 is ethyl, R2 is OSO2CF3 and R5 is as defined in Table V.

[0511] Table G-10 provides 17 compounds G-10.001 to G-10.017 of formula Ic-Qb, wherein X is SO, R1 is ethyl, R2 is OCF3 and R5 is as defined in Table V.

[0512] Table G-11 provides 17 compounds G-11.001 to G-11.017 of formula Ic-Qb, wherein X is SO2, R1 is ethyl, R2 is SCF3 and R5 is as defined in Table V.

[0513] Table G-12 provides 17 compounds G-12.001 to G-12.017 of formula Ic-Qb, wherein X is SO2, R1 is ethyl, R2 is SOCF3 and R5 is as defined in Table V.

[0514] Table G-13 provides 17 compounds G-13.001 to G-13.017 of formula Ic-Qb, wherein X is SO2, R1 is ethyl, R2 is SO2CF3 and R5 is as defined in Table V.

[0515] Table G-14 provides 17 compounds G-14.001 to G-14.017 of formula Ic-Qb, wherein X is SO2, R1 is ethyl, R2 is OSO2CF3 and R5 is as defined in Table V.

[0516] Table G-15 provides 17 compounds G-15.001 to G-15.017 of formula Ic-Qb, wherein X is SO2, R1 is ethyl, R2 is OCF3 and R5 is as defined in Table V.

[0517] Table G-16 provides 17 compounds G-16.001 to G-16.017 of formula Ic-Qb, wherein R2 is OCHF2, R1 is ethyl, X is S and R5 is as defined in Table V.

[0518] Table G-17 provides 17 compounds G-17.001 to G-17.017 of formula Ic-Qb, wherein R2 is OCHF2, R1 is ethyl, X is SO and R5 is as defined in Table V.

[0519] Table G-18 provides 17 compounds G-18.001 to G-18.017 of formula Ic-Qb, wherein R2 is OCHF2, R1 is ethyl, X is SO2 and R5 is as defined in Table V.

[0520] Tables H-1 to H-18 below show additional specific compounds of the present invention.

[0521]

[0522] Table H-1 provides 17 compounds H-1.001 to H-1.017 of formula Id-Qb, wherein X is S, R1 is ethyl, R2 is SCF3 and R6 is as defined in Table W.

[0523] Table H-2 provides 17 compounds H-2.001 to H-2.017 of formula Id-Qb, wherein X is S, R1 is ethyl, R2 is SOCF3 and R6 is as defined in Table W.

[0524] Table H-3 provides 17 compounds H-3.001 to H-3.017 of formula Id-Qb, wherein X is S, R1 is ethyl, R2 is SO2CF3 and R6 is as defined in Table W.

[0525] Table H-4 provides 17 compounds H-4.001 to H-4.017 of formula Id-Qb, wherein X is S, R1 is ethyl, R2 is OSO2CF3 and R6 is as defined in Table W.

[0526] Table H-5 provides 17 compounds H-5.001 to H-5.017 of formula Id-Qb, wherein X is S, R1 is ethyl, R2 is OCF3 and R6 is as defined in Table W.

[0527] Table H-6 provides 17 compounds H-6.001 to H-6.017 of formula Id-Qb, wherein X is SO, R1 is ethyl, R2 is SCF3 and R6 is as defined in Table W.

[0528] Table H-7 provides 17 compounds H-7.001 to H-7.017 of formula Id-Qb, wherein X is SO, R1 is ethyl, R2 is SOCF3 and R6 is as defined in Table W.

[0529] Table H-8 provides 17 compounds H-8.001 to H-8.017 of formula Id-Qb, wherein X is SO, R1 is ethyl, R2 is SO2CF3 and R6 is as defined in Table W.

[0530] Table H-9 provides 17 compounds H-9.001 to H-9.017 of formula Id-Qb, wherein X is SO, R1 is ethyl, R2 is OSO2CF3 and R6 is as defined in Table W.

[0531] Table H-10 provides 17 compounds H-10.001 to H-10.017 of formula Id-Qb, wherein X is SO, R1 is ethyl, R2 is OCF3 and R6 is as defined in Table W.

[0532] Table H-11 provides 17 compounds H-11.001 to H-11.017 of formula Id-Qb, wherein X is SO2, R1 is ethyl, R2 is SCF3 and R6 is as defined in Table W.

[0533] Table H-12 provides 17 compounds H-12.001 to H-12.017 of formula Id-Qb, wherein X is SO2, R1 is ethyl, R2 is SOCF3 and R6 is as defined in Table W.

[0534] Table H-13 provides 17 compounds H-13.001 to H-13.017 of formula Id-Qb, wherein X is SO2, R1 is ethyl, R2 is SO2CF3 and R6 is as defined in Table W.

[0535] Table H-14 provides 17 compounds H-14.001 to H-14.017 of formula Id-Qb, wherein X is SO2, R1 is ethyl, R2 is OSO2CF3 and R6 is as defined in Table W.

[0536] Table H-15 provides 17 compounds H-15.001 to H-15.017 of formula Id-Qb, wherein X is SO2, R1 is ethyl, R2 is OCF3 and R6 is as defined in Table W.

[0537] Table H-16 provides 17 compounds H-16.001 to H-16.017 of formula Id-Qb, wherein R1 is ethyl, X is S, R2 is OCHF2 and R6 is as defined in Table W.

[0538] Table H-17 provides 17 compounds H-17.001 to H-17.017 of formula Id-Qb, wherein R1 is ethyl, X is SO, R2 is OCHF2 and R6 is as defined in Table W.

[0539] Table H-18 provides 17 compounds H-18.001 to H-18.017 of formula Id-Qb, wherein R1 is ethyl, X is SO2, R2 is OCHF2 and R6 is as defined in Table W.

[0540] The compounds of formula I according to the invention are active ingredients of preventive and / or therapeutic value in the field of pest control. Even at low application rates, they have a very favorable biocidal spectrum and are well tolerated by warm-blooded species, fish, and plants. These active ingredients according to the invention act on all or individual developmental stages of normally sensitive as well as resistant animal pests (such as insects or representatives of the order Acarina). The insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i.e., destruction of the pests occurs immediately or only after a certain period of time (e.g., during molting); or indirectly, for example, by reducing egg laying and / or hatching rates, corresponding to a good activity of at least 50% to 60% destruction (mortality).

[0541] Examples of the animal pests mentioned above are:

[0542] From the order Acarina, e.g.

[0543] Acalitus spp., Aculus spp., Acaricalus spp., Aceria spp., Acarus siro, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia spp., Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides spp., Eotetranychus spp., Eriophyes spp.), Hemitarsonemus spp., Hyalomma spp., Ixodes spp., Olygonychus spp., Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp., Polyphagotarsonemus spp., Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp.), Steneotarsonemus spp., Tarsonemus spp., and Tetranychus spp.;

[0544] From the order Phthirus, e.g.

[0545] Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp., and Phylloxera spp.;

[0546] From the order Coleoptera, e.g.

[0547] Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp., Astylus atromaculatus, Ataenius spp., Atomaria linearis, Chaetocnema tibialis, Cerotomas spp., Conoderus spp., Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephalas spp., Dermestes spp., Diabrotica spp.), Argentine beetle (Diloboderus abderus), herbivorous ladybird species (Epilachna spp.), Eremnus species, Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa ​​decemLineata, Lissorhoptrus spp., Liogenys spp., Maecolaspis spp., Maladera castanea, American leaf beetle species (Megascelis spp.), rapeseed beetle (Melighetes aeneus), Melolontha spp., Myochrousarmatus, Orycaephilus spp., Otiorhynchus spp., Phyllophaga spp.), Phlyctinus spp., Popillia spp., Psylliodes spp., Rhyssomatus aubtilis, Rhizopertha spp., Scarabeidae, Sitophilus spp., Sitotroga spp.), Somaticus spp., Cryptorhynchus spp., Sternechus subsignatus, Tenebrio spp., Tribolium spp., and Trogoderma spp.;

[0548] From the order Diptera, e.g.

[0549] Aedes spp., Anopheles spp., Antherigonas occata, Bactrocea oleae, Bibio hortulanus, Bradysia spp., Calliphora erythrocephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Delia spp., Drosophila melanogaster, Fannia spp., Gastrophilus spp., Geomyza tripunctata, Glossina spp.), Hypoderma spp., Hyppobosca spp., Liriomyza spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Rhagoletis spp., Riveria quadrifasciata, Scatella spp., Sciara spp., Stomoxys spp., Tabanus spp.), tapeworm species (Tannia spp.) and tipula species (Tipula spp.);

[0550] From the order Hemiptera, e.g.

[0551] Acanthocoris scabrator, Green stink bug, Alfalfa blind bug, Amblypelta nitida, Bathycoelia thalassina, Soil stink bug, Cockspur, Clavigralla tomentosicollis, Creontiades spp., Cocoa stink bug, Dichelops furcatus, Cotton stink bug, Edessa spp., Euschistus spp., Eurydema pulchrum, Flat shield bug, Brown-winged stink bug, Horcias nobilellus, Rice stink bug, Lygus spp., Tropical scale bug, Murgantiahistrionic, Neomegalotomus spp., Tobacco stink bug tenuis), green stink bugs, Nysius simulans, Oebalus insularis, skin stink bugs, wall stink bugs, red assassin bugs, cocoa stink bugs, Scaptocoris castanea, black stink bugs (Scotinophara spp.), Thyanta spp., trypanosoma spp., cassava web stink bugs (Vatigailludens);

[0552] Pea aphid (Acyrthosium pisum), Adalges species, Agallina ensigera, Targuiron vein psyllid, Aleurodicus species, Aleurocanthus species, Sugarcane hole whitefly, Aleurothrixus floccosus, Cabbage whitefly (Aleyrodes brassicae), Cotton leafhopper (Amarasca biguttula), Lemon leafhopper, Kidney Shield Scale species, Aphididae, Aphid species, Aspidiotus species, Tomato groove aphid, Bactericera cockerelli, Whitefly species, Brachycaudus species, Cabbage aphid, Cavariella species, Cavariella aegopodii Scop.), wax scale species, black-brown round shield scale, orange-brown round shield scale, leafhopper species, large white leafhopper (Cofana spectra), Cryptophyllum species, leafhopper species, brown soft scale, corn yellow-winged leafhopper, naked whitefly species, citrus psyllid, wheat aphid, western round tail aphid species, small green leafhopper species, apple aphid, grape leafhopper species, Gascardia species, red eucalyptus psyllid (Glycaspis brimblecombei), cabbage constrictor aphid (Hyadaphis pseudobrassicae), large tail aphid species (Hyalopterus spp), hyperomyzuspallidus species, lemon green leafhopper (Idioscopus clypealis), African leafhopper, Laodelphax striatellus species, water-hard scale, oyster shield scale species, radish aphid (Lopaphis erysimi), Lyogenys maidis, Aphid species, Cicada species, Metcalfa pruinosa, Aphid, Cicada, Aphid species, Neotoxoptera sp, Nilaparvata species, Nilaparvata spp.), pear green aphid, Odonaspis ruthae, sugarcane cotton aphid, bayberry whitefly, Caulis psyllid, Shield scale species, Gall aphid species, Corn waxhopper, Flathorn planthopper species, Hob wart aphid, Phylloxera species (Phylloxera spp.), Mosella species, Mulberry white scale species, Mealybug species, Cotton blind bug (Pseudatomoscelis seriatus), Psyllid species, Cotton scale (Pulvinaria aethiopica), Toothed scale species, Quesada gigas, Electric leafhopper (Reciliadorsalis), Constrictor aphid species, Black helmet scale species, Banded leafhopper species, Schistosoma species, Wheat aphid species (Sitobion spp.), White-backed planthopper, Spissistilus festinus, Striped planthopper (Tarophagus Proserpina), aphid species, whitefly species, Tridiscus sporoboli, Trionymus spp., African psyllids, scaly scale, flame leafhopper, Zyginidia scutellaris;

[0553] From the order Hymenoptera, e.g.

[0554] Acromyrmex, Arge spp., Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplocampa spp., Lasius spp., Monomorium pharaonis, Neodiprions spp., Pogonomyrmex spp., imported fire ants, Solenopsis spp., and Vespa spp.

[0555] From the order Isoptera, e.g.

[0556] Coptotermes spp., Corniternes cumulans, Incisitermes spp., Macrotermes spp., Mastotermes spp., Microtermes spp., Reticulitermes spp.; Tropical fire ants (Solenopsis geminate)

[0557] From the order Lepidoptera, for example,

[0558] Species of the genus Long-winged Tortoise, species of the genus Brown-banded Tortoise, species of the genus Clearwing, species of the genus Noctua, cotton leafworm, species of the genus Amylois, species of the genus Mucuna, species of the genus Yellow Tortoise, species of the genus Argyresthia, species of the genus Banded Tortoise, species of the genus Spodoptera, cotton miner, corn armyworm, powdery moth, peach fruit moth, species of the genus Graminus, species of the genus Colored Tortoise, Chrysoteuchia topiaria, grape fruit moth, species of the genus Leaf Roller, species of the genus Cloud Tortoise, species of the genus Sheath Moth, Colias lesbia, Cosmophila flava), grass borer species, cabbage borer, apple anomaly moth, boxwood moth, moth moth species, boxwood moth, boxwood moth, boxwood moth, Sudan bollworm, Spodoptera species, sweet potato stem borer, mealybug species, Epinotia spp., Estigmene acrea, Etiella zinckinella, flower moth species, ring moth, yellow tussock moth, root cutter species, Feltia jaculiferia, Grapholita spp., cloud moth, Heliothis species, cabbage borer, Herpetogramma spp., gypsy moth, tomato borer, Lasmopalpus lignosellus, spiral leafminer, leafminer species, grape moth, Loxostege bifidalis, tussock moth species, miner species, Malacosoma spp., cabbage armyworm, tobacco hornworm, Mythimna spp., noctuid species, fall moth species, Orniodes indica, European corn borer, microtomidae species, brown moth species, small-eyed moth, stem borer, red bell moth, coffee leaf miner, one-star armyworm, potato moth, cabbage butterfly, Pieris species, diamondback moth, white nest moth species, leaf moth species, mint ash moth (Rachiplusia nu), western bean incense (Richia albicosta), white grain borer species (Scirpophaga spp.), Spodoptera species, Cyprinodon species, Spodoptera species, Cotton leaf roller, Cnaphalocrocis species, Heteroptera species, Trichoplusia species, Tomato leafminer, and Lymantria species;

[0559] From the order Mallophaga, for example,

[0560] Damalina spp. and Trichodectes spp.;

[0561] From the order Orthoptera, for example,

[0562] Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp., Scapteriscus spp., and Schistocerca spp.;

[0563] From the order Psocoptera, for example,

[0564] Liposcelis spp.;

[0565] From the order Siphonaptera, for example,

[0566] Ceratophyllus spp., Ctenocephalides spp., and Xenopsylla cheopis;

[0567] From the order Thysanoptera, for example,

[0568] Calliothrips phaseoli, Frankliniella spp., Heliothrips spp., Hercinothrips spp., Parthenothrips spp., Scirtothrips aurantii, Sericothrips variabilis, Taeniothrips spp., Thrips spp.

[0569] From the order of the Thysanura, for example, Lepisma saccharina.

[0570] The active ingredients according to the invention can be used for controlling, i.e. suppressing or destroying pests of the aforementioned type, which occur in particular on plants, especially on useful and ornamental plants in agriculture, horticulture and forestry, or on organs of these plants, such as fruits, flowers, leaves, stems, tubers or roots, and in some cases even plant organs formed at a later point in time still remain protected against these pests.

[0571] In particular, suitable target crops are cereals, such as wheat, barley, rye, oats, rice, corn or sorghum; beets, such as sugar beets or fodder beets; fruits, such as pome, stone or soft fruit, such as apples, pears, plums, peaches, apricots, cherries or berries, such as strawberries, raspberries or blackberries; leguminous crops, such as beans, lentils, peas or soybeans; oilseed crops, such as rapeseed, mustard, poppy, olives, sunflower, coconut, castor, cocoa beans or peanuts; cucurbits such as pumpkin, cucumber, or melon; fiber plants such as cotton, flax, hemp, or jute; citrus fruits such as oranges, lemons, grapefruits, or tangerines; vegetables such as spinach, lettuce, asparagus, cabbage, carrots, onions, tomatoes, potatoes, or bell peppers; lauraceae such as avocado, cinnamon, or camphor; and also tobacco, nuts, coffee, eggplant, sugarcane, tea, pepper, grapevines, hops, plantago, and latex plants.

[0572] The compositions and / or methods of the present invention may also be used on any ornamental and / or vegetable crop, including flowers, shrubs, broadleaf trees, and evergreen plants.

[0573] For example, the present invention can be used with any of the following ornamental plant species: Ageratum species, Alonsoa species, Anemone species, Anisodontea capsenisis, Anthemis species, Antirrhinum species, Aster species, Begonia species (e.g., Rieger Begonia, Begonia sempervirens, Begonia tubéreux), Bougainvillea species, Brachycome species, Brassica species (ornamentals), Calceolaria species, Capsicum, Catharanthus roseus, Canna species, Centaurea species, Chrysanthemum species, Cineraria species (C. maritime), Coreopsis species, Crassula coccinea, Cupheaignea, Dahlia species, Delphinium species, Dicentra species, Dorotheantus species. spp.), Lisianthus, Forsythia species, Fuchsia species, Geranium gnaphalium, Gerbera species, Globe amaranth, Heliotrope species, Sunflower species, Hibiscus species, Hydrangea species, Hydrangea species, Rhododendron, Impatiens species (African balsam), Amaranth species (Iresines spp.), Kalanchoe species, Lantana, March flower, Lion's ear, Lilium species, Mesembryanthemum species, Physalis species, Monarda species, Dracaena species, Marigold species, Dianthus species (carnation), Canna species, Oxalis species, Daisy species, Pelargonium species (Shieldleaf Pelargonium, Horseshoe Pelargonium), Viola species (Viola tricolor), Petunia species, Phlox species, Plecthranthus species spp.), poinsettia species, creeper species (five-leaf creeper, Parthenocissus quinquefolia), primula species, ranunculus species, azalea species, Rosa species (roses), rudbeckia species, African violet species, salvia species, Scaevola aemola, Schizanthus wisetonensis, sedum species, Solanum species, Surfinia petunia species (Surfinia spp.), marigold species, Nicotiana species, verbena species, zinnia species, and other bedding plants.

[0574] For example, the present invention can be used with any of the following vegetable species: Allium species (garlic, onion, A. oschaninii, leek, shallot, scallion), fennel, celery (Apium graveolus), asparagus, beets, Brassica species (cabbage, Chinese cabbage, turnip), peppers, chickpeas, endive, chicory species (chicory, endive), watermelon (Citrillus lanatus), Cucumber species (cucumber, melon), Cucurbita species (zucchini, Indian pumpkin), Cyanara spp. (artichoke, cardoon), wild carrot, fennel, Hypericum species, lettuce, Lycopersicon species (tomato, cherry tomato), mint species, basil, parsley, Phaseolus species (bean, pea), peas, radish, edible rhubarb, Rosemary species, sage species, black salsify (Scorzonera hispanica), eggplant, spinach, new Valerian species (V. eriocarpa), and broad beans.

[0575] Preferred ornamental plant species include African violet, begonia, dahlia, gerbera, hydrangea, verbena, rose, kalanchoe, poinsettia, aster, cornflower, coreopsis, delphinium, monarda, phlox, rudbeckia, sedum, petunia, violet, impatiens, geranium, chrysanthemum, ranunculus, fuchsia, salvia, hydrangea, rosemary, sage, St. John's wort, mint, sweet pepper, tomato, and cucumber.

[0576] The active ingredients according to the invention are particularly suitable for controlling the bean aphid, cucumber leaf beetle, tobacco budworm, peach aphid, diamondback moth and sea moth on cotton, vegetables, corn, rice and soybean crops. The active ingredients according to the invention are also particularly suitable for controlling the cabbage looper (preferably on vegetables), the codling moth (preferably on apples), the green leafhopper (preferably on vegetables, in vineyards), the potato beetle (preferably on potatoes) and the striped stem borer (preferably on rice).

[0577] The active ingredients according to the invention are particularly suitable for controlling the bean aphid, cucumber leaf beetle, tobacco budworm, peach aphid, diamondback moth and sea moth on cotton, vegetables, corn, rice and soybean crops. The active ingredients according to the invention are also particularly suitable for controlling the cabbage looper (preferably on vegetables), the codling moth (preferably on apples), the green leafhopper (preferably on vegetables, in vineyards), the potato beetle (preferably on potatoes) and the striped stem borer (preferably on rice).

[0578] In another aspect, the present invention may also relate to a method for controlling damage to plants and parts thereof by plant-parasitic nematodes (endoparasitic, semi-endoparasitic and ectoparasitic nematodes), in particular the following plant-parasitic nematodes, such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other species of root knot nematodes; cyst-forming nematodes, Globodera rostochiensis and other species of Globodera; Heterodera avenae, Heteroderaglycines, Heterodera exigua and other species of Globodera; schachtii), Heterodera trifolii, and other Heterodera species; Seed gall nematodes, Anguina species; Stem and foliar nematodes, Aphelenchoides species; Sting nematodes, Belonolaimus longicaudatus, and other Belonolaimus species; Pine nematodes, Bursaphelenchus xylophilus, and other Bursaphelenchus species; Ring nematodes, nematodes), Criconema species, Criconemella species, Criconemoides species, Mesocriconema species; Stemand bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci, and other Ditylenchus species; Awl nematodes, Dolichodorus species;Spiral nematodes, Heliocotylenchus multicinctus, and other species of the genus Helicotylenchus; Sheath and sheathoid nematodes, species of the genera Hemicycliophora, and species of the genera Hemicriconemoides; Hirshmanniella species; Lancenematodes, species of the genus Hoploaimus; False rootknot nematodes, species of the genus Nacobbus; Needle nematodes, Longidoruse longatus, and other species of the genus Longidorus; Pin nematodes, species of the genus Pratylenchus; Lesion nematodes. nematodes), Pratylenchus negletus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi, and other Pratylenchus species; Burrowing nematodes, Radopholus similis, and other Radopholus species; Reniform nematodes, Rotylenchus robustus, Rotylenchus reniformis, and other Rotylenchus species; Scutellonema species; Stubby root nematodes, Trichodorus primitivus) and other Trichodorus species, Paratrichodorus species; Stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius, and other Tylenchorhynchus species;Citrus nematodes, Tylenchulus species; Dagger nematodes, Xiphinema species; and other plant-parasitic nematode species, such as Subanguina spp., Hypsoperine spp., Macroposthonia spp., Melinius spp., Punctodera spp., and Quinisulcius spp.

[0579] The compounds of the present invention also have activity against mollusks. Examples include, for example, the Pomacea family; the Arion family (A. ater, A. circumscriptus, A. hortensis, A. rufus); the Bradybaenidae family (Bradybaenidae); fruticum); Cepaea (Cepaea hortensis, C. nemoralis); Ochlodina; Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum); Discus (D. rotundatus); Euomphalia; Galba (Galba trunculata); Helicelia (H. itala, H. obvia); Helicigona (Helicidae). arbustorum; Helicodiscus; Helix (H. aperta); Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L. tenellus); Lymnaea; Milax (M. gagates, M. marginatus, M. sowerbyi); Opeas; Pomacea (P. canaticulata); Vallonia and Zanitoides.

[0580] The term "crops" is to be understood as also including crop plants which have been transformed by the use of recombinant DNA techniques such that they are able to synthesize one or more selectively acting toxins, such as are known, for example, from toxigenic bacteria, in particular those of the genus Bacillus.

[0581] Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, for example, insecticidal proteins from Bacillus cereus or Bacillus japonicus; or insecticidal proteins from Bacillus thuringiensis, such as delta-endotoxins, for example Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1, or Cry9C, or vegetative insecticidal proteins (Vips), for example Vip1, Vip2, Vip3, or Vip3A; or insecticidal proteins of bacterial colonizing nematodes, for example, Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophila, or Xenorhabdus spp. nematophilus); toxins produced by animals, such as scorpion toxins, spider toxins, bee toxins and other insect-specific neurotoxins; toxins produced by fungi, such as streptomycin, plant lectins, such as pea lectin, barley lectin or snowdrop lectin; agglutinin; protease inhibitors, such as trypsin inhibitor, silk proteinase inhibitor, potato glycoprotein, cystatin, papain inhibitor; ribosome inactivating protein (RIP), such as ricin, maize-RIP, abrin, luffain, saporin or bryophyllin; steroid metabolizing enzymes, such as 3-hydroxysteroid oxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidase, ecdysteroid inhibitors, HMG-COA-reductase, ion channel blockers, such as sodium channel or calcium channel blockers, juvenile hormone esterase, diuretic hormone receptor, stilbene synthase, bibenzyl synthase, chitinase and glucanase.

[0582] In the context of the present invention, δ-endotoxins (e.g., Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1, or Cry9C) or vegetative insecticidal proteins (Vips) (e.g., Vip1, Vip2, Vip3, or Vip3A) are understood to include, but are not limited to, mixed toxins, truncated toxins, and modified toxins. Mixed toxins are recombinantly produced by combining different domains of those proteins (see, e.g., WO 02 / 15701). Truncated toxins, such as truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of a naturally occurring toxin are replaced. In such amino acid replacements, it is preferred that a non-naturally occurring protease recognition sequence be inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G recognition sequence is inserted into the Cry3A toxin (see WO 03 / 018810).

[0583] Examples of such toxins or transgenic plants capable of synthesizing such toxins are disclosed in, for example, EP-A-0 374 753, WO 93 / 07278, WO 95 / 34656, EP-A-0 427 529, EP-A-451 878 and WO 03 / 052073.

[0584] Methods for preparing such transgenic plants are generally known to those skilled in the art and are described, for example, in the publications mentioned above. CryI-type deoxyribonucleic acids and their preparation are known, for example, from WO 95 / 34656, EP-A-0 367474, EP-A-0 401 979 and WO 90 / 13651.

[0585] The toxins included in the transgenic plants render the plants tolerant to harmful insects. Such insects can be found in any insect taxonomic group, but are particularly common among beetles (Coleoptera), two-winged insects (Diptera), and moths (Lepidoptera).

[0586] Transgenic plants comprising one or more genes encoding insecticide resistance and expressing one or more toxins are known and some of them are commercially available. Examples of such plants are: (corn variety expressing Cry1Ab toxin); YieldGard (corn variety expressing Cry3Bb1 toxin); YieldGard (corn varieties expressing Cry1Ab and Cry3Bb1 toxins); (corn variety expressing Cry9C toxin); Herculex (a maize variety expressing the Cry1Fa2 toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) that confers tolerance to the herbicide glufosinate ammonium); NuCOTN (cotton variety expressing Cry1Ac toxin); Bollgard (cotton variety expressing Cry1Ac toxin); Bollgard (cotton varieties expressing Cry1Ac and Cry2Ab toxins); (cotton variety expressing Vip3A and Cry1Ab toxins); (potato variety expressing Cry3A toxin); GT Advantage (GA21 glyphosate tolerance trait), CB Advantage (Bt11 corn borer (CB) trait) and

[0587] Further examples of such genetically modified crops are:

[0588] 1. Bt11 corn, from Syngenta Seeds SAS, Chemin de Hobit 27, F-31 790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. This genetically modified maize plant is resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia inermis) by transgenic expression of a truncated Cry1Ab toxin. Bt11 corn also transgenicly expresses the PAT enzyme to confer tolerance to the herbicide glufosinate ammonium.

[0589] 2. Bt176 maize, from Syngenta Seeds, 27 Rue de Hobbitt, F-31 790 Saint-Sauveur, France, registration number C / FR / 96 / 05 / 10. This genetically modified maize strain is resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia inermis) by transgenic expression of the toxin Cry1Ab. Bt176 maize also transgenicly expresses the enzyme PAT to confer tolerance to the herbicide glufosinate ammonium.

[0590] 3. MIR604 maize, from Syngenta Seeds, 27 Rue de Hobbit, F-31 790 Saint-Sauveur, France, registration number C / FR / 96 / 05 / 10. This maize plant is rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin G protease recognition sequence. The preparation of this transgenic maize plant is described in WO 03 / 018810.

[0591] 4. MON 863 maize, from Monsanto Europe SA, 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / DE / 02 / 9. MON 863 expresses the Cry3Bb1 toxin and confers resistance to certain coleopteran insects.

[0592] 5. IPC 531 cotton, from Monsanto Europe SA, 270-272 Avenue Tervuren, B-1150 Brussels, Belgium, registration number C / ES / 96 / 02.

[0593] 6.1507 maize, from Pioneer Overseas Corporation, Avenue Tedesco, 7B-1160 Brussels, Belgium, registration number C / NL / 00 / 10. Genetically modified maize expressing the protein Cry1F for resistance to certain lepidopteran insects and the protein PAT for tolerance to the herbicide glufosinate-ammonium.

[0594] 7. NK603×MON 810 corn, from Monsanto Europe, 270-272 Boulevard Tervuren, B-1150 Brussels, Belgium, registration number C / GB / 02 / M3 / 03. This corn is a conventionally bred hybrid corn variety, produced by crossing the genetically modified varieties NK603 and MON 810. NK603×MON 810 corn transgenically expresses the protein CP4 EPSPS obtained from the Agrobacterium strain CP4, rendering it herbicide tolerant. (contains glyphosate), and also Cry1Ab toxin obtained from Bacillus thuringiensis subsp. kurstakia, which confers resistance to certain lepidopteran insects, including the European corn borer.

[0595] Transgenic crops of insect-resistant plants are also described in the BATS (Zentrum für Biosicherheit und Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) report 2003 ( http: / / bats.ch )middle.

[0596] The term "crop" should be understood to also include crop plants that have been transformed using recombinant DNA technology so that they can synthesize antipathogenic substances with selective action, such as, for example, so-called "pathogenesis-related proteins" (PRPs, see, for example, EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants that can synthesize such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95 / 33818, and EP-A-0 353 191. Methods for producing such transgenic plants are generally known to those skilled in the art and are described, for example, in the publications mentioned above.

[0597] Crops can also be modified to increase resistance to fungal (eg, Fusarium, Anthracnose, or Phytophthora), bacterial (eg, Pseudomonas), or viral (eg, Potato Leaf Roll Virus, Tomato Spotted Wilt Virus, Cucumber Mosaic Virus) pathogens.

[0598] Crops also include those with increased resistance to nematodes, such as Heterodera glycines.

[0599] Crops with tolerance to abiotic stress include those with increased tolerance to drought, high salinity, high temperature, cold, frost or light radiation, for example, through expression of NF-YB or other proteins known in the art.

[0600] Antipathogenic substances that can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers of sodium channels and calcium channels, for example viral KP1, KP4 or KP6 toxins; stilbene synthases; bibenzyl synthases; chitinases; glucanases; so-called "pathogenesis-related proteins" (PRPs; see, for example, EP-A-0 392 225); antipathogenic substances produced by microorganisms, such as peptide antibiotics or heterocyclic antibiotics (see, for example, WO 95 / 33818) or proteins or polypeptide factors that are involved in plant pathogen defense (so-called "plant disease resistance genes", as described in WO 03 / 000906).

[0601] Other areas of use of the compositions according to the invention are the protection of stored goods and storage rooms and the protection of raw materials such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, in particular the protection of humans, domestic animals and productive livestock from pests of the types mentioned.

[0602] The present invention also provides methods for controlling pests (such as mosquitoes and other disease vectors; see also http: / / www.who.int / malaria / vector_control / irs / en / ). In one embodiment, the method for controlling pests comprises applying the composition of the present invention to the target pests, their locus, or a surface or substrate by painting, rolling, spraying, coating, or dipping. By way of example, IRS (indoor residual spraying) application to surfaces (such as walls, ceilings, or floor surfaces) is contemplated by the methods of the present invention. In another embodiment, application of such compositions to substrates such as nonwoven or fabric materials in the form of (or for use in the manufacture of) netting, coverings, bedding, curtains, and tents is contemplated.

[0603] In one embodiment, the method for controlling this type of harmful organism comprises applying the composition of the present invention of pest-killing effective dose to target harmful organism, their place or surface or substrate, so that on this surface or substrate, effective pest-killing activity of retention is provided.Such application can be carried out by brushing, rolling, spraying, coating or dipping pest-killing composition of the present invention.By way of example, the IRS application of surface (such as wall, ceiling or floor surface) is considered by method of the present invention, so that effective pest-killing activity of retention is provided on this surface.In another embodiment, it is considered to use this type of composition for the residual control of the harmful organism on substrate, and described substrate is the fabric material as being in the form (or can be used in the manufacture of these articles) of netting, covering, quilt, curtain and tent.

[0604] The substrate to be treated (including nonwovens, fabrics or nettings) can be made of natural fibers such as cotton, raffia, jute, flax, sisal, burlap or wool, or synthetic fibers such as polyamide, polyester, polypropylene, polyacrylonitrile, etc. Polyester is particularly suitable. Methods for treating textiles are known, for example WO 2008 / 151984, WO 2003 / 034823, US 5631072, WO 2005 / 64072, WO 2006 / 128870, EP 1724392, WO 2005113886 or WO 2007 / 090739.

[0605] A further area of ​​use of the compositions according to the invention is in the field of tree injection / trunk treatment of all ornamental trees as well as all kinds of fruit and nut trees.

[0606] In the field of tree injection / trunk treatment, the compounds according to the invention are particularly suitable for combating wood-boring insects from the orders Lepidoptera mentioned above and from the orders Coleoptera, in particular against the wood-boring insects listed in the following Tables A and B:

[0607] Table A. Examples of economically important exotic wood-boring insects.

[0608]

[0609] Table B. Examples of economically important native wood-boring insects.

[0610]

[0611]

[0612]

[0613]

[0614] The present invention can also be used to control any insect pest that may be present in turfgrass, including, for example, beetles, caterpillars, fire ants, ground pearls, millipedes, woodlice, mites, mole crickets, scale insects, mealybugs, ticks, cicadas, southern wheat stink bugs, and white grubs. The present invention can be used to control insect pests at all stages of their life cycle, including eggs, larvae, nymphs, and adults.

[0615] In particular, the present invention can be used to control insect pests that feed on the roots of turfgrasses, including grubs (such as Cyclocephala spp. (e.g., labeled beetles, C. lurida), Rhizotrogus spp. (e.g., European beetles, European root-cutting gill beetles (R. majalis)), Cotinus spp. (e.g., Green June beetles, Green June flower beetles (C. nitida)), Popillia spp. (e.g., Japanese beetles, Japanese arc beetles (P. japonica)), Phyllophaga spp. (e.g., May / June beetles), Ataenius spp. (e.g., Black turfgrass ataenius, Black velvet beetles (A. spretulus)), Maladera spp. (e.g., Black turfgrass ataenius, Black velvet beetles (A. spretulus)), spp.) (e.g., Asiatic garden beetle, M. castanea, and Tomarus spp.), ground beetles (Margarodes spp.), mole crickets (tawny, southern, and short-winged; Scapteriscus spp., Gryllotalpa africana), and leatherjackets (European crane fly, Tipula spp.).

[0616] The present invention can also be used to control insect pests of turfgrass in thatched homes, including armyworms (such as the fall armyworm Spodoptera frugiperda, and the common armyworm Pseudaletia unipuncta), cutworms, weevils (Sphenophorus spp., such as S. venatus verstitus and S. parvulus), and grass borers (such as Crambus spp. and the tropical grass borer, Herpetogramma phaeopteralis).

[0617] The present invention can also be used to control insect pests in turfgrasses that live above ground and feed on turfgrass leaves, including wheat stink bugs (such as the southern wheat stink bug, Blissus insularis), Bermudagrass mite (Eriophyes cynodoniensis), Grass mealybug (Antonina graminis), Propsapia bicincta, leafhoppers, cutworms (Noctuidae), and Schizaphis graminis.

[0618] The present invention can also be used to control other pests in turfgrass, such as introduced fire ants (Solenopsis invicta) that create nests in lawns.

[0619] In the hygiene sector, the compositions according to the invention are effective against ectoparasites such as hard ticks, soft ticks, scabies, autumn mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas.

[0620] Examples of such parasites are:

[0621] From the order of the Pediculus: Haemaphysalis spp., Linognathus spp., Pediculus hominis spp., and Phtirus spp., Phitirus spp.

[0622] From the order Trichophagus: Felicola species, Brachypelago species, Ducklingia species, Cattlelicia species, Werneckiella species, Lepikentron species, Cattlelicia species, Trichopelago species and Felicola species (Felicola spp.).

[0623] From the order Diptera and the suborders Nematocerina and Brachycerina, for example, Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp. spp.), Musca spp., Hydrotaea spp., Biting flies spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp. spp.) and Melophagus spp.

[0624] From the order of the Siphonapterida, for example, Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllum spp.

[0625] From the order of the Heteropterida, for example, Cimex spp., Triatominae spp., Panstrongylus spp.

[0626] From the order of the Blattarida, for example, Blatta orientalis, Periplaneta americana, Blattelagermanica and Supella spp.

[0627] Subclass Acaria (family Acarida) and orders Meta-stigmata and Meso-stigmata, for example, Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyommas spp., Boophilus spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp. spp.), Sternostoma spp., and Varroa spp.

[0628] From the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example, Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp. spp.), Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcooptes spp., Notoedress spp., Knemidocoptes spp., Cytodites spp., and Laminosioptes spp.

[0629] The compositions according to the invention are also suitable for protecting materials in the case of, for example, wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and construction from infestation by insects.

[0630] The compositions according to the invention can be used, for example, to combat the following pests: beetles, such as Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale), Minthes rugicollis, Xyleborus spec., Tryptodendron spec., Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec., and Dinoderus minutus, as well as Hymenoptera, such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus, and Urocerus augu, and termites, such as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes spp. indicola), Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis, and Coptotermes formosanus, as well as borers such as Silverfish (Lepisma saccharina).

[0631] The compounds according to the invention can be used as pesticides in unmodified form, but they are usually formulated into compositions in various ways using formulation adjuvants such as carriers, solvents and surfactants. These formulations can be in different physical forms, for example, in the form of dusting powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent pellets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, flowable oils, aqueous dispersions, oily dispersions, suspoemulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or water-miscible organic solvents as carriers), impregnated polymer films or in other known forms, for example, from the Manual on Development and Use of FAO and WHO Specifications for Pesticides, United Nations, 1st edition, second revision (2010). Such formulations can be used directly or can be diluted before use. Dilution can be performed with, for example, water, liquid fertilizers, micronutrients, biological organisms, oils or solvents.

[0632] These formulations can be prepared, for example, by mixing the active ingredient with a formulation adjuvant in order to obtain a composition in the form of a finely divided solid, granules, solution, dispersion or emulsion. The active ingredients can also be formulated with other adjuvants such as finely divided solids, mineral oils, oils of plant or animal origin, modified oils of plant or animal origin, organic solvents, water, surface-active substances or combinations thereof.

[0633] These active ingredients can also be contained in very fine microcapsules. Microcapsules contain active ingredients in porous carriers. This allows the active ingredients to be released (e.g., slowly released) into the environment in controlled amounts. Microcapsules typically have a diameter of from 0.1 to 500 microns. The amount of active ingredient they contain is approximately from 25% to 95% of the capsule weight by weight. These active ingredients can be in the form of a holistic solid, in the form of fine particles in a solid or liquid dispersion, or in the form of a suitable solution. The encapsulated membrane can include, for example, natural or synthetic rubber, cellulose, styrene / butadiene copolymer, polyacrylonitrile, polyacrylate, polyester, polyamide, polyurea, polyurethane, or chemically modified polymers and starch xanthate or other polymers known to those skilled in the art. Alternatively, very fine microcapsules can be formed, in which the active ingredient is contained in the form of finely dispersed particles in a solid matrix of a base material, but these microcapsules themselves are not wrapped.

[0634] Formulation adjuvants suitable for preparing the compositions according to the invention are known per se. As liquid carriers, water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol rosinate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl Formamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, dipropylene glycol, alkyl pyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, α-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, γ-butyrolactone, glycerol, acetic acid glyceryl, diacetic acid glyceryl, triacetic acid glyceryl, decaglycerol Hexadecane, Hexanediol, Isoamyl Acetate, Isobornyl Acetate, Isooctane, Isophorone, Cumene, Isopropyl Myristate, Lactic Acid, Lauramine, Mesityl Oxide, Methoxypropanol, Methyl Isoamyl Ketone, Methyl Isobutyl Ketone, Methyl Laurate, Methyl Caprylate, Methyl Oleate, Methylene Chloride, m-Xylene, n-Hexane, n-Octylamine, Octadecanoic Acid, Octylamine Acetate, Oleic Acid, Oleylamine, o-Xylene, Phenol, Polyethylene Glycol, Propionic Acid, Propyl Lactate , propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol and higher molecular weight alcohols such as amyl alcohol, tetrahydrofuranol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone, etc.

[0635] Suitable solid carriers are for example talcum, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, diatomaceous earth, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed hulls, wheat flour, soy flour, pumice, wood flour, ground walnut shells, lignin and similar materials. Many surfactants can be advantageously used in both solid and liquid formulations, especially in those formulations that can be diluted by a carrier before use. Surfactants can be anionic, cationic, nonionic or polymeric and they can be used as emulsifiers, wetting agents or suspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate; salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol / alkylene oxide addition products, such as ethoxylated nonylphenol; alcohol / alkylene oxide addition products, such as ethoxylated tridecanol; soaps, such as sodium stearate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; salts of dialkylsulfosuccinates, such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary ammoniums, such as dodecyltrimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and dialkyl phosphates; as well as other substances, such as described in: McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Company. Corp., Ridgewood New Jersey (1981).

[0636] The other adjuvant that can be used for the pest-killing preparation comprises crystallization inhibitor, viscosity modifier, suspending agent, dye, antioxidant, foaming agent, light absorber, mixing aid, defoamer, complexing agent, neutralize or change the material and buffer solution of pH, corrosion inhibitor, spices, wetting agent, absorption enhancer, micronutrient, plasticizer, flow aid, lubricant, dispersant, thickening agent, antifreeze, microbicide and liquid and solid fertilizer.Composition according to the present invention can comprise additive, this additive comprises the alkyl ester of oil, mineral oil, this type of oil or the mixture of this type of oil and oil derivative of plant or animal origin.The amount of the oil additive in the composition according to the present invention is normally based on mixture to be used from 0.01% to 10%.For example, can after spraying mixture and having prepared, oil additive is added in the spray tank with desired concentration. Preferred oil additives include mineral oil or oil of vegetable origin, such as rapeseed oil, olive oil or sunflower oil; emulsified vegetable oil; alkyl esters of oil of vegetable origin, such as methyl derivatives; or oil of animal origin, such as fish oil or tallow. Preferred oil additives include C8-C 22 Alkyl esters of fatty acids, especially C12 -C 18 Methyl derivatives of fatty acids, such as the methyl esters of lauric acid, palmitic acid, and oleic acid (methyl laurate, methyl palmitate, and methyl oleate, respectively). Many oil derivatives are known from the Compendium of Herbicide Adjuvants, 10th edition, Southern Illinois University, 2010.

[0637] These compositions according to the invention generally comprise from 0.1% to 99% by weight, in particular from 0.1% to 95% by weight, of a compound according to the invention and from 1% to 99.9% by weight of formulation adjuvants, preferably including from 0 to 25% by weight of surface-active substances. While commercial products may preferably be formulated as concentrates, the end user will generally use dilute formulations.

[0638] The application rate varies within wide limits and depends on the nature of the soil, the application method, the crop plants, the harmful organisms to be controlled, the prevailing climatic conditions, and other factors dictated by the application method, the time of application, and the target crop. In general, the compound can be applied at a rate of from 1 to 2000 l / ha, in particular from 10 to 1000 l / ha.

[0639] A preferred formulation may have the following composition (wt %):

[0640] Emulsifiable concentrates :

[0641] Active ingredient: 1% to 95%, preferably 60% to 90%

[0642] Surfactant: 1% to 30%, preferably 5% to 20%

[0643] Liquid carrier: 1% to 80%, preferably 1% to 35%

[0644] Dusting agent :

[0645] Active ingredient: 0.1% to 10%, preferably 0.1% to 5%

[0646] Solid carrier: 99.9% to 90%, preferably 99.9% to 99%

[0647] Suspension concentrate:

[0648] Active ingredient: 5% to 75%, preferably 10% to 50%

[0649] Water: 94% to 24%, preferably 88% to 30%

[0650] Surfactant: 1% to 40%, preferably 2% to 30%

[0651] wettable powder :

[0652] Active ingredient: 0.5% to 90%, preferably 1% to 80%

[0653] Surfactant: 0.5% to 20%, preferably 1% to 15%

[0654] Solid carrier: 5% to 95%, preferably 15% to 90%

[0655] Granules:

[0656] Active ingredient: 0.1% to 30%, preferably 0.1% to 15%

[0657] Solid carrier: 99.5% to 70%, preferably 97% to 85%

[0658] The following examples further illustrate (but do not limit) the present invention.

[0659]

[0660]

[0661] The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable grinder to obtain a wettable powder which can be diluted with water to give a suspension of the desired concentration.

[0662] <![CDATA[ Powder for dry seed treatment ]]> a) b) c) Active ingredient 25% 50% 75% Light mineral oil 5% 5% 5% Highly dispersed silicic acid 5% 5% - Kaolin 65% 40% - talc - 20%

[0663] The combination is thoroughly mixed with adjuvants and the mixture is thoroughly ground in a suitable grinder to obtain a dust that can be used directly for seed treatment.

[0664] <![CDATA[ Emulsifiable concentrates ]]> Active ingredient 10% Octylphenol polyglycol ether (4-5 mol of ethylene oxide) 3% Calcium dodecylbenzenesulfonate 3% Castor oil polyglycol ether (35 mol of ethylene oxide) 4% Cyclohexanone 30% Xylene mixture 50%

[0665] Emulsions of any desired dilution which can be used in plant protection can be obtained from these concentrates by dilution with water.

[0666]

[0667]

[0668] A ready-to-use dusting powder is obtained by mixing the combination with a carrier and grinding the mixture in a suitable grinder. Such dusts can also be used for dry seed dressing of seeds.

[0669] <![CDATA[ Extruder pellets ]]> Active ingredient 15% Sodium lignin sulfonate 2% Carboxymethyl cellulose 1% Kaolin 82%

[0670] The combination is mixed and ground with the adjuvants, and the mixture is moistened with water.

[0671] The mixture is extruded and then dried in a stream of air.

[0672] <![CDATA[ Coated granules ]]> Active ingredient 8% Polyethylene glycol (molecular weight 200) 3% Kaolin 89%

[0673] This finely ground combination is applied uniformly in a mixer to the kaolin moistened with polyethylene glycol. In this way, non-dusting coated granules are obtained.

[0674] Suspension concentrates

[0675] Active ingredient 40% Propylene glycol 10% Nonylphenol polyglycol ether (15 mol of ethylene oxide) 6% Sodium lignin sulfonate 10% Carboxymethyl cellulose 1% Silicone oil (in the form of a 75% emulsion in water) 1% water 32%

[0676] The finely ground combination is intimately mixed with adjuvants to give a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation materials can be treated and protected against microbial infestation by spraying, pouring or immersion.

[0677] Flowable concentrate for seed treatment

[0678] Active ingredient 40% Propylene glycol 5% Copolymer butanol PO / EO 2% Tristyrylphenol with 10-20 moles of EO 2% 1,2-Benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5% Monoazo-pigment calcium salt 5% Silicone oil (in the form of a 75% emulsion in water) 0.2% water 45.3%

[0679] The finely ground combination is intimately mixed with adjuvants to give a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation materials can be treated and protected against microbial infestation by spraying, pouring or immersion.

[0680] Extended-release capsule suspension

[0681] 28 parts of the combination are mixed with 2 parts of an aromatic solvent and 7 parts of a toluene diisocyanate / polymethylene-polyphenyl isocyanate mixture (8:1). This mixture is emulsified in a mixture of 1.2 parts of polyvinyl alcohol, 0.05 parts of a defoamer, and 51.6 parts of water until the desired particle size is reached. To this emulsion, 2.8 parts of a mixture of 1,6-hexanediamine in 5.3 parts of water are added. The mixture is stirred until the polymerization reaction is complete. The resulting capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersant. The capsule suspension formulation contains 28% active ingredient. The diameter of the medium capsules is 8-15 microns. The resulting formulation is applied to the seeds as an aqueous suspension in a device suitable for this purpose.

[0682] Formulation types include emulsion concentrates (EC), suspension concentrates (SC), suspoemulsions (SE), capsule suspensions (CS), water-dispersible granules (WG), emulsifiable granules (EG), emulsions, water-in-oil emulsions (EO), oil-in-water emulsions (EW), microemulsions (ME), oil dispersions (OD), oil suspensions (OF), oil-soluble concentrates (OL), soluble concentrates (SL), ultra-low volume suspensions (SU), ultra-low volume concentrates (UL), finished products (TK), dispersible concentrates (DC), wettable powders (WP), soluble granules (SG), or any technically feasible formulation in combination with agriculturally acceptable adjuvants.

[0683] Preparation example:

[0684] "Mp" refers to the melting point in ° C. Free radical represents a methyl group. 1 H NMR measurements were recorded on a Brucker 400 MHz spectrometer, and chemical shifts are given in ppm relative to a TMS standard. Spectra were measured in deuterated solvents as indicated. The compounds were characterized using any of the following LCMS methods. Characteristic LCMS values ​​obtained for each compound are the retention time ("Rt", reported in minutes) and the measured molecular ion (M+H). + or (MH) - .

[0685] LCMS method:

[0686] Method 1:

[0687] Spectra were recorded on a mass spectrometer from Waters (SQD single quadrupole mass spectrometer) equipped with an electrospray source (polarity: positive or negative, full scan, capillary voltage: 3.00 kV, cone range: 41 V, source temperature: 150°C, desolvation temperature: 500°C, cone gas flow: 50 L / Hr, desolvation gas flow: 1000 L / Hr, mass range: 110 to 800 Da) and a Class H UPLC from Waters: binary pump, heated column compartment and diode array detector. Column: Waters UPLC HSS T3C18, 1.8 μm, 30×2.1 mm, temperature: 40° C., DAD wavelength range (nm): 210 to 400, solvent gradient: A = water + 5% acetonitrile + 0.1% HCOOH, B = acetonitrile + 0.05% HCOOH: gradient: 0 min 10% B; 0.-0.2 min 10%-50% B; 0.2-0.7 min 50%-100% B; 0.7-1.3 min 100% B; 1.3-1.4 min 100%-10% B; 1.4-1.6 min 10% B; flow rate (mL / min) 0.6.

[0688] Method 2:

[0689] Spectra were recorded on a mass spectrometer from Agilent Technologies (6410 triple quadrupole mass spectrometer) equipped with an electrospray source (polarity: positive or negative ion, MS2 scan, capillary voltage: 4.00 kV, fragmentor voltage: 100 V, desolvation temperature: 350°C, gas flow: 11 L / min, nebulizer gas: 45 psi, mass range: 110 to 1000 Da) and a 1200 series HPLC from Agilent: quaternary pump, heated column compartment and diode array detector. Column: KINETEX EVO C18, 2.6 μm, 50×4.6 mm, temperature: 40°C, DAD wavelength range (nm): 210 to 400, solvent gradient: A = water + 5% acetonitrile + 0.1% HCOOH, B = acetonitrile + 0.1% HCOOH: gradient: 0 min 0% B, 100% A; 0.9-1.8 min 100% B; flow rate (mL / min) 1.8.

[0690] Method 3:

[0691] Spectra were recorded on a mass spectrometer from Waters (SQD single quadrupole mass spectrometer) equipped with an electrospray source (polarity: positive or negative, full scan, capillary voltage: 3.00 kV, cone range: 41 V, source temperature: 150°C, desolvation temperature: 500°C, cone gas flow: 50 L / Hr, desolvation gas flow: 1000 L / Hr, mass range: 110 to 800 Da) and a Class H UPLC from Waters: binary pump, heated column compartment and diode array detector. Column: Waters UPLC HSS T3 C18, 1.8 μm, 30×2.1 mm, temperature: 40° C., DAD wavelength range (nm): 210 to 400, solvent gradient: A=water+5% acetonitrile+0.1% HCOOH, B=acetonitrile+0.1% HCOOH: gradient: 0 min 10% B; 0.-0.2 min 10%-50% B; 0.2-0.7 min 50%-100% B; flow rate (mL / min) 0.8.

[0692] Example H1: 2-[3-Ethylsulfonyl-6-(trifluoromethyl)benzothiophen-2-yl]-6-(trifluoromethyl)-3H-pyrrolidone Preparation of pyrrolidine [3,4-c] pyridin-1-one (compound P1)

[0693]

[0694] Step 1: Preparation of 3-chloro-6-(trifluoromethyl)benzothiophene-2-carbonyl chloride (Intermediate I-1) Ethyl fluoromethyl)benzothiophene-2-carboxylate (Intermediate I-2)

[0695]

[0696] To a solution of (E)-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid (4.00 g, 19.0 mmol) in N,N-dimethylformamide (1.6 mL) and pyridine (0.80 mL) was slowly added thionyl chloride (6.90 mL, 93.0 mmol) at room temperature. The reaction mixture was heated to 145 ° C and stirred for 2 hours. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure to give crude intermediate I-1.

[0697]

[0698] To the crude intermediate I-1 was slowly added ethanol (48 mL) at 0°C. The reaction mixture was heated to 80°C and stirred for 2 hours. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (100% cyclohexane) to give the desired product (2.98 g). 1 H NMR (400MHz, CDCl3) δppm 1.46 (t, J=7.2Hz, 3H), 4.47 (q, J=7.2Hz, 2H), 7.73 (dd, J=8.5, 1.0Hz, 1H), 8.07-8.15 (m, 2H).

[0699] Step 2: Preparation of ethyl 3-ethylsulfanyl-6-(trifluoromethyl)benzothiophene-2-carboxylate (Intermediate I-3)

[0700]

[0701] To a solution of ethyl 3-chloro-6-(trifluoromethyl)benzothiophene-2-carboxylate (Intermediate I-2 prepared as described above, 76%, 18.8 g, 42.6 mmol) in N,N-dimethylformamide (188 mL) was added sodium ethanethiolate (6.45 g, 76.7 mmol). The reaction mixture was stirred at room temperature for 6 hours, then diluted with water and extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (100% cyclohexane) to give the desired product (9.20 g). 1 H NMR (400MHz, CDCl3) δppm 1.22 (t, 3H), 1.47 (t, 3H), 3.06 (q, 2H), 4.48 (q, 2H), 7.61-7.74 (m, 1H), 8.15 (s, 1H), 8.32 (d, 1H).

[0702] Step 3: Preparation of ethyl 3-ethylsulfonyl-6-(trifluoromethyl)benzothiophene-2-carboxylate (Intermediate I-4)

[0703]

[0704] To a solution of ethyl 3-ethylsulfanyl-6-(trifluoromethyl)benzothiophene-2-carboxylate (Intermediate I-3 prepared as described above, 9.20 g, 28.0 mmol) in dichloromethane (140 mL) was added 3-chloro-perbenzoic acid (15.0 g, 61.0 mmol) at 0°C. The reaction mixture was stirred at room temperature for 2 hours, then quenched with 2M sodium hydroxide at 0°C and extracted twice with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude material was purified by silica gel flash chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (5.50 g). 1 HNMR(400MHz,CDCl3)δppm 1.40(t,3H),1.46(t,3H),3.60(q,J=7.5Hz,2H),4.51(q,J=7.2Hz,2H),7.77(dd,J=8.9,1.3Hz,1H),8.19(s,1H),8.75(d,J=8.9Hz,1H).

[0705] Step 4: Preparation of 3-ethylsulfonyl-6-(trifluoromethyl)benzothiophene-2-carboxylic acid (Intermediate I-5)

[0706]

[0707] To a solution of ethyl 3-ethylsulfonyl-6-(trifluoromethyl)benzothiophene-2-carboxylate (Intermediate I-4 prepared as described above, 5.50 g, 15.0 mmol) in methanol (44 mL) was added a solution of sodium hydroxide (1.20 g, 30.0 mmol) in water (22 mL). The reaction mixture was stirred at room temperature for 6 hours, then acidified with 2N aqueous hydrochloric acid, diluted with water and extracted three times with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to give the desired product (5.20 g), which was used without further purification. 1 H NMR (400MHz, DMSO-d6) δppm 1.22 (t, J = 7.3Hz, 3H), 3.63 (q, J = 7.3Hz, 2H), 7.93 (dd, J = 8.9, 1.6Hz, 1H), 8.59 (d, J = 8.9Hz, 1H), 8.77 (s, 1H).

[0708] Step 5: tert-Butyl N-[3-ethylsulfonyl-6-(trifluoromethyl)benzothiophen-2-yl]carbamate (Intermediate Preparation of I-6)

[0709]

[0710] To a solution of 3-ethylsulfonyl-6-(trifluoromethyl)benzothiophene-2-carboxylic acid (intermediate I-5, 5.20 g, 15.0 mmol prepared as described above) in tert-butanol (100 mL) triethylamine (3.50 mL, 25.0 mmol) was added. The reaction mixture was heated to 90 ° C and stirred for 10 minutes, then diphenylphosphoryl azide (5.40 mL, 25.0 mmol) was added dropwise over 15 minutes. The resulting reaction mixture was stirred at 90 ° C for 1 hour and after being cooled to room temperature, quenched with water and salt water and extracted three times with ethyl acetate. The combined organic layer was dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (ethyl acetate gradient in cyclohexane) to obtain the desired product (2.50 g). 1 H NMR (400MHz, CDCl3) δppm 1.28 (t, 3H), 1.60 (s, 9H), 3.28 (q, J = 7.3Hz, 2H), 7.67 (d, J = 8.7Hz, 1H), 8.02 (s, 1H), 8.14 (d, J = 8.7Hz, 1H), 9.96 (s, 1H).

[0711] Step 6: Preparation of 3-ethylsulfonyl-6-(trifluoromethyl)benzothiophene-2-amine (Intermediate I-7)

[0712]

[0713] To a solution of tert-butyl N-[3-ethylsulfonyl-6-(trifluoromethyl)benzothiophene-2-yl]carbamate (intermediate I-6, 2.30 g, 5.60 mmol prepared as described above) in dichloromethane (23 mL) was added 2,2,2-trifluoroacetic acid (5.20 mL, 67.0 mmol) dropwise. The reaction mixture was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The resulting residue was diluted with water, neutralized with saturated aqueous sodium bicarbonate solution and extracted three times with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (100% cyclohexane) to give the desired product (0.600 g). 1 H NMR (400MHz, CDCl3) δppm 1.34 (t, 3H), 3.22 (q, J = 7.3Hz, 2H), 6.26 (br s, 2H), 7.58 (d, J = 8.6Hz, 1H), 7.82 (s, 1H), 7.93 (d, J = 8.6Hz, 1H).

[0714] Step 7: 5-[[[3-Ethylsulfonyl-6-(trifluoromethyl)benzothiophen-2-yl]amino]methyl]-2-(trifluoromethyl)benzothiophen-2-yl Preparation of methyl)pyridine-4-carboxylate (Intermediate I-8)

[0715]

[0716] To a solution of 3-ethylsulfonyl-6-(trifluoromethyl)benzothiophene-2-amine (Intermediate I-7 prepared as described above, 0.600 g, 1.94 mmol) in N,N-dimethylformamide (15 mL) was added sodium hydride (60%, 0.116 g, 2.91 mmol) at 0°C and the reaction mixture was stirred at this temperature for 30 minutes. A solution of methyl 5-(bromomethyl)-2-(trifluoromethyl)pyridine-4-carboxylate (Intermediate IP-6 prepared as described below; 60%, 1.35 g, 2.72 mmol) in N,N-dimethylformamide (6 mL) was then added and the reaction mixture was further stirred at 0°C for 2 hours. The mixture was diluted with water and extracted twice with ethyl acetate. The combined organic layers were concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (0.910 g). LCMS (Method 1): m / z 527 [M+H] + , retention time Rt = 1.24min.

[0717] Step 8: 5-[[[3-Ethylsulfonyl-6-(trifluoromethyl)benzothiophen-2-yl]amino]methyl]-2-(trifluoromethyl)benzothiophen-2-yl Preparation of 4-methyl)pyridine-4-carboxylic acid (Intermediate I-9)

[0718]

[0719] To a suspension of methyl 5-[[[3-ethylsulfonyl-6-(trifluoromethyl)benzothiophen-2-yl]amino]methyl]-2-(trifluoromethyl)pyridine-4-carboxylate (Intermediate I-8 prepared as described above, 0.800 g, 1.52 mmol) in methanol (16 mL) at 0° C. was added a solution of dihydroxybarium octahydrate (0.959 g, 3.04 mmol) in water (8 mL). The reaction mixture was stirred at room temperature for 2 hours, then diluted with water, acidified with 2N aqueous hydrochloric acid solution and extracted three times with ethyl acetate. The combined organic layers were concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (methanol gradient in ethyl acetate) to give the desired product (0.570 g, 0.779 mmol). LCMS (Method 1): m / z 513 [M+H] + , retention time Rt = 1.12min.

[0720] Step 9: 2-[3-Ethylsulfonyl-6-(trifluoromethyl)benzothiophen-2-yl]-6-(trifluoromethyl)-3H-pyrrole Preparation of 3,4-c]pyridin-1-one (title compound P1)

[0721]

[0722] To a solution of 5-[[[3-ethylsulfonyl-6-(trifluoromethyl)benzothiophen-2-yl]amino]methyl]-2-(trifluoromethyl)pyridine-4-carboxylic acid (Intermediate I-9 prepared as described above, 0.620 g, 1.21 mmol) in pyridine (3.1 mL) was added phosphorus(V)oxychloride (0.228 mL, 2.42 mmol) at 0°C. The reaction mixture was stirred at 0°C for 4 hours, then diluted with water, acidified with 1N aqueous hydrochloric acid and extracted three times with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (80 mg). LCMS (Method 1): m / z 495 [M+H] + , retention time Rt = 1.16min. 1 H NMR (400MHz, CDCl3) δppm 1.42(t,J=7.5Hz,3H),3.46(q,J=7.5Hz,2H),5.15(s,2H),7.81(d,J=8.8Hz,1H),8.21(m,2H),8.52(d,J=8.8Hz,1H),9.06(s,1H).

[0723] Example H2: 6-[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]- Preparation of 7H-pyrrolo[3,4-b]pyridin-5-one (compound P2)

[0724]

[0725] Step 1: tert-Butyl N-[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]carbamate Preparation of ester (intermediate II-1)

[0726]

[0727] To a solution of 3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid (CAS 2181821-89-4; 2.50 g, 7.76 mmol) in tert-butanol (50 mL) was added triethylamine (1.75 mL, 12.4 mmol). The reaction mixture was heated to 90 ° C and stirred for 10 minutes, then diphenylphosphoryl azide (2.73 mL, 12.4 mmol) was added dropwise over 15 minutes. The resulting reaction mixture was stirred at 90 ° C for 40 minutes. After cooling to room temperature, the mixture was quenched with water and brine and extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (ethyl acetate gradient in cyclohexane) to give the desired product (0.850 g). 1 HNMR(400MHz,DMSO-d6)δppm 1.27(t,3H),1.48(s,9H),3.66(q,J=7.34Hz,2H),7.47(dd,J=7.34,1.96Hz,1H),8.24(s,1H),8.94(d,J=7.34Hz,1H),9.57(s,1H).

[0728] Step 2: Preparation of methyl 2-chloro-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate II-2)

[0729]

[0730] To a solution of 2-chloro-5-(trifluoromethyl)pyridine-3-carboxylic acid (CAS 505084-59-3; 7.00 g, 31.0 mmol) in N,N-dimethylformamide (70 mL) was added cesium carbonate (12.1 g, 37.2 mmol). The reaction mixture was stirred at room temperature for 5 minutes, then iodomethane (2.90 mL, 46.6 mmol) was added. Stirring was continued at room temperature for 1 hour. The reaction mixture was diluted with ice water and extracted three times with ethyl acetate. The combined organic layers were washed with ice water and brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to give the desired product (7.00 g), which was used without further purification. LCMS (Method 1): m / z 240 / 242 [M+H] + , retention time Rt = 1.00min. 1 H NMR (400MHz, CDCl3) δppm 4.01 (s, 3H), 8.41 (d, 1H), 8.78 (d, 1H).

[0731] Step 3: Preparation of methyl 2-methyl-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate II-3)

[0732]

[0733] Methylboric acid (7.73g, 125mmol), tripotassium phosphate (26.6g, 125mmol), tricyclohexylphosphine (1.17g, 4.17mmol) were loaded into the reactor, followed by toluene (100mL) and water (13mL). The flask was purged with nitrogen for 15 minutes. In the reaction mixture, 2-chloro-5-(trifluoromethyl)pyridine-3-methyl formate (intermediate II-2 prepared as described above, 10.0g, 41.7mmol) and palladium (II) acetate (0.469g, 2.09mmol) were added. First, the reaction mixture was heated to 100°C and stirred for 2 hours, then stirred at 90°C overnight. After cooling to room temperature, the mixture was diluted with water and ethyl acetate and filtered through a diatomaceous earth pad. These layers were separated, and the organic layer was dried over sodium sulfate, filtered, and concentrated under reduced pressure to obtain the desired product (5.00g), which was used without further purification. LCMS (Method 1): m / z 220 [M+H] + , retention time Rt = 0.93min. 1 H NMR (400MHz, CDCl3) δppm 2.92 (s, 3H), 3.97 (s, 3H), 8.44 (d, 1H), 8.87 (m, 1H).

[0734] Step 4: Preparation of methyl 2-(bromomethyl)-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate II-4)

[0735]

[0736] To a solution of methyl 2-methyl-5-(trifluoromethyl)pyridine-3-carboxylate (intermediate II-3 prepared as described above, 3.50 g, 16.0 mmol) in tetrachloromethane (80 mL) was added N-bromo-succinimide (4.00 g, 22.0 mmol) and benzoyl peroxide (70%, 1.40 g, 4.00 mmol). The reaction mixture was heated to 70° C. and stirred for 3 hours. After cooling to room temperature, it was diluted with ice water and extracted three times with dichloromethane. The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (1.40 g). LCMS (Method 1): m / z 298 / 300 [M+H] + , retention time Rt = 1.01min. 1H NMR (400MHz, CDCl3) δppm: 4.03 (s, 3H) 5.08 (s, 2H), 8.53 (d, J = 2.01Hz, 1H), 8.96 (m, 1H).

[0737] Similarly, ethyl 2-(bromomethyl)-5-(trifluoromethyl)pyridine-3-carboxylate (II-4-a) can be prepared:

[0738]

[0739] LCMS (Method 1): m / z 312 / 314 [M+H] + , retention time 1.14min. 1 H NMR (400MHz, CDCl3) δ / ppm: 1.47 (t, 3H), 4.49 (q, 2H), 5.07 (s, 2H), 8.51 (s, 1H), 8.95 (s, 1H).

[0740] Similarly, methyl 2-(bromomethyl)-5-(trifluoromethyl)benzoate (CAS 875895-66-2; II-4-b) can be prepared:

[0741]

[0742] 1 H NMR (400MHz, CDCl3) δ / ppm: 3.99 (s, 3H), 4.98 (s, 2H), 7.62 (d, J = 8.1Hz, 1H), 7.76 (dd, J = 8.1, 1.5Hz, 1H), 8.24 (d, J = 1.5Hz, 1H).

[0743] Similarly, methyl 2-(bromomethyl)-5-(difluoromethoxy)benzoate (944718-50-7; II-4-c) can be prepared from methyl 5-(difluoromethoxy)-2-methyl-benzoate (CAS 1190320-23-0):

[0744]

[0745] 1 H NMR (400MHz, CDCl3) δ / ppm: 3.98 (s, 3H), 4.96 (s, 2H), 6.57 (t, 1H), 7.28 (dd, 1H), 7.50 (d, 1H), 7.74 (d, 1H).

[0746] Step 5: 2-[[tert-Butoxycarbonyl-[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridine-2- Preparation of methyl]amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate II-5)

[0747]

[0748] To a solution of tert-butyl N-[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]carbamate (intermediate II-1 prepared as described above, 0.450 g, 1.14 mmol) in acetonitrile (10 mL) was added methyl 2-(bromomethyl)-5-(trifluoromethyl)pyridine-3-carboxylate (intermediate II-4 prepared as described above, 0.443 g, 1.49 mmol) and cesium carbonate (0.560 g, 1.72 mmol). The reaction mixture was heated to 50 ° C and stirred for 2 hours. After cooling to room temperature, it was quenched with ice water and extracted twice with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (ethyl acetate gradient in cyclohexane) to give the desired product (0.510 g). LCMS (method 1): m / z 611 [M+H] + , retention time Rt = 1.25min. 1 H NMR (400MHz, CDCl3) δppm 1.37(s,9H),1.47(t,3H),3.71(br q,2H),3.98(s,3H),5.55(s,2H),7.14(br d,1H),7.81(s,1H),8.58(s,1H),8.92(br d,1H),8.97(s,1H).

[0749] Step 6: 2-[[[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]amino]methane Preparation of methyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate II-6)

[0750]

[0751] To a solution of methyl 2-[[tert-butoxycarbonyl-[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate II-5 prepared as described above, 0.510 g, 0.835 mmol) in dichloromethane (10 mL) was added 2,2,2-trifluoroacetic acid (0.673 mL, 8.35 mmol) dropwise at 0°C. The reaction mixture was stirred at room temperature overnight, then quenched with saturated aqueous sodium bicarbonate solution and extracted three times with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to give the desired product (0.400 g), which was used without further purification. LCMS (Method 1): m / z 511 [M+H] + , retention time Rt = 1.17min. 1H NMR(400MHz,DMSO-d6)δppm 1.19(t,3H),3.43(q,J=7.34Hz,2H),3.96(s,3H),5.17(d,J=5.5Hz,2H),7.05(t,J=5.5Hz,1H),7.31 (dd,J=7.09,1.83Hz,1H),7.95(s,1H),8.55(d,J=1.83Hz,1H),8.71(d,J=7.09Hz,1H),9.14(s,1H).

[0752] Step 7: 2-[[[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]amino]methane Preparation of 5-(trifluoromethyl)pyridine-3-carboxylic acid (Intermediate II-7)

[0753]

[0754] To a solution of methyl 2-[[[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate II-6 prepared as described above, 0.400 g, 0.784 mmol) in methanol (8 mL) and water (4 mL) was added dihydroxybarium octahydrate (0.494 g, 1.57 mmol). The reaction mixture was stirred at room temperature for 16 hours, then acidified with 2N aqueous hydrochloric acid and extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure to give the desired product (0.380 g). LCMS (Method 1): m / z 497 [M+H] + , retention time Rt = 1.04min. 1 H NMR(400MHz,DMSO-d6)δppm 1.18(t,3H),3.43(q,2H),5.19(d,J=5.4Hz,2H),7.12(t,J=5.4Hz,1H),7.31(dd,J=7. 1,1.9Hz,1H),7.98(s,1H),8.53(d,J=1.9Hz,1H),8.70(d,J=7.1Hz,1H),9.12(s,1H).

[0755] Step 8: 6-[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl) Preparation of 4-(2-amino-4-pyrrolo[3,4-b]pyridin-5-one (title compound P2)

[0756]

[0757] To a solution of 2-[[[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylic acid (Intermediate II-7 prepared as described above, 0.300 g, 0.604 mmol) in pyridine (6 mL) was added phosphorus(V)oxychloride (0.114 mL, 1.21 mmol) at 0°C. The reaction mixture was slowly brought to room temperature and stirred for 1 hour, then acidified with 1N aqueous hydrochloric acid and extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (0.187 g). LCMS (Method 1): m / z 479 [M+H] + , retention time Rt = 1.06min. 1 H NMR (400MHz, CDCl3) δppm 1.53(t,J=7.46Hz,3H),3.84(q,J=7.46Hz,2H),5.25(s,2H),7.29(d,J=7. 34Hz, 1H), 8.04 (s, 1H), 8.48 (s, 1H), 9.03 (d, J = 7.34Hz, 1H), 9.13 (s, 1H).

[0758] Example H3: 2-[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]-6- Preparation of (trifluoromethylsulfonyl)isoindolin-1-one (Compound P33)

[0759]

[0760] Step 1: Preparation of 4-(2,2,2-trifluoroethoxy)pyridin-2-amine (Intermediate III-1)

[0761]

[0762] To a solution of 2-aminopyridine-4-ol (15.0 g, 136 mmol) in DMSO (150 mL) was added potassium carbonate (95.5 g, 681 mmol) and 2-iodo-1,1,1-trifluoroethane (72.2 g, 341 mmol) and the reaction mixture was heated to 100 ° C and stirred for 12 hours. After cooling to room temperature, the reaction mixture was extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (14.0 g). LCMS (method 1): m / z 193 [M+H] + , retention time Rt = 0.19 min. 1H NMR (400MHz, DMSO-d6) δppm: 4.73 (q, 2H), 5.93 (s, 2H), 6.02 (d, 1H), 6.24 (dd, 1H), 7.79 (d, 1H).

[0763] Step 2: Preparation of ethyl 7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridine-2-carboxylate (Intermediate III-2) preparation

[0764]

[0765] To a solution of 4-(2,2,2-trifluoroethoxy)pyridin-2-amine (intermediate III-1, 14.0 g, 72.9 mmol prepared as described above) in ethanol (140 mL) was added 3-bromo-2-oxo-propionic acid ethyl ester (17.1 g, 87.4 mmol, 11.0 mL) and sodium bicarbonate (12.2 g, 146 mmol). The reaction mixture was heated to 85 ° C and stirred for 7 hours. After cooling to room temperature, the reaction mixture was diluted with water and extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (11.0 g). LCMS (method 1): m / z 289 [M + H] + , retention time Rt = 1.19 min. 1 H NMR (400MHz, DMSO-d6) δppm: 1.31 (t, 3H), 4.29 (q, 2H), 6.75 (dd, 1H), 7.02 (d, 1H), 8.07 (d, 1H), 8.11 (s, 1H).

[0766] Step 3: 3-chloro-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (Intermediate Preparation of III-3)

[0767]

[0768] To a solution of ethyl 7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridine-2-carboxylate (Intermediate III-2 prepared as described above, 12.0 g, 41.6 mmol) in acetonitrile (120 mL) was added 1-chloropyrrolidine-2,5-dione (6.67 g, 50.0 mmol) and the reaction mixture was stirred at room temperature for 16 hours. Ice-cold water was added to the reaction mixture, and the precipitated compound was filtered and dried to give the desired product (10.5 g), which was used without further purification. LCMS (Method 2): m / z 323 / 325 [M+H] + , retention time Rt = 2.32min. 1H NMR (400MHz, CDCl3) δppm: 1.48 (t, 3H), 4.40-4.54 (m, 4H), 6.88 (dd, 1H), 7.01 (d, 1H), 8.08 (d, 1H).

[0769] Step 4: Ethyl 3-ethylsulfanyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridine-2-carboxylate Preparation of (Intermediate III-4)

[0770]

[0771] To a solution of ethyl 3-chloro-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridine-2-carboxylate (Intermediate III-3 prepared as described above, 9.60 g, 30.0 mmol) in methylsulfinylmethane (96.0 mL) was added portionwise sodium ethanethiolate (5.00 g, 60.0 mmol) at 15° C.-20° C., and the reaction mixture was stirred at room temperature for 2 hours. Ice-cold water was added to the reaction mixture, and the precipitated compound was filtered and dried to give the desired product (9.60 g), which was used without further purification. LCMS (Method 1): m / z 349 [M+H] + , retention time Rt = 1.47 min. 1 H NMR (400MHz, DMSO-d6) δppm: 1.05(t,3H), 1.34(t,3H), 2.85(q,2H), 4.33(q,2H), 4.94(q,2H), 6.97(dd,1H), 7.28(d,1H), 8.56(d,1H).

[0772] Step 5: Ethyl 3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridine-2-carboxylate Preparation of (Intermediate III-5)

[0773]

[0774] To a solution of ethyl 3-ethylsulfanyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridine-2-carboxylate (Intermediate III-4, 9.60 g, 28.0 mmol prepared as described above) in trifluorotoluene (96.0 mL) was added 3-chloroperoxybenzoic acid (18.4 g, 74.9 mmol) at 0°C. The reaction mixture was stirred at room temperature for 24 hours, then quenched with water and 2M aqueous sodium hydroxide solution, and the product was extracted twice with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (8.10 g). LCMS (Method 1): m / z 381 [M+H] + , retention time Rt = 0.96min.1 HNMR (400MHz, CDCl3) δppm: 1.36 (t, 3H), 1.48 (t, 3H), 3.73 (q, 2H), 4.42-4.56 (m, 4H), 6.90 (dd, 1H), 7.06 (d, 1H), 9.16 (d, 1H).

[0775] Step 6: 3-Ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridine-2-carboxylic acid (intermediate Preparation of body III-6)

[0776]

[0777] To a solution of ethyl 3-ethylsulfonyl-6-(trifluoromethyl)benzothiophene-2-carboxylate (Intermediate III-5 prepared as described above, 8.10 g, 21.0 mmol) in tetrahydrofuran (81 mL) was added a solution of lithium hydroxide (0.77 g, 32.0 mmol) in water (32 mL) at 0° C.-5° C. The reaction mixture was stirred at room temperature for 16 hours and then acidified with 2N aqueous hydrochloric acid. The formed precipitate was filtered and dried to give the desired product (6.00 g), which was used without further purification. LCMS (Method 1): m / z 353 [M+H] + , retention time Rt = 0.83min. 1 H NMR (400MHz, DMSO-d6) δppm: 1.21(t,3H), 3.64(q,3H), 5.00(q,2H), 7.15(dd,1H), 7.46(d,1H), 8.87(d,1H).

[0778] Step 7: N-[3-ethylsulfonyl-7-(2,2,2-trifluoromethoxy)imidazo[1,2-a]pyridin-2-yl]amino Preparation of tert-butyl formate (Intermediate III-7)

[0779]

[0780] To a solution of 3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridine-2-carboxylic acid (intermediate III-6, 3.50 g, 9.90 mmol prepared as described above) in tert-butanol (70 mL) was added triethylamine (2.20 mL, 16.0 mmol). The reaction mixture was heated to 90 ° C and stirred for 10 minutes, and then diphenylphosphoryl azide (3.50 mL, 16.0 mmol) was added dropwise over 15 minutes. After the resulting reaction mixture was stirred at 90 ° C for 30 minutes and cooled to room temperature, it was quenched with water and brine and the product was extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (2.90 g). LCMS (method 1): m / z 424 [M+H] + , retention time Rt = 1.03min. 1 H NMR (400MHz, CDCl3) δppm: 1.32 (t, 3H), 1.56 (s, 9H), 3.22 (q, 2H), 4.41 (q, 2H), 6.79 (dd, 1H), 7.05 (d, 1H), 8.16 (s, 1H), 8.51 (d, 1H).

[0781] Step 8: 2-[[tert-Butoxycarbonyl-[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2- Preparation of methyl a]pyridin-2-yl]amino]methyl]-5-(trifluoromethylsulfonyl)benzoate (Intermediate III-8)

[0782]

[0783] To a solution of tert-butyl N-[3-ethylsulfonyl-7-(2,2,2-trifluoromethoxy)imidazo[1,2-a]pyridin-2-yl]carbamate (intermediate III-7, 1.00 g, 2.4 mmol prepared as described above) in acetonitrile (15 mL) was added cesium carbonate (1.20 g, 3.50 mmol) and then a solution of methyl 2-(bromomethyl)-5-(trifluoromethylsulfonyl)benzoate (prepared according to WO20 / 174094, 1.80 g, 3.50 mmol) in acetonitrile (2 mL) was added dropwise. The reaction mixture was heated to 50 ° C and stirred for 2 hours. After cooling to room temperature, it was diluted with water and the product was extracted three times with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (ethyl acetate gradient in cyclohexane) to give the desired product (2.10 g). LCMS (method 2): m / z 704 [M+H] + , retention time Rt = 1.68min.

[0784] Step 9: 2-[[[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]amino Preparation of methyl]-5-(trifluoromethylsulfonyl)benzoate (Intermediate III-9)

[0785]

[0786] To a solution of methyl 2-[[tert-butoxycarbonyl-[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethylsulfonyl)benzoate (Intermediate III-8 prepared as described above, 2.70 g, 3.80 mmol) in trifluorotoluene (14.0 mL) was added 2,2,2-trifluoroacetic acid (5.90 mL, 77.0 mmol). The reaction mixture was stirred at room temperature for 4 hours, then diluted with water and the product was extracted with ethyl acetate. The combined organic layers were washed with saturated aqueous sodium bicarbonate solution, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (1.30 g). LCMS (Method 2): m / z 604 [M+H] + , retention time Rt = 1.60min.

[0787] Step 10: 2-[[[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl] Preparation of [amino]methyl]-5-(trifluoromethylsulfonyl)benzoic acid (Intermediate III-10)

[0788]

[0789] To a solution of methyl 2-[[[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethylsulfonyl)benzoate (Intermediate III-9 prepared as described above, 0.70 g, 1.16 mmol) in NMP (14.0 mL) was added lithium chloride (0.34 g, 8.12 mmol) and the reaction mixture was stirred in a microwave at 150 ° C for 1.5 hours. The mixture was diluted with water and then acidified with 2N aqueous hydrochloric acid. The precipitate formed was filtered and dried to give the desired product (0.35 g), which was used without further purification. LCMS (Method 2): m / z 590 [M+H] + , retention time Rt = 1.51 min.

[0790] Step 11: 2-[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]-6- Preparation of (trifluoromethylsulfonyl)isoindolin-1-one (Compound P33)

[0791]

[0792] To a solution of 2-[[[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethylsulfonyl)benzoic acid (Intermediate III-10 prepared as described above, 0.80 g, 1.36 mmol) in pyridine (4.00 mL) was added phosphoryl chloride (0.26 mL, 2.71 mmol) at 0°C, and the reaction mixture was stirred at room temperature for 10 minutes. The mixture was diluted with water, then acidified with 1N aqueous hydrochloric acid solution, and the product was extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (0.29 g). LCMS (Method 2): m / z 572 [M+H] + , retention time Rt = 1.53min. 1 H NMR(400MHz, CDCl3)δppm:1.50(t,3H),3.79(q,2H),4.48(q,2H),5.21(s,2H),6 .90(dd,1H),6.97(d,1H),7.88(d,1H),8.31(dd,1H),8.63(s,1H),8.78(d,1H).

[0793] Example H4: N-[3-ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridine-6- Preparation of [1,2-a]pyridin-6-yl]imidazo[1,2-a]pyridin-6-yl]acetamide (Compound P36)

[0794]

[0795] Step 1: 2-[[(6-Bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-tert-butoxycarbonyl-amino Preparation of ethyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate IV-1)

[0796]

[0797] To a solution of tert-butyl N-(6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)carbamate (intermediate IQ-8, 0.84 g, 2.08 mmol prepared similarly to intermediate III-7 above) in acetonitrile (13.0 mL) was added cesium carbonate (1.02 g, 3.12 mmol). The reaction mixture was stirred at room temperature for 5 minutes, then a solution of ethyl 2-(bromomethyl)-5-(trifluoromethyl)pyridine-3-carboxylate (intermediate II-4-a, 0.84 g, 2.70 mmol prepared similarly to intermediate II-4 above) in acetonitrile (8.4 mL) was added dropwise, and the resulting mixture was stirred at 50 ° C for 2 hours. After cooling to room temperature, ice-cold water was added and the product was extracted twice with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (0.95 g). LCMS (Method 1): m / z 635 / 637 [M+H] + , retention time 1.26min.

[0798] 1 H NMR (400MHz, DMSO-d6) δppm: 9.15(s,1H),8.88(s,1H),8.57(br s,1H),7.72(brd,1h),7.64(br d,1H),5.38(br s,2H),4.36(q,2H),3.68-3.80(m,2H),1.29-1.40(t,6H),1.27(s,9H).

[0799] Step 2: 2-[[(6-Bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)amino]methyl]-5-(trifluoromethyl)- Preparation of ethyl (fluoromethyl)pyridine-3-carboxylate (Intermediate IV-2)

[0800]

[0801] To a solution of ethyl 2-[[(6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-tert-butoxycarbonyl-amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate IV-1 prepared as described above, 0.95 g, 1.50 mmol) in trifluorotoluene (4.8 mL) was added 2,2,2-trifluoroacetic acid (2.29 mL, 29.9 mmol). The reaction mixture was stirred at room temperature for 4 hours, then diluted with water and extracted with ethyl acetate. The organic phase was washed with aqueous sodium bicarbonate, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (0.75 g). LCMS (Method 1): m / z 535 / 537 [M+H] +, retention time 1.18min.

[0802] 1 H NMR (400MHz, DMSO-d6) δppm: 9.14(d,1H),8.60(d,1H),8.52(d,1H),7.61(dd,1H),7.44(d,1H),6.90(br s,1H),5.13(s,2H),4.41(q,2H),3.43(d,2H),1.39(t,3H),1.13-1.23(t,3H).

[0803] Step 3: 2-[[(6-Bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)amino]methyl]-5-(trifluoromethyl)- Preparation of (4-fluoromethyl)pyridine-3-carboxylic acid (Intermediate IV-3)

[0804]

[0805] To a suspension of ethyl 2-[[(6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate IV-2 prepared as described above, 0.90 g, 1.68 mmol) in methanol (18 mL) was added dihydroxybarium octahydrate (1.33 g, 4.20 mmol) in water (9 mL). The reaction mixture was stirred at room temperature for 18 hours and then concentrated under reduced pressure. Water was added to the residue and the mixture was acidified with 2N aqueous hydrochloric acid solution. The precipitate formed was filtered and dried under reduced pressure to give the desired product (0.68 g), which was used without further purification. LCMS (Method 1): m / z 507 / 509 [M+H] + , retention time 1.01min.

[0806] Step 4: 6-(6-Bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyridin-2-yl Preparation of pyrrolidine [3,4-b] pyridin-5-one (compound P21)

[0807]

[0808] To a solution of 2-[[(6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylic acid (intermediate IV-3, 4.3 g, 8.5 mmol prepared as described above) in pyridine (22 mL) was added phosphoryl chloride (1.6 mL, 17 mmol) at 0°C, and the mixture was stirred at room temperature for 10 minutes. Water was added to the reaction mixture, which was acidified with 1N aqueous hydrochloric acid solution, and the product was extracted three times with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (ethyl acetate gradient in cyclohexane). The purified product was dissolved in acetonitrile and water was added. The formed precipitate was filtered and dried to give the desired product (2.6 g). LCMS (method 1): m / z 489 / 491 [M+H] + , retention time 1.11min. 1 H NMR (400MHz, DMSO-d6) δppm: 9.32 (d, 1H), 8.97 (t, 1H), 8.74 (d, 1H), 7.87 (d, 2H), 5.26 (s, 2H), 3.89 (q, 2H), 1.35 (t, 3H).

[0809] Step 5: N-[3-ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridine-6- Preparation of tert-butyl]imidazo[1,2-a]pyridin-6-yl]carbamate (Intermediate IV-4)

[0810]

[0811] To a solution of 6-(6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (compound P21, 0.5 g, 1.02 mmol prepared as described above) in toluene (5 mL) was added tert-butyl carbamate (0.14 g, 1.23 mmol) and dicyclohexyl-[2-(2,4,6-triisopropylphenyl)phenyl]phosphane (0.58 g, 1.23 mmol). The mixture was degassed with argon, and then cesium carbonate (0.54 g, 1.64 mmol) and palladium diacetate (23 mg, 0.10 mmol) were added. The reaction mixture was stirred at 110 ° C for 2 hours. After cooling, the reaction mixture was poured into water and the product was extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered through a celite pad, and the filtrate was concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (0.12 g). LCMS (Method 1): m / z 526 [M+H] + , retention time 1.10min.

[0812] Step 6: 6-(6-amino-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-Preparation of pyrrolo[3,4-b]pyridin-5-one (Intermediate IV-5)

[0813]

[0814] To a solution of tert-butyl N-[3-ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-6-yl]imidazo[1,2-a]pyridin-6-yl]carbamate (Intermediate IV-4 prepared as described above, 0.12 g, 0.23 mmol) in trifluorotoluene (0.6 mL) was added 2,2,2-trifluoroacetic acid (0.35 mL, 4.57 mmol). The reaction mixture was stirred at room temperature for 16 hours, then diluted with water and the product was extracted with ethyl acetate. The organic phase was washed with aqueous sodium bicarbonate, dried over sodium sulfate, filtered and concentrated under reduced pressure to give the desired product (23 mg), which was used without further purification. LCMS (Method 1): m / z 426 [M+H] + , retention time 0.95min.

[0815] Step 7: N-[3-ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridine-6- Preparation of [1,2-a]pyridin-6-yl]imidazo[1,2-a]pyridin-6-yl]acetamide (P36)

[0816]

[0817] To a solution of 6-(6-amino-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Intermediate IV-5, 23 mg, 0.054 mmol prepared as described above) in acetonitrile (0.23 mL) was added triethylamine (0.023 mL, 0.16 mmol). The solution was cooled to 0-5°C and then acetyl chloride (0.004 mL, 0.054 mmol) was added dropwise. The reaction mixture was stirred at 25°C for 1 hour, diluted with water, and the product was extracted with ethyl acetate. The organic phase was dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (13 mg). LCMS (Method 2): m / z 468 [M+H] + , retention time 1.25min. 1 H NMR(400MHz, CDCl3)δppm:9.49(s,1H),9.11(s,1H),8.47(s,1H),7.64(d, 1H),7.43-7.49(m,2H),5.2(s,2H),3.76(q,2H),2.26(s,3H),1.53(t,3H).

[0818] Example H5: 2-[3-ethylsulfonyl-2-[1-oxo-6-(trifluoromethoxy)isoindolin-2-yl]imidazo Preparation of [1,2-a]pyridin-6-yl]oxy-2-methyl-propionitrile (Compound P26)

[0819]

[0820] Step 1: 2-[[tert-Butyloxycarbonyl-(3-ethylsulfonyl-6-methoxy-imidazo[1,2-a]pyridin-2-yl) Preparation of methyl]amino]methyl]-5-(trifluoromethoxy)benzoate (Intermediate V-1)

[0821]

[0822] To a solution of tert-butyl N-(3-ethylsulfonyl-6-methoxy-imidazo[1,2-a]pyridin-2-yl)carbamate (intermediate IQ-5, 1.0 g, 2.8 mmol prepared similarly to intermediate III-7 above) in acetonitrile (15.0 mL) was added cesium carbonate (1.4 g, 4.2 mmol). The reaction mixture was stirred at room temperature for 5 minutes, and then a solution of methyl 2-(bromomethyl)-5-(trifluoromethoxy)benzoate (prepared according to WO 20 / 174094, 1.3 g, 4.2 mmol) in acetonitrile (2 mL) was added dropwise. The reaction mixture was stirred at 50 ° C for 2 hours, cooled, diluted with ice-cold water, and the product was extracted twice with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (ethyl acetate gradient in cyclohexane) to obtain the desired product (1.9 g). LCMS (method 1): m / z 588 [M+H] + , retention time 1.24min.

[0823] Step 2: 2-[[(3-ethylsulfonyl-6-methoxy-imidazo[1,2-a]pyridin-2-yl)amino]methyl]-5- Preparation of methyl (trifluoromethoxy)benzoate (Intermediate V-2)

[0824]

[0825] To a solution of methyl 2-[[tert-butoxycarbonyl-(3-ethylsulfonyl-6-methoxy-imidazo[1,2-a]pyridin-2-yl)amino]methyl]-5-(trifluoromethoxy)benzoate (Intermediate V-1 prepared as described above, 1.9 g, 3.2 mmol) in trifluorotoluene (9.5 mL) was added 2,2,2-trifluoroacetic acid (4.9 mL, 65 mmol). The reaction mixture was stirred at room temperature for 4 hours, then diluted with water and extracted with ethyl acetate. The organic phase was washed with aqueous sodium bicarbonate, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (0.75 g). LCMS (Method 1): m / z 488 [M+H] + , retention time 1.15min.

[0826] 1H NMR (400MHz, DMSO-d6) δppm: 8.06(d,1H),7.73-7.8(m,1H),7.65(d,1H),7.59(br d,1H),7.39(d,1H),7.27(dd,1H),6.61(br t,1H),4.85(br d,2H),3.91(s,3H),3.83(m,3H),3.30-3.42(m,2H),1.09(t,3H).

[0827] Step 3: 2-[[(3-ethylsulfonyl-6-methoxy-imidazo[1,2-a]pyridin-2-yl)amino]methyl]-5- Preparation of (trifluoromethoxy)benzoic acid (Intermediate V-3)

[0828]

[0829] To a suspension of methyl 2-[[(3-ethylsulfonyl-6-methoxy-imidazo[1,2-a]pyridin-2-yl)amino]methyl]-5-(trifluoromethoxy)benzoate (Intermediate V-2 prepared as described above, 1.0 g, 2.1 mmol) in methanol (20 mL) was added dihydroxybarium octahydrate (1.6 g, 5.1 mmol) in water (10 mL). The reaction mixture was stirred at room temperature for 18 hours and then concentrated under reduced pressure. Water was added to the residue, and the mixture was then acidified with 2N aqueous hydrochloric acid solution, and the resulting precipitate was filtered and dried under reduced pressure to give the desired product (0.84 g), which was used without further purification. LCMS (Method 1): m / z 474 [M+H] + , retention time 1.10min.

[0830] Step 4: 2-(3-ethylsulfonyl-6-methoxy-imidazo[1,2-a]pyridin-2-yl)-6-(trifluoromethoxy) Preparation of Isoindolin-1-one (Intermediate V-4)

[0831]

[0832] To a solution of 2-[[(3-ethylsulfonyl-6-methoxy-imidazo[1,2-a]pyridin-2-yl)amino]methyl]-5-(trifluoromethoxy)benzoic acid (Intermediate V-3 prepared as described above, 0.9 g, 1.90 mmol) in pyridine (4.5 mL) was added phosphoryl chloride (0.36 mL, 3.8 mmol, 2 equivalents) at 0°C. The mixture was stirred at room temperature for 10 minutes, quenched by the addition of water, acidified with 1N aqueous hydrochloric acid solution, and the product was extracted three times with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane). The purified product was dissolved in acetonitrile and water was added. The formed precipitate was filtered and dried to give the desired product (0.7 g). LCMS (Method 2): m / z 456 [M+H] +, retention time 1.48min. 1 H NMR (400MHz, DMSO-d6) δppm: 8.35(d,1H),7.87(d,1H),7.74-7.82(m,3H),7.52(dd,1H),5.08(s,2H),3.90(s,3H),3.82(q,2H),1.34(t,3H).

[0833] Step 5: 2-(3-ethylsulfonyl-6-hydroxy-imidazo[1,2-a]pyridin-2-yl)-6-(trifluoromethoxy)iso Preparation of indolin-1-one (Intermediate V-5)

[0834]

[0835] To 2-(3-ethylsulfonyl-6-methoxy-imidazo[1,2-a]pyridin-2-yl)-6-(trifluoromethoxy)isoindolin-1-one (Intermediate V-4, 0.65 g, 1.43 mmol prepared as described above) was added a 1M solution of tribromoborane in dichloromethane (14.3 mL, 14.3 mmol) at 0°C and the reaction mixture was stirred at room temperature for 2 hours. The mixture was slowly poured into ice and extracted twice with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (0.59 g). LCMS (Method 2): m / z 442 [M+H] + , retention time 1.43min. 1 H NMR (400MHz, DMSO-d6) δppm: 10.22(s,1H),8.4(d,1H),7.86(d,1H),7.70-7.80(m,3H),7.37(dd,1H),5.05(s,2H),3.73(q,2H),1.32(t,3H).

[0836] Similarly, 6-(3-ethylsulfonyl-6-hydroxy-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (V-5-a) can be prepared:

[0837]

[0838] LCMS (Method 1): m / z 427 [M+H] + , retention time 0.99min. 1H NMR (400MHz, CDCl3) δ / ppm: 1.31(t,3H),3.72(q,2H),5.19(s,2H),7.38(dd,1H),7.74(d,1H),8.39(d,1H),8.71(d,1H),9.32(d,1H),10.26(s,1H).

[0839] Step 6: 2-[3-ethylsulfonyl-2-[1-oxo-6-(trifluoromethoxy)isoindolin-2-yl]imidazo[1, Preparation of 2-a]pyridin-6-yl]oxy-2-methyl-propionamide (Intermediate V-6)

[0840]

[0841] To a solution of 2-(3-ethylsulfonyl-6-hydroxy-imidazo[1,2-a]pyridin-2-yl)-6-(trifluoromethoxy)isoindolin-1-one (Intermediate V-5, 0.58 g, 1.31 mmol prepared as described above) in acetonitrile (12.0 mL) was added cesium carbonate (0.86 g, 2.63 mmol). The reaction mixture was stirred at room temperature for 5 minutes, then 2-bromo-2-methyl-propionamide (0.44 g, 2.63 mmol) was added and stirring was continued at 60° C. for 12 hours. The mixture was concentrated under reduced pressure and dissolved with water and ethyl acetate. The organic layer was washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (ethyl acetate gradient in cyclohexane) to give the desired product (0.32 g). LCMS (Method 2): m / z 527 [M+H] + , retention time 1.40min. 1 H NMR (400MHz, DMSO-d6) δppm: 8.51(d,1H),7.87(d,1H),7.76-7.83(m,3H),7.73(s,1 H),7.51(dd,1H),7.42(s,1H),5.09(s,2H),3.76(q,2H),1.49(s,6H),1.34(t,3H).

[0842] Similarly, 2-[3-ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-6-yl]imidazo[1,2-a]pyridin-6-yl]oxy-2-methyl-propionamide (V-6-a) can be prepared:

[0843]

[0844] LCMS (Method 1): m / z 512 [M+H] + , retention time 1.02min.

[0845] Step 7: 2-[3-ethylsulfonyl-2-[1-oxo-6-(trifluoromethoxy)isoindolin-2-yl]imidazo[1, Preparation of 2-a]pyridin-6-yl]oxy-2-methyl-propionitrile (Compound P26)

[0846]

[0847] To a solution of 2-[3-ethylsulfonyl-2-[1-oxo-6-(trifluoromethoxy)isoindolin-2-yl]imidazo[1,2-a]pyridin-6-yl]oxy-2-methyl-propionamide (Intermediate V-6, 0.32 g, 0.61 mmol prepared as described above) in tetrahydrofuran was added triethylamine (2.43 mmol, 4 equivalents) at 0°C, followed by the dropwise addition of trifluoroacetic anhydride (2.43 mmol, 4 equivalents) at 0°C. The reaction mixture was stirred at room temperature for 3 hours, then carefully quenched and basified with aqueous sodium bicarbonate solution. The aqueous phase was extracted twice with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (0.25 g). LCMS (Method 2): m / z 509 [M+H] + , retention time 1.52min. 1 H NMR (400MHz, CDCl3) δppm:8.89(s,1H),7.82(s,1H),7.70(d,1H),7.61(d,1H),7.51(br d,2H),5.10(s,2H),3.83(q,2H),1.82(s,6H),1.52(t,3H).

[0848] Example H6: 2-[3-Ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridine-6- Preparation of [1,2-a]pyridin-6-yl]-2-methyl-propionitrile (compound P35)

[0849]

[0850] Step 1: Preparation of 2-(6-chloro-3-pyridyl)-2-methyl-propionitrile (Intermediate VI-1)

[0851]

[0852] To a solution of 2-(6-chloro-3-pyridyl)acetonitrile (5.00 g, 33.0 mmol) in tetrahydrofuran (50 mL) was added sodium hydride (60% mass in oil) (3.30 g, 82.0 mmol) at 0°C. The reaction mixture was stirred at 0°C for 15 minutes, then iodomethane (5.10 mL, 82 mmol) was added at 0°C. The reaction mixture was stirred at room temperature for 2 hours, diluted with ice-cold water and the product was extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was used without further purification. This reaction was carried out in 6 batches to give the desired product (35.0 g). LCMS (Method 1): m / z 180 [M+H] +, retention time 0.99min. 1 H NMR (400MHz, CDCl3) δppm: 1.77 (s, 6H), 7.38 (d, 1H), 7.78 (dd, 1H), 8.52 (d, 1H).

[0853] Step 2: 2-(6-Chloro-3-pyridinyl)-2-methyl-propionitrile N-[5-(1-cyano-1-methyl-ethyl)-2-pyridine Preparation of tert-butyl]carbamate (Intermediate VI-2)

[0854]

[0855] To a solution of 2-(6-chloro-3-pyridyl)-2-methyl-propionitrile (intermediate VI-1, 20.0 g, 110 mmol prepared as described above) in 1,4-dioxane (400 mL) was added tert-butyl carbamate (19.5 g, 166 mmol) and cesium carbonate (54.2 g, 166 mmol). The reaction mixture was purged with argon for 15 minutes, and then 2-dicyclohexylphosphine-2′, 4′, 6′-triisopropylbiphenyl (X-Phos, 16.2 g, 33.2 mmol) and palladium (II) acetate (3.73 g, 16.7 mmol) were added and the reaction mixture was stirred at 110 ° C for 3 hours. After cooling to room temperature, the mixture was diluted with cold water and the product was extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was used without further purification (30.0 g). LCMS (Method 1): m / z 262 [M+H] + , retention time 1.08min.

[0856] Step 3: Preparation of 2-(6-amino-3-pyridyl)-2-methyl-propionitrile (Intermediate VI-3)

[0857]

[0858] To a solution of tert-butyl N-[5-(1-cyano-1-methyl-ethyl)-2-pyridyl]carbamate (intermediate VI-2, 28.0 g, 107 mmol prepared as described above) in trifluorotoluene (140 mL) was added 2,2,2-trifluoroacetic acid (164 mL, 2143 mmol). The reaction mixture was stirred at room temperature for 16 hours, then diluted with water and the product was extracted with ethyl acetate. The organic phase was washed with aqueous sodium bicarbonate, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (ethyl acetate gradient in cyclohexane) to give the desired product (21.0 g). LCMS (Method 1): m / z 162 [M+H] + , retention time 0.17min. 1H NMR (400MHz, CDCl3) δppm: 1.72 (s, 6H), 6.92 (d, 1H), 7.80 (d, 1H), 7.88 (dd, 1H).

[0859] Step 4: 6-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (Intermediate VI-4) Preparation

[0860]

[0861] To a solution of 2-(6-amino-3-pyridyl)-2-methyl-propionitrile (intermediate VI-3 prepared as described above, 15.0 g, 93.1 mmol) in ethanol (150 mL) was added NaHCO (15.6 g, 186 mmol) and ethyl 3-bromo-pyruvate (40.3 g, 186 mmol). The reaction mixture was stirred at 85° C. for 4 hours and then allowed to cool to room temperature. The mixture was diluted with cold water and the product was extracted with ethyl acetate. The organic phase was washed with aqueous sodium bicarbonate, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (13.2 g). LCMS (Method 1): m / z 258 [M+H] + , retention time 1.08min. 1 H NMR (400MHz, CDCl3) δppm: 1.43 (t, 3H), 1.78 (s, 6H), 4.46 (q, 2H), 7.24-7.31 (m, 1H), 7.72 (d, 1H), 8.21 (s, 1H), 8.30-8.33 (m, 1H).

[0862] Step 5: 3-Chloro-6-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (Intermediate Preparation of VI-5)

[0863]

[0864] To a solution of ethyl 6-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridine-2-carboxylate (intermediate VI-4, 13.2 g, 51.3 mmol prepared as described above) in acetonitrile (264 mL) was added N-chlorosuccinimide (8.22 g, 61.6 mmol). The reaction mixture was stirred at 50 ° C for 4 hours. The reaction mixture was diluted with cold water and extracted with ethyl acetate. The organic phase was washed with aqueous sodium bicarbonate, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was used without further purification (11.0 g). LCMS (Method 1): m / z 292 [M + H] + , retention time 1.31min. 1H NMR (400MHz, CDCl3) δppm: 1.48 (t, 3H), 1.84 (s, 6H), 4.52 (q, 2H), 7.50 (dd, 1H), 7.90 (d, 1H), 8.31 (m, 1H).

[0865] Step 6: 6-(1-cyano-1-methyl-ethyl)-3-ethylsulfanyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl Preparation of ester (intermediate VI-6)

[0866]

[0867] To a solution of ethyl 3-chloro-6-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridine-2-carboxylate (intermediate VI-5 prepared as described above, 11.0 g, 37.7 mmol) in dimethyl sulfoxide (110 mL) was added sodium ethanethiolate (6.34 g, 75.4 mmol) in portions. The reaction mixture was stirred at room temperature for 1 hour, then diluted with cold water and the formed precipitate was filtered and dried to give the desired product (8.00 g). LCMS (Method 1): m / z 318 [M+H] + , retention time 1.07min. 1 H NMR (400MHz, CDCl3) δppm: 1.21 (t, 3H), 1.47 (t, 3H), 1.82 (s, 6H), 2.97 (q, 2H), 4.50 (q, 2H), 7.40 (s, 1H), 7.74 (d, 1H), 8.69 (d, 1H). LCMS (Method 1): m / z 318[M+H] + , retention time 1.07min.

[0868] Step 7: 6-(1-Cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl Preparation of ester (intermediate VI-7)

[0869]

[0870] To a solution of 6-(1-cyano-1-methyl-ethyl)-3-ethylsulfanyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (Intermediate VI-6 prepared as described above, 8.00 g, 25.0 mmol) in trifluorotoluene (120 mL) was added portionwise 3-chloroperoxybenzoic acid (16.0 g, 63.0 mmol). The reaction mixture was stirred at room temperature for 24 hours. After dilution with saturated aqueous sodium bicarbonate solution, the resulting precipitate was filtered and dried. The crude residue was purified by silica gel chromatography (gradient of ethyl acetate in cyclohexane) to give the desired product (6.70 g). LCMS (Method 1): m / z 350 [M+H]+, retention time 1.01 min. 1H NMR (400MHz, CDCl3) δppm: 1.40(t,3H), 1.49(t,3H), 1.83(s,6H), 3.76(q,2H), 4.54(q,2H), 7.66(dd,1H), 7.89(d,1H), 9.41(d,1H).

[0871] Step 8: 6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid (middle Preparation of Intermediate VI-8)

[0872]

[0873] To a solution of 6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (intermediate VI-7, 6.7 g, 19.0 mmol prepared as described above) in tetrahydrofuran (67 mL) and water (27 mL) was added lithium hydroxide (1.60 g, 38.0 mmol) in water (32 mL) in portions at 0°C-5°C. The reaction mixture was stirred at room temperature for 5 hours, then acidified with 2N aqueous hydrochloric acid solution, diluted with water and the product extracted with ethyl acetate. The organic phase was dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was used without further purification (5.30 g). LCMS (Method 1): m / z 322 [M+H] + , retention time 0.89min. 1 H NMR (400MHz, DMSO-d6) δppm: 1.25 (t, 3H), 1.78 (s, 6H), 3.72 (q, 2H), 7.89 (dd, 1H), 7.96 (d, 1H), 9.12 (s, 1H), 13.79-14.02 (m, 1H).

[0874] Step 9: N-[6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl] Preparation of tert-butyl carbamate (intermediate VI-9)

[0875]

[0876] To a solution of 6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid (intermediate VI-8, 5.30 g, 16.0 mmol prepared as described above) in tert-butanol (27 mL) and toluene (53 mL) was added triethylamine (3.00 mL, 21.0 mmol) followed by dropwise addition of diphenylphosphoryl azide (4.70 mL, 21.0 mmol). The reaction mixture was stirred at 80 ° C for 30 minutes and then cooled to room temperature. The mixture was diluted with ice, the product was extracted with ethyl acetate, the organic phase was dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (ethyl acetate gradient in cyclohexane) to give the desired product (1.80 g). LCMS (Method 1): m / z 393 [M + H] + , retention time 1.04min. 1 H NMR (400MHz, DMSO-d6) δppm: 1.26 (t, 3H), 1.47 (s, 9H), 1.77 (s, 6H), 3.65 (q, 2H), 7.77-7.84 (m, 2H), 8.79 (s, 1H), 9.40 (s, 1H).

[0877] Step 10: 2-[[tert-Butoxycarbonyl-[6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo] Preparation of [1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylic acid ethyl ester (Intermediate VI-10)

[0878]

[0879] To a solution of tert-butyl N-[6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]carbamate (intermediate VI-9, 0.50 g, 1.27 mmol prepared as described above) in acetonitrile (7.50 mL) was added cesium carbonate (0.63 g, 1.91 mmol) and then a solution of ethyl 2-(bromomethyl)-5-(trifluoromethyl)pyridine-3-carboxylate (intermediate II-4-a, 0.52 g, 1.66 mmol prepared similarly to intermediate II-4 above) in acetonitrile (7.50 mL) was added dropwise. The reaction mixture was heated to 50 ° C and stirred for 2 hours. After cooling to room temperature, it was diluted with water and the product was extracted three times with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was used without further purification (0.60 g). LCMS (method 1): m / z 624 [M+H] + , retention time 1.52min.

[0880] Step 11: 2-[[[6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2- Preparation of ethyl]amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate VI-11)

[0881]

[0882] To a solution of ethyl 2-[[tert-butoxycarbonyl-[6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate VI-10 prepared as described above, 0.60 g, 0.96 mmol) in trifluorotoluene (3.00 mL) was added 2,2,2-trifluoroacetic acid (1.47 mL, 19.2 mmol). The reaction mixture was stirred at room temperature for 16 hours, then diluted with water and the product was extracted with ethyl acetate. The combined organic layers were washed with saturated aqueous sodium bicarbonate solution, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was used without further purification (0.48 g). LCMS (Method 1): m / z 524 [M+H] + , retention time 1.12min. 1 H NMR (400MHz, DMSO-d6) δppm: 1.18(t,3H),1.39(t,3H),1.74(s,6H),3.41(q,2H),4.42(q,2H),5.14(br d,2H),6.90(br t,1H),7.53(d,1H),7.67(dd,1H),8.53(d,1H),8.56(d,1H),9.13(m,1H).

[0883] Step 12: 2-[[[6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2- Preparation of [3-(4-(4-(2-methyl-1-thiazolyl)amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylic acid (Intermediate VI-12)

[0884]

[0885] To a solution of ethyl 2-[[[6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylate (Intermediate VI-11 prepared as described above, 0.48 g, 0.92 mmol) in methanol (9.60 mL) was added dihydroxybarium octahydrate (0.72 g, 2.29 mmol) dissolved in water (4.8 mL). The reaction mixture was stirred at room temperature for 4 hours, and then the volatiles were removed under reduced pressure. The residue was acidified with 2N aqueous hydrochloric acid solution, and the formed precipitate was filtered and dried to give the desired product (0.41 g). LCMS (Method 1): m / z 496 [M+H] + , retention time 1.02min. 1H NMR (400MHz, DMSO-d6) δppm: 1.18 (t, 3H), 1.74 (s, 6H), 3.42 (q, 2H), 5.16 (br d,2H),6.98(t,1H),7.55(d,1H),7.67(dd,1H),8.52(d,1H),8.57(s,1H),9.11-9.13(m,1H).

[0886] Step 13: 2-[3-ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridine-6- Preparation of [1,2-a]pyridin-6-yl]-2-methyl-propionitrile (P35)

[0887]

[0888] To a solution of 2-[[[6-(1-cyano-1-methyl-ethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]amino]methyl]-5-(trifluoromethyl)pyridine-3-carboxylic acid (Intermediate VI-12 prepared as described above, 0.40 g, 0.81 mmol) in pyridine (2.00 mL) was added phosphoryl chloride (0.15 mL, 1.65 mmol) at 0°C. The reaction mixture was stirred at room temperature for 10 minutes, then diluted with water, acidified with 1N aqueous hydrochloric acid solution and the product extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (gradient of ethyl acetate in cyclohexane) to give the desired product (0.25 g). LCMS (Method 1): m / z 478 [M+H] + , retention time 1.04min. 1 H NMR (400MHz, CDCl3) δppm: 1.55 (t, 3H), 1.86 (s, 6H), 3.83 (q, 2H), 5.23 (s, 2H), 7.66 (dd, 1H), 7.79 (d, 1H), 8.49 (s, 1H), 9.04 (s, 1H), 9.13 (s, 1H).

[0889] Example H7: 6-[6-(2,2-difluoroethoxy)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]-3- Preparation of (trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P19)

[0890]

[0891] To a solution of 6-(3-ethylsulfonyl-6-hydroxy-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (intermediate V-5-a prepared as described above) (40 mg, 0.094 mmol) in acetonitrile (0.8 mL) was added potassium carbonate (3 equivalents, 0.281 mmol) and 2,2-difluoroethyl trifluoromethanesulfonate (1.3 equivalents, 0.122 mmol) at room temperature. The reaction mixture was stirred at room temperature overnight, then added to water (10 mL) and the product was extracted twice with ethyl acetate (2x8 mL). The combined organic layers were washed with brine (10 mL), dried over sodium sulfate, filtered and concentrated under vacuum. The crude residue was purified by combiflash chromatography (50%-60% ethyl acetate in cyclohexane) to give the desired product (32 mg). LCMS (Method 1): m / z 491 [M+H] + , retention time 1.09min.

[0892] Example H8: 6-[6-(Difluoromethoxy)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]-3-(trifluoro Preparation of methyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P10)

[0893]

[0894] To a solution of 6-(3-ethylsulfonyl-6-hydroxy-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Intermediate V-5-a prepared as described above) (0.1 g, 0.235 mmol) and potassium carbonate (1.5 eq., 0.352 mmol) in N,N-dimethylformamide (3 mL) was added sodium 2-chloro-2,2-difluoro-acetate (2.0 eq., 0.469 mmol). The reaction mixture was stirred at 60° C. for 5 hours, then diluted with water (20 mL), and the product was extracted with ethyl acetate (3×10 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude product was purified by combiflash (silica gel, 30% ethyl acetate in cyclohexane) to give the desired product (26 mg). LCMS (Method 1): m / z 477 [M+H] + , retention time 1.00min.

[0895] Example H9: 6-(7-Cyclopropyl-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)- Preparation of 7H-pyrrolo[3,4-b]pyridin-5-one (Compound P24)

[0896]

[0897] To 6-(7-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P22) (240 mg, 0.40 mmol) in toluene (4 mL) and water (0.8 mL) was added potassium carbonate (3 equiv.), cyclopropylboronic acid (2 equiv.), and the solution was flushed with argon for 10 minutes. 1,1'-Bis(diphenylphosphino)ferrocene-palladium(II) dichloromethane complex (0.05 equiv.) was added and the solution was further flushed with nitrogen for 5 minutes before being heated in a microwave at 110°C for 1.5 hours. After cooling to room temperature, the mixture was diluted with water and the product was extracted three times with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by combiflash column chromatography (0%-30% ethyl acetate in cyclohexane) to give the desired product (133 mg) as a solid. LCMS (Method 2): m / z 451 [M+H] + , retention time 1.48min.

[0898] Table P: Examples of compounds of formula (I)

[0899]

[0900]

[0901]

[0902]

[0903]

[0904]

[0905]

[0906]

[0907]

[0908] Intermediate preparation:

[0909] Example I1: Preparation of ethyl 5-(bromomethyl)-2-(trifluoromethyl)pyridine-4-carboxylate (Intermediate IP-5)

[0910]

[0911] Step A1: 5-chloro-2-(trifluoromethyl)pyridine-4-carboxylic acid (Intermediate IP-1) and 5-chloro-2-(trifluoromethyl)pyridine Preparation of 2,2,6,6-tetramethylpiperidin-1-ium 4-pyridinecarboxylate (Intermediate IP-2)

[0912]

[0913] 2.0M butyllithium solution (165mL, 330mmol, 4.00 equivalents) in tetrahydrofuran is added dropwise to -78 DEG C of cooling solutions of 2,2,6,6-tetramethylpiperidine (35.0g, 248mmol, 3.00 equivalents) in tetrahydrofuran (500mL). After the addition is complete, the reaction mixture is stirred at -50 DEG C for 30min and cooled to -78 DEG C again, followed by the addition of a solution of 5-chloro-2-(trifluoromethyl)pyridine (15.0g, 82.6mmol) in tetrahydrofuran (100mL). The reaction mixture is stirred at -78 DEG C for 30min and then added to a saturated solution of CO in tetrahydrofuran cooled at -78 DEG C via a cannula. Once the addition is complete, the reaction mixture is warmed to room temperature and quenched by adding a saturated aqueous ammonium chloride solution (200mL). The aqueous phase was extracted twice with ethyl acetate (200 mL), and the combined organic phases were dried over sodium sulfate, filtered, and concentrated under reduced pressure to give 5-chloro-2-(trifluoromethyl)pyridine-4-carboxylic acid 2,2,6,6-tetramethylpiperidin-1-ium salt (Intermediate IP-2). The aqueous phase was acidified to pH 3 by adding 2M aqueous hydrochloric acid solution and extracted twice with a 90 / 10 mixture of dichloromethane / methanol (200 mL). The combined organic phases were dried over sodium sulfate, filtered, and concentrated under reduced pressure to give 5-chloro-2-(trifluoromethyl)pyridine-4-carboxylic acid (Intermediate IP-1). Both crude materials were used in the next step without further purification. LCMS (Method 1): m / z 226 [M+H] + , retention time 0.67min.

[0914] 1 H NMR (400 MHz, DMSO-d6) δ / ppm: 8.18 (s, 1H), 8.98 (s, 1H) for 5-chloro-2-(trifluoromethyl)pyridine-4-carboxylic acid (IP-1).

[0915] Step A2: Preparation of ethyl 5-chloro-2-(trifluoromethyl)pyridine-4-carboxylate (Intermediate IP-3)

[0916]

[0917] The mixture of 5-chloro-2-(trifluoromethyl)pyridine-4-formic acid (intermediate IP-1 prepared as described above) (1.00g, 4.43mmol) and concentrated sulfuric acid (1.00mL) in ethanol (30mL) is heated under reflux overnight. After cooling to room temperature, the reaction mixture is concentrated and the residue is diluted with ice water (50mL). The aqueous phase is extracted twice with ethyl acetate (2x30mL), the organic phase merged is washed with salt water (30mL), dried over sodium sulfate, filtered and concentrated. The crude material is passed through silica gel flash chromatography (ethyl acetate in cyclohexane) to give the desired compound in a yellow liquid.

[0918] LCMS (method 1): m / z 254 [M+H] + , retention time 1.10min. 1 H NMR (400MHz, CDCl3) δ / ppm: 1.45 (t, J = 7.12Hz, 3H), 4.49 (q, J = 7.12Hz, 2H), 8.04 (s, 1H), 8.82 (s, 1H).

[0919] Step A3: Preparation of ethyl 5-methyl-2-(trifluoromethyl)pyridine-4-carboxylate (Intermediate IP-4)

[0920]

[0921] Potassium phosphate (4.5g, 21.3mmol, 3.0 equivalents) and tricyclohexylphosphine (0.2g, 0.71mmol, 0.10 equivalents) are added to a mixture of 5-chloro-2-(trifluoromethyl)pyridine-4-carboxylic acid ethyl ester (intermediate IP-3 prepared as described above) (1.8g, 7.1mmol) and methyl-boric acid (1.3g, 21.3mmol, 3.0 equivalents) in toluene (50mL) and water (5.0mL). The mixture is purged with nitrogen for 10min, and then palladium acetate (0.08g, 0.035mmol, 0.05 equivalents) is added. Purge is continued for 10min and the reaction mixture is heated at 100°C for 2 hours. After cooling to room temperature, the mixture is diluted with water (50mL) and ethyl acetate (50mL) and filtered through diatomaceous earth (washed with ethyl acetate). The phases are separated, the aqueous phase is extracted with ethyl acetate, and the organic phases combined are dried over sodium sulfate, filtered and concentrated. The crude material was purified by flash chromatography on silica gel (ethyl acetate in cyclohexane) to give the desired compound as a pale yellow liquid. LCMS (Method 1): m / z 234 [M+H] + , retention time 1.08min. 1 H NMR (400MHz, CDCl3) δ / ppm: 1.44 (t, J = 7.16Hz, 3H), 2.66 (s, 3H), 4.44 (q, J = 7.16Hz, 2H), 8.08 (s, 1H), 8.68 (s, 1H).

[0922] Step A4: Preparation of ethyl 5-(bromomethyl)-2-(trifluoromethyl)pyridine-4-carboxylate (Intermediate IP-5)

[0923]

[0924] N-Bromosuccinimide (1.40 g, 7.80 mmol, 1.40 equiv) and benzoyl peroxide (0.42 g, 1.70 mmol, 0.30 equiv) were added to a solution of ethyl 5-methyl-2-(trifluoromethyl)pyridine-4-carboxylate (intermediate IP-4 prepared as described above) (1.30 g, 5.60 mmol) in tetrachloromethane (45 mL). The reaction mixture was heated at 70 ° C overnight. After cooling to room temperature, the reaction mixture was diluted with ice water (20 mL) and the aqueous phase was extracted twice with ethyl acetate (10 mL). The combined organic phases were dried over sodium sulfate, filtered and concentrated. The crude material was purified by flash chromatography on silica gel (ethyl acetate in cyclohexane) to give the desired product. LCMS (method 1): m / z 312 / 314 [M+H] + , retention time 1.12min. 1 H NMR (400MHz, CDCl3) δ / ppm: 1.44 (t, J = 7.15Hz, 3H), 4.50 (q, J = 7.15Hz, 2H), 4.94 (s, 2H), 7.27 (s, 1H), 8.14 (s, 1H), 8.85 (s, 1H).

[0925] Similarly, methyl 5-(bromomethyl)-2-(trifluoromethyl)picolinate (IP-6) can be prepared:

[0926]

[0927] LCMS (Method 1): m / z 298 / 300 [M+H] + , retention time 1.06min. 1 HNMR (400MHz, CDCl3) δ / ppm: 4.04 (s, 3H), 4.95 (s, 2H), 8.15 (s, 1H), 8.87 (s, 1H).

[0928] Example I2: N-[6-(1,1-difluoroethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]aminomethane Preparation of tert-butyl ester (intermediate IQ-7)

[0929]

[0930] Step 1: Preparation of 6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (Intermediate IP-7) Preparation

[0931]

[0932] Obtained from 6-bromo-3-ethylsulfanyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (CAS 2093460-48-9) by following procedure example H3 / step 5. LCMS (method 1): m / z 361 / 363 [M+H]+ , retention time Rt = 0.93min.

[0933] Step 2: 6-(1-ethoxyvinyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (middle Preparation of intermediate IP-8

[0934]

[0935] To a solution of ethyl 6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylate (intermediate IP-7 prepared as described above) (5 g, 13.15 mmol) in N,N-dimethylformamide (52.6 mL) was added tributyl(1-ethoxyvinyl)tin (6.0 g, 15.78 mmol, 5.61 mL). The reaction mixture was flushed with nitrogen for 15 minutes, followed by the addition of bis(triphenylphosphine)palladium(II) dichloride (0.466 g, 0.657 mmol). The resulting mixture was heated at 80° C. for 3 hours, then cooled to room temperature and used directly in the next step.

[0936] Step 3: 6-Acetyl-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (Intermediate IP-9) Preparation

[0937]

[0938] To the crude solution of 6-(1-ethoxyvinyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (intermediate IP-8) obtained above, 2N aqueous hydrochloric acid solution (20 mL) was added and stirring was continued at room temperature for 60 minutes. The mixture was diluted with water (100 mL) and the product was extracted with ethyl acetate (100 mL). The organic layer was filtered through celite, the celite bed was washed with ethyl acetate (20 mL), the combined organic layers were washed with brine (10 mL), dried over sodium sulfate, filtered and concentrated under vacuum. The crude material was purified by combiflash (silica gel, 30%-60% ethyl acetate in cyclohexane) to obtain the desired product. LCMS (method 1): m / z 325[M+H] + , retention time Rt = 0.96min.

[0939] Step 4: 6-(1,1-difluoroethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (intermediate Preparation of IP-10

[0940]

[0941] To a solution of 6-acetyl-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (intermediate IP-9 prepared as described above) (2.6 g, 7.6 mmol) in toluene (26 mL) was added bis(2-methoxyethyl)aminosulfur trifluoride (13 g, 30 mmol, 11 mL) dropwise under nitrogen. The reaction mixture was stirred at 80 ° C for 12 hours, cooled and carefully quenched by adding saturated aqueous sodium carbonate solution. After further dilution with ice-cold water (100 mL), the product was extracted with ethyl acetate (3x75 mL), and the combined organic phases were dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by combiflash (20%-50% ethyl acetate in cyclohexane) to give the desired product. LCMS (method 1): m / z 347 [M+H] + , retention time Rt = 1.04min.

[0942] Step 5: 6-(1,1-difluoroethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid (Intermediate Preparation of IP-11

[0943]

[0944] Obtained by following Procedure Example H3 / Step 6 from 6-(1,1-difluoroethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester (Intermediate IP-10).

[0945] LCMS (method 1): m / z 319 [M+H] + , retention time Rt = 0.92min.

[0946] Step 6: N-[6-(1,1-difluoroethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]aminomethane Preparation of tert-butyl ester (intermediate IQ-7)

[0947]

[0948] Obtained by following procedure Example H3 / Step 7 from 6-(1,1-difluoroethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridine-2-carboxylic acid (Intermediate IP-11). 1 H NMR (400MHz, DMSO-d6) δppm 9.47 (s, 1H), 8.85 (d, 1H), 7.84 (d, 1H), 7.77 (dd, 1H), 3.68 (q, 2H), 2.08 (t, J = 19.07Hz, 3H), 1.48 (s, 9H), 1.26 (t, 3H).

[0949] Table Q: Examples of intermediate compounds of formula (XIX-Qa-1)

[0950]

[0951]

[0952]

[0953]

[0954] Table R: Examples of intermediate compounds of formula (X-Qa-1)

[0955]

[0956]

[0957]

[0958]

[0959] Where CyPr = cyclopropyl and 1-CNCyPr = 1-cyanocyclopropyl

[0960] By adding other insecticides, acaricides and / or fungicidal active ingredients, the activity of the composition according to the present invention can be significantly widened and adapted to prevailing conditions. Mixtures of compounds of Formula I with other insecticides, acaricides and / or fungicidal active ingredients can also have other unexpected advantages, which can also be described as synergistic in a wider sense. For example, better tolerance of plants, reduced phytotoxicity, insects can be controlled at their different developmental stages, or better behavior during their production (e.g., during grinding or mixing, during their storage or during their use).

[0961] Suitable active ingredients to be added here are, for example, representatives of the following classes of active ingredients: organophosphorus compounds, nitrophenol derivatives, thioureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridylmethyleneamino derivatives, macrolides, neonicotinoids and Bacillus thuringiensis preparations.

[0962] The following mixtures of a compound of formula I with an active ingredient are preferred (the abbreviation "TX" means "a compound selected from the group consisting of the compounds described in Tables A-1 to A-12, B-1 to B-12, C-1 to C-18, D-1 to D-18, E-1 to E-12, F-1 to F-12, G-1 to G-18, and H-1 to H-18 and Table P of the present invention"):

[0963] Adjuvants selected from the group consisting of: petroleum (alias) (628) + TX; insect control active substances selected from the group consisting of Abamectin + TX, Acetoquin + TX, Acetamiprid + TX, Acetamipril + TX, Flumethrin + TX, Acynonapyr + TX, Bifenapyr + TX, Afolan + TX, Cotton Boll + TX, Allethrin + TX, α-Cypermethrin + TX, Alpha-Cypermethrin + TX, Sulfonamido + TX, Methicillin + TX, Triazoline + TX, Cypermethrin + TX, Benzophenone + TX, Benzpyrimoxan + TX, β-Cypermethrin + TX, β-Cypermethrin + TX, Bifenazate + TX, Bifenthrin + TX, Bifenazate + TX, Bifenathiaceate + TX, Bifenathiaceate + TX, Bifenathiaceate + TX, Bifenathiaceate + TX, Bifenathiaceate + TX, Bifenathiaceate + TX, Allethrin + TX, bio-allethrin S)-cyclopentyl isomer + TX, bio-resmethrin + TX, bistrifluan + TX, broflanilide + TX, bromothrin + TX, bromophos-ethyl + TX, buprofezin + TX, butacarb + TX, cadusafos + TX, carbaryl + TX, butacarb + TX, batan + TX, CAS No.: 1632218-00-8 + TX, CAS No.: 1808115-49-2 + TX, CAS No.: 2032403-97-5 + TX, CAS No.: 2044701-44-0 + TX, CAS No.: 2128706-05-6 + TX, CAS No.: 22467 57-58-2 (or 2249718-27-0) + TX, CAS No. 907187-07-9 + TX, chlorantraniliprole + TX, chlordane + TX, chlorfenapyr + TX, chlorpromazine + TX, clenpyrine + TX, cloethocarb + TX, clothianidin + TX, 2-chlorophenyl N-methylcarbamate (CPMC) + TX, benzonitrile + TX, cyantraniliprole + TX, cyclofenapyr + TX, cyclobutrifluram + TX, pyrethroids + TX, cycloxanil + TX, cyflumetofen + TX, cyetpyrafen + TX, cyflumetofen + TX X、Cyfluthrin+TX、Cyhalodiamide+TX、Flucypermethrin+TX、Cypermethrin+TX、Cyproflanilide+TX、Cyromazine+TX、Deltamethrin+TX、Fenpyraclostrobin+TX、Chlormet+TX、Dibrom+TX、Dicloromezin+TX、Dimpropyridaz+TX、Dimorpholine+TX、Dinotriptyline+TX、Dinotefuran+TX、Vegetopyrin+TX、Emamectin (Azemectite)+TX、D-Chlorpheniramine+TX、ε-momfluorothrin+TX、ε-Metofluthrin + TX, Cypermethrin + TX, Ethion + TX, Ethiopromide + TX, Ethofenprox + TX, Ethozolin + TX, Fenamiphos + TX, Fenfluthrin + TX, Fenthiocarb + TX, Fenoxycarb + TX, Cypermethrin + TX, Fenpyroxymate + TX, Fensulfuron + TX, Fenthion + TX, Yesalin + TX, Cypermethrin + TX, Fipronil + TX, Flometoquin + TX, Flonicamid + TX, Fifop-Azur + TX, Fluazaindolizine + TX, Fifenpyroxymate + TX, Fensulfuron ... Diamide + TX, Flumethrin + TX, Flucitrinate + TX, Flufenacet + TX, Flucythrin + TX, Fluthiazolin + TX, Flumethrin + TX, Flufenacet + TX, Flupyram + TX, Flupentiofenox + TX, Flupyrimin + TX, Fluralaner + TX, Fluvalinate + TX, Fluxametamide + TX, Fosthiazol + TX, γ-Cyhalothrin + TX, Gossyplure, TM+TX, pyrimidine +TX, chlorfenapyr +TX, halfenprox +TX, heptafluthrin +TX, hexythiazox +TX, hydrazone +TX, imidophos +TX, imidacloprid +TX, imiprodinil +TX, indoxacarb +TX, iodomethane +TX, iprodione +TX, Isocycloseram +TX, isothiocarb +TX, ivermectin +TX, kappa-bifenthrin +TX, kappa-tefluthrin +TX, lambda-cyhalothrin +TX, lepidomectin +TX, chlorfenuron +TX, metaflumizone +TX, metaldehyde +TX, metamifentrin +TX, methomyl +TX, methoxyfenozide +TX, methoxyfluthrin Ester + TX, Metformin + TX, Zikewei + TX, Acarb + TX, Momfluorothrin + TX, Methionine + TX, Nicofluprole + TX; Nitenpyram + TX, Nithiothiazide + TX, Oxymethoate + TX, Oxamyl + TX, Oxazosulfyl + TX, Parathion-ethyl + TX, Permethrin + TX, Phenothrin + TX, Phosphamidon + TX, Piperonyl Butoxide + TX, Pirimicarb + TX, Pyrimidophos-ethyl + TX, Pyrimidophos-methyl + TX, Polyhedrosis virus + TX, Promethrin + TX, Profenofos + TX, Profluthrin + TX, Propargite + TX, Amidophos + TX, Propoxur + TX, Prothiophos + TX, Profenthrin (P rotrifenbute)+TX, Pyflubumide+TX, Pymetrozine+TX, Pyraclofos+TX, Pyrafluprole+TX, Pyridaben+TX, Pyridalyl+TX, Pyrifluquinazon+TX, Pyrimidine+TX, Pyrimidine+TX, Pyriflupyrid+TX, Pyriflufen+TX, Resmothrin+TX, Sarolaner+TX, Selamectin+TX, Silafluthrin+TX, Spinetoram+TX, Spinosad+TX, Spirodiclofen+TX, Spiromefox+TX, Spiropyrim+TX, Spiropidion+TX, Spirotetramat+TX X, sulfone cypermethrin + TX, tebufenoxam + TX, tebufenpyrad + TX, butyl pyrimidinphos (Tebupirimiphos) + TX, tefluthrin + TX, temephos + TX, tetrachlorantraniliprole + TX, tetrachlorantraniliprole (Tetrachlorantraniliprole) + TX, tetrachlorthiazolin + TX, tetrafluthrin + TX, acaricide + TX, flucyramid + TX, θ-cypermethrin + TX, thiacloprid + TX, thiamethoxam + TX, thiophanate + TX, thiodicarb + TX, long-lasting carboxylic acid + TX, methyl sulfophos + TX, thiophanate + TX, tioxazafen + TX, tolfenpyrad + TX, toxaphene + TX, tralomethrin + TX,Transfluthrin + TX, Triazophos + TX, Trichlorfon + TX, Chlorpyrifos + TX, Trichlorfon + TX, Triflumezopyrim + TX, Tyclopyrazoflor + TX, ζ-Cypermethrin + TX, Seaweed extract and fermentation products derived from sugar acyl + TX, Seaweed extract and fermentation products derived from sugar acyl (containing urea + TX, amino acids + TX, potassium and molybdenum, and EDTA-chelated manganese) + TX, Seaweed extract and fermented plant products + TX, Seaweed extract and fermented plant products (containing plant hormones + TX, vitamins + TX, EDTA-chelated copper + TX, zinc + TX, and iron + TX), Azadirachtin + TX, Bacillus aizawai + TX, Bacillus chitinosporus AQ746 (NRRL Accession No. B-21 618)+TX, Bacillus firmus+TX, Bacillus kurstaki+TX, Bacillus mycoides AQ726 (NRRL Accession No. B-21664)+TX, Bacillus pumilus (NRRL Accession No. B-30087)+TX, Bacillus pumilus AQ717 (NRRL Accession No. B-21662)+TX, Bacillus species AQ178 (ATCC Accession No. 53522)+TX, Bacillus species AQ175 (ATCC Accession No. 55608)+TX, Bacillus species AQ177 (ATCC Accession No. 55609)+TX, unspecified Bacillus subtilis+TX, Bacillus subtilis AQ153 (ATCC Accession No. 55614) + TX, Bacillus subtilis AQ30002 (NRRL Accession No. B-50421) + TX, Bacillus subtilis AQ30004 (NRRL Accession No. B-50455) + TX, Bacillus subtilis AQ713 (NRRL Accession No. B-21661) + TX, Bacillus subtilis AQ743 (NRRL Accession No. B-21665) + TX, Bacillus thuringiensis AQ52 (NRRL Accession No. B-21619) + TX, Bacillus thuringiensis BD#32 (NRRL Accession No. B-21530) + TX, Bacillus thuringiensis subsp. Kurstaki BMP 123+TX, Beauveria bassiana+TX, D-limonene+TX, Granulovirus+TX, Harpin+TX, Helicoverpa armigera nuclear polyhedrosis virus+TX, Heliothis corneum nuclear polyhedrosis virus+TX, Heliothis virescens nuclear polyhedrosis virus+TX, Australian Helicoverpa armigera nuclear polyhedrosis virus+TX, Metarhizium species+TX, Muscodor albus 620 (NRRL accession number 30547)+TX,Muscodor roseus A3-5 (NRRL Accession No. 30548) + TX, neem-based products + TX, Paecilomyces fumosorum + TX, Paecilomyces lilacinus + TX, Pasteuria szabalensis + TX, Pasteuria penetranta + TX, Pasteuria mycoides + TX, Pasteuria thornei + TX, Pasteuria + TX, p-cymene + TX, Plutella xylostella granulosis virus + TX, Plutella xylostella nuclear polyhedrosis virus + TX, polyhedrosis virus + TX, pyrethrum + TX, QRD 420 (terpenoid blend) + TX, QRD 452 (terpenoid blend) + TX, QRD 460 (terpenoid blend) + TX, Quillaja sapodilla + TX, Rhodococcus sphaeroides AQ719 (NRRL Accession No. B-21663) + TX, Spodoptera frugiperda nuclear polyhedrosis virus + TX, Streptomyces flavus (NRRL Accession No. 30232) + TX, Streptomyces sp. (NRRL Accession No. B-30145) + TX, terpenoid blend + TX, and Verticillium sp.;

[0964] an algaecide selected from the group consisting of bethoxazin [CCN] + TX, copper dioctanoate (IUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endoxan (295) + TX, fentin (347) + TX, slaked lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347) + TX;

[0965] Anthelmintics selected from the group consisting of: avermectin (1) + TX, clefonate (1011) + TX, cyclohexine + TX, doramectin (alias) [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin (alias) [CCN] + TX, ivermectin (alias) [CCN] + TX, milbemycin oxime (alias) [CCN] + TX, moxidectin (alias) [CCN] + TX, piperazine [CCN] + TX, selamectin (alias) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX;

[0966] Avicides selected from the group consisting of chloralose (127) + TX, endrin (1122) + TX, fenthion (346) + TX, pyridin-4-amine (IUPAC name) (23) and strychnine (745) + TX;

[0967] Bactericide selected from the group consisting of: 1-hydroxy-1H-pyridine-2-thione (IUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (IUPAC name) (170) + TX, copper hydroxide (IUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1105) + TX, dodesine (1112) + TX, fenaminosulf (1144) + TX, formaldehyde (404) + TX, mercaptophenone ( Synonyms) [CCN] + TX, kasugamycin (483) + TX, kasugamycin hydrochloride hydrate (483) + TX, nickel bis(dimethyldithiocarbamate) (IUPAC name) (1308) + TX, nitrapyrin (580) + TX, octhilinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (611) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, chlorpheniramine (766) + TX, and thimerosal (synonyms) [CCN] + TX;

[0968] A biological agent selected from the group consisting of: GV of cotton brown banded moth (alias) (12) + TX, Agrobacterium radiobacterium (alias) (13) + TX, Amblyseius spp. (alias) (19) + TX, NPV of celery budworm (alias) (28) + TX, Anagrus atomus (alias) (29) + TX, Aphelinus abdominalis (alias) (33) + TX, Aphidius colemani (alias) (34) + TX, Aphidoletes aphidimyza (alias) (35) + TX, NPV of lucerne budworm (alias) (38) + TX, Bacillus firmus (alias) (48) + TX, Bacillus sphaericus Neide)(scientific name)(49)+TX、Bacillus thuringiensis Berliner)(scientific name)(51)+TX、Bacillus thuringiensis subsp.aizawai)(scientific name)(51)+TX、Bacillus thuringiensis subsp.israelensis)(scientific name)(51)+TX、Bacillus thuringiensis subsp.japonensis)(scientific name)(51)+TX、Bacillus thuringiensis subsp.kurstaki)(scientific name)(51)+TX、Bacillus thuringiensis subsp.tenebrionis (scientific name) (51) + TX, Beauveria bassiana (alias) (53) + TX, Beauveria brongniartii (alias) (54) + TX, Chrysoperla carnea (alias) (151) + TX, Cryptolaemus montrouzieri (alias) (178) + TX, Codling moth GV (alias) (191) + TX, Dacnusa sibirica (alias) (212) + TX, Diglyphus isaea (alias) (254) + TX, Encarsia formosa (scientific name) (293) + TX, Eretmocerus eremicus) (alias) (300) + TX, Spodoptera exigua NPV (alias) (431) + TX, Heterorhabditis bacteriophora and H. megidis (alias) (433) + TX, Hippodamia convergens (alias) (442) + TX, Leptomastix dactylopii (alias) (488) + TX, Macrolophus caliginosus (alias) (491) + TX, Spodoptera exigua NPV (alias) (494) + TX, Metaphycus helvolus (alias) (522) + TX, Metarhizium anisopliae var.acridum)(scientific name)(523)+TX, Metarhizium anisopliae var.anisopliae)(scientific name)(523)+TX, Neodiprionsertifer NPV and Neodiprionsertifer rubrum (N.lecontei)NPV (alias) (575) + TX, Paecilomyces spp. (alias) (596) + TX, Paecilomyces fumosoroseus (alias) (613) + TX, Phytoseiulus persimilis (alias) (644) + TX, Spodopteraexigua multicapsid nuclear polyhedrosis virus (scientific name) (741) + TX, Steinernema bibionis (alias) (742) + TX, Steinernema carpocapsae (alias) (742) + TX, Steinernema glaseri (alias) (742) + TX, Steinernema riobrave) (alias) (742) + TX, Steinernema riobravis (alias) (742) + TX, Steinernema scapterisci (alias) (742) + TX, Steinernema spp. (alias) (742) + TX, Trichogramma spp. (alias) (826) + TX, Typhlodromus occidentalis (alias) (844) and Verticillium lecanii (alias) (848) + TX;

[0969] Soil disinfectant selected from the group consisting of methyl iodide (IUPAC name) (542) and methyl bromide (537) + TX;

[0970] A chemical sterilant selected from the group consisting of: apholanate [CCN] + TX, bis(aziridine) methylaminophosphine sulfide (bisazir) (alias) [CCN] + TX, busulfan (alias) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alias) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methylsulfonate Methotepa [CCN] + TX, methylapholate [CCN] + TX, morzid [CCN] + TX, penfluron (other name) [CCN] + TX, tepa [CCN] + TX, thiohempa (other name) [CCN] + TX, thiotepa (other name) [CCN] + TX, trotamide (other name) [CCN] and urethaneimide (other name) [CCN] + TX;

[0971] An insect pheromone selected from the group consisting of (E)-dec-5-en-1-yl acetate and (E)-dec-5-en-1-ol (IUPAC name) (222) + TX, (E)-tridec-4-en-1-yl acetate (IUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (IUPAC name) (541) + TX, (E,Z)-tetradec-4,10-dien-1-yl acetate (IUPAC name) (779) + TX, (Z)-dodec-7-en-1-yl acetate (IUPAC name) (285) + TX, (Z)-hexadecan-11-enal (IUPAC name) (436) + TX, (Z)-hexadecan-11-en-1-yl acetate (IUPAC name) (437) + TX X, (Z)-hexadec-13-en-11-yn-1-yl acetate (IUPAC name) (438) + TX, (Z)-eicos-13-en-10-one (IUPAC name) (448) + TX, (Z)-tetradec-7-en-1-al (IUPAC name) (782) + TX, (Z)-tetradec-9-en-1-ol (IUPAC name) (783) + TX, (Z)-tetradec-9-en-1-yl acetate (IUPAC name) (784) + TX, (7E,9Z)-dodec-7,9-dien-1-yl acetate (IUPAC name) (283) + TX, (9Z,11E)-tetradec-9,11-dien-1-yl acetate (IUPAC name) (780) + TX, (9Z,12E)-tetradec-9,12-Dien-1-yl acetate (IUPAC name) (781) + TX, 14-methyloctadec-1-ene (IUPAC name) (545) + TX, 4-methylnonan-5-ol and 4-methylnonan-5-one (IUPAC name) (544) + TX, alpha-multistriatin (alias) [CCN] + TX, western pine beetle gathering pheromone (brevicomin) (alias) [CCN] + TX, codlelure (alias) [CCN] + TX, codlemon mone)(alias)(167)+TX、cuelure)(alias)(179)+TX、disparlure)(277)+TX、1-dodecane-8-en-1-yl acetate(IUPAC name)(286)+TX、1-dodecane-9-en-1-yl acetate(IUPAC name)(287)+TX、10-10-dien-1-yl acetate(IUPAC name)(284)+TX、dominicalure(alias)[CCN]+TX、ethyl 4-methyloctanoate(IUPAC name) C name) (317) + TX, eugenol (alias) [CCN] + TX, southern pine beetle gathering pheromone (frontalin) (alias) [CCN] + TX, gossyplure (alias) (420) + TX, grandlure (421) + TX, grandlure I (alias) (421) + TX, grandlure II (alias) (421) + TX, grandlure III (alias) (421) + TX, grandlure IV (alias) (421) + TX, hexalure )[CCN]+TX、ipsdienol(alias)[CCN]+TX、ipsenol(alias)[CCN]+TX、japonilure(alias)(481)+TX、lineatin(alias)[CCN]+TX、litlure(alias)[CCN]+TX、looplure(alias)[CCN]+TX、medlure[CCN]+TX、megatomoic acid(alias)[CCN]+TX、methyl eugenol(alias)(540)+TX、muscalure(563)+TX、octadeca-2,13-dien-1-yl acetate(IUPAC name)(588)+TX、octadeca-3,13-Dien-1-yl acetate (IUPAC name) (589) + TX, orfralure (alias) [CCN] + TX, oryctalure (alias) (317) + TX, ostramone (alias) [CCN] + TX, siglure [CCN] + TX, sordidin (alias) (736) + TX, sulcatol )(Synonym)[CCN]+TX, tetradec-11-en-1-yl acetate (IUPAC name) (785)+TX, Mediterranean fruit fly attractant (839)+TX, Mediterranean fruit fly attractant A (Synonym) (839)+TX, Mediterranean fruit fly attractant B1 (Synonym) (839)+TX, Mediterranean fruit fly attractant B2 (Synonym) (839)+TX, Mediterranean fruit fly attractant C (Synonym) (839) and trunc-call (Synonym)[CCN]+TX;

[0972] Insect repellents selected from the group consisting of 2-(octylthio)ethanol (IUPAC name) (591) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (IUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (IUPAC name) (1048) + TX, DEET [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1137) + TX, hexylurea [CCN] + TX, methoquin-butyl (1276) + TX, methyl neodecylamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX;

[0973] Molluscicides selected from the group consisting of bis(tributyltin) oxide (IUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, chloranil (999) + TX, copper acetyl arsenite [CCN] + TX, copper sulfate (172) + TX, triphenyltin (347) + TX, iron phosphate (IUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-ethanolamine (576) + TX, pentachlorophenol ( 623)+TX, sodium pentachlorophenoxide (623)+TX, tazimcarb (1412)+TX, thiodicarb (799)+TX, tributyltin oxide (913)+TX, trifenmorph (1454)+TX, trimethacarb (840)+TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347)+TX, pyriprole [394730-71-3]+TX;

[0974] A nematicide selected from the group consisting of: AKD-3088 (compound code) + TX, 1,2-dibromo-3-chloropropane (IUPAC / Chemical Abstracts name) (1045) + TX, 1,2-dichloropropane (IUPAC / Chemical Abstracts name) (1062) + TX, 1,2-dichloropropane and 1,3-dichloropropene (IUPAC name) (1063) + TX, 1,3-dichloropropene (233) + TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide (IUPAC / Chemical Abstracts name) Abstract name) (1065) + TX, 3-(4-chlorophenyl)-5-methylrhodanine (IUPAC name) (980) + TX, 5-methyl-6-thioxo-1,3,5-thiadiazin-3-yl acetic acid (IUPAC name) (1286) + TX, 6-isopentenylaminopurine (alias) (210) + TX, avermectin (1) + TX, acetofenamide [CCN] + TX, cotton bell carb (15) + TX, aldicarb (16) + TX, aldicarb (863) + TX, AZ60541 (compound code) + TX, benclothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben (alias) + TX, chlorpyrifos (109) + TX, carbofuran (118) + TX, carbon disulfide (945) + TX, carbofuran (119) + TX, chloropicrin (141) + TX, chlorpyrifos (145) + TX, chlorpyrifos (999) + TX, cyclohexane + TX, cytokinin (alias) (2 10)+TX, dazomethane (216)+TX, DBCP (1045)+TX, DCIP (218)+TX, diamidafos (1044)+TX, dimethoate (1051)+TX, dicliphos (alias)+TX, dimethoate (262)+TX, doramectin (alias) [CCN]+TX, emamectin (291)+TX, emamectin benzoate (291)+TX, eprinomectin (alias) [CCN]+TX, ethoprophos (312) + TX, dibromoethane (316) + TX, fenamiphos (326) + TX, fenpyrad (alias) + TX, fensulfonyl (1158) + TX, thiazophos (408) + TX, butythiophos (1196) + TX, furfural (alias) [CCN] + TX, GY-81 (research code) (423) + TX, thiophene [CCN] + TX, iodomethane (IUPAC name) (542) + TX, isamidophos (1230) + TX , chlorfenapyr (1231) + TX, ivermectin (alias) [CCN] + TX, kinetin (alias) (210) + TX, methyl azomethine (1258) + TX, metamectin (519) + TX, metamectin potassium salt (alias) (519) + TX, metamectin sodium salt (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime (alias) [CCN] + TX, moxidectin (alias) [CCN] + TX, Myrotheciumverrucaria) combination (alias) (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX, phosphamidon (639) + TX, phosphamidon [CCN] + TX, clomiphene (alias) + TX, selamectin (alias) [CCN] + TX, spinosad (737) + TX, terbufos (alias) + TX, terbufos (773) + TX, tetrachlorothiophene (IUPAC / Chemical Abstract name) (1422) + TX, thiafenox (alias) + TX, cypermethrin (1434) + TX, triazophos (820) + TX, triazuron (alias) + TX, dimethylol [CCN] + TX, YI-5302 (compound code) and zeatin (alias) (210) + TX, fluensulfone [318290-98-1] + TX, fluopyram + TX;

[0975] A nitrification inhibitor selected from the group consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX;

[0976] Plant activators selected from the group consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alias) (720) + TX;

[0977] Rodenticide, the rodenticide is selected from the group consisting of: 2-isovaleryl indane-1,3-dione (IUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, α-chlorohydrin [CCN] + TX, aluminum phosphide (640) + TX, antoquinone (880) + TX, arsenic trioxide (882) + TX, barium carbonate (891) + TX, dithiocarbamide (912) + TX, brodifacoum (89) + TX, bromodisulfuron (89) + TX, Bromadiolone (including α-bromadiolone) + TX, bromodiolone (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlordiolone (140) + TX, cholecalciferol (alias) (850) + TX, chlordiol (1004) + TX, chlordiol (1005) + TX, chlordiol (175) + TX, chlordiol (1009) + TX, bromodiol (246) + TX, thiazolin (249) + TX, difacoum (273) + TX, calciferol (301) + T X、Fluorofuram (357) + TX、Fluoroacetamide (379) + TX、Fluorofuram (1183) + TX、Fluorofuram hydrochloride (1183) + TX、γ-HCH (430) + TX、HCH (430) + TX、Hydrogen cyanide (444) + TX、Methyl iodide (IUPAC name) (542) + TX、Lindan (430) + TX、Magnesium phosphide (IUPAC name) (640) + TX、Methyl bromide (537) + TX、Fluorofuram (1318) + TX、Fluorofuram ( 1336) + TX, phosphine (IUPAC name) (640) + TX, phosphorus [CCN] + TX, warfarin (1341) + TX, potassium arsenite [CCN] + TX, warfarin (1371) + TX, scilla glycoside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoroacetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851), and zinc phosphide (640) + TX;

[0978] Synergists selected from the group consisting of 2-(2-butoxyethoxy)ethyl piperate (IUPAC name) (934) + TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (IUPAC name) (903) + TX, farnesol with nerolidol (alias) (324) + TX, MB-599 (research code) (498) + TX, MGK 264 (research code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (research code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX;

[0979] Animal repellents, which are selected from the group consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper cyclohexane [CCN] + TX, copper oxychloride (171) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetate (422) + TX, methiocarb (530) + TX, pyridin-4-amine (IUPAC name) (23) + TX, salamine (804) + TX, trimethacarb (840) + TX, zinc cyclohexane [CCN] and ziram (856) + TX;

[0980] Virucidal agents selected from the group consisting of: imipenem (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX;

[0981] A wound protective agent selected from the group consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX;

[0982] Biologically active substances, the biologically active substances are selected from 1,1-bis(4-chloro-phenyl)-2-ethoxyethanol+TX, 2,4-dichlorophenylbenzenesulfonate+TX, 2-fluoro-N-methyl-N-1-naphthylacetamide+TX, 4-chlorophenylphenylsulfone+TX, acetofenapyr+TX, aldisulfonyl+TX, sagofos+TX, fomanphos+TX, amitriptyline+TX, amitriptyline hydrogen oxalate+TX, amitraz+TX, cypermethrin+TX, arsenic trioxide+TX, azobenzene+TX, azophos+TX, benomyl+TX, benoxafos+TX, benzyl benzoate+TX, bixafenthion+TX, bromothiophene+TX, bromothiophene+TX, bromothiophene Phosphorus + TX, bromopyralid + TX, buprofen + TX, butanone carbendazim + TX, butanone sulfonate + TX, butylpyridaben + TX, calcium polysulfide + TX, octachlorocamphene + TX, chlormethoxam + TX, trithion + TX, cypermethrin + TX, cypermethrin + TX, cypermethrin + TX, chlordimeform + TX, chlordimeform hydrochloride + TX, chlorfenapyr + TX, chlorfenapyr + TX, dimethoate + TX, ethyl chlorfenapyr + TX, chlordimeform (chloromebuform) + TX, chlorfenapyr + TX, propyl chlorfenapyr + TX, chlorfenapyr + TX, chlorfenapyr + TX, chlorfenapyr I + TX, chlordimeform II + TX, chlordimeform + TX, closantel + TX, coumaphos + TX, crotamiton + TX, Baclofos+TX, Thiamin+TX, Fructofos+TX, DCPM+TX, DDT+TX, Dinophos+TX, Dinophos-O+TX, Dinophos-S+TX, Demeton-methyl+TX, Demeton-O+TX, Demeton-O-methyl+TX, Demeton-S+TX, Demeton-S-methyl+TX, Demeton-S-methyl+TX, Demeton-S-methyl+TX, Demeton-S-methyl+TX, Demeton-S-methylsulfon+TX, Dichlorvos+TX, Dichlorvos+TX, Dichlorvos+TX, Dichlorvos+TX, Dimethoate+TX, Dimethoate+TX, Dimethoate+TX, Dimethoate+TX, Dimethoate+TX, Dimethoate-4+TX, Dimethoate -6+TX, anthelmintic+TX, nitropentyl+TX, nitrobenzene acaricide+TX, nitrobutyl+TX, dithiophos+TX, sulfodiphenyl+TX, disu...

Claims

1. A compound having formula (I) in G1 and G2 are independently CH or N; R2 is C1-C2 haloalkyl, C1-C2 haloalkylsulfanyl, C1-C2 haloalkylsulfinyl, C1-C2 haloalkylsulfonyl, C1-C2 haloalkoxy or C1-C2 haloalkylsulfonyloxy; Q is a group of formula Qa or Qb wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring; And among them, X is S, SO or SO2; R1 is C1-C4 alkyl; R4 is hydrogen and R3 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or R3 is hydrogen and R4 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy or -NHC(O)CH3; or R6 is hydrogen and R5 is hydrogen, bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or R5 is hydrogen and R6 is bromo, methyl, trifluoromethyl, 1,1-difluoroethyl, cyclopropyl, 1-cyanocyclopropyl, 1-cyano-1-methyl-ethyl, 1-cyano-1-methyl-ethoxy, methoxy, isopropoxy, difluoromethoxy, 2,2,2-trifluoroethoxy, 2,2-difluoroethoxy, or -NHC(O)CH3; or an agrochemically acceptable salt of a compound of formula I.

2. The compound according to claim 1, which is represented by a compound having formula (I-1) in, R2, G1, G2, X, R1, R3 and R4 are as defined in formula (I) in claim 1; or an agrochemically acceptable salt thereof.

3. The compound according to claim 1, which is represented by a compound having formula (I-2) in, R2, G1, G2, X, R1, R5 and R6 are as defined in formula (I) in claim 1; or an agrochemically acceptable salt thereof.

4. The compound according to claim 1, wherein G1 is N and G2 is CH, or G1 is CH and G2 is N.

5. The compound according to claim 1, wherein G1 and G2 are both N, or G1 and G2 are both CH.

6. The compound according to claim 1, which is represented by a compound having formula (I-3) wherein Q is a group of formula Qa or Qb wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring; and R2, X, R1, R3, R4, R5 and R6 are as defined in formula (I) in claim 1; or an agrochemically acceptable salt thereof.

7. The compound according to claim 1, which is represented by a compound having formula (I-4) wherein Q is a group of formula Qa or Qb wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring; and R2, X, R1, R3, R4, R5 and R6 are as defined in formula (I) in claim 1; or an agrochemically acceptable salt thereof.

8. The compound according to claim 1, which is represented by a compound having formula (I-5) wherein Q is a group of formula Qa or Qb wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring; and R2, X, R1, R3, R4, R5 and R6 are as defined in formula (I) in claim 1; or an agrochemically acceptable salt thereof.

9. The compound according to claim 1, which is represented by a compound having formula (I-6) wherein Q is a group of formula Qa or Qb wherein the arrow indicates the point of attachment to the nitrogen atom of the bicyclic ring; and R2, X, R1, R3, R4, R5 and R6 are as defined in formula (I) in claim 1; or an agrochemically acceptable salt thereof.

10. The compound according to claim 1, wherein: X is S or SO2; and R1 is ethyl.

11. The compound according to claim 1, wherein: R2 is -CF3, -CF2CF3, -SCF3, -SOCF3, -SO2CF3, -OCHF2, -OCF3 or -OSO2CF3.

12. The compound according to claim 11, wherein R2 is -CF3, -OCHF2, -OCF3 or -SO2CF3.

13. The compound according to claim 1, selected from the group consisting of: 2-[3-Ethylsulfonyl-6-(trifluoromethyl)benzothiophen-2-yl]-6-(trifluoromethyl)-3H-pyrrolo[3,4-c]pyridin-1-one (Compound P1); 6-[3-Ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P2); 1-[3-Ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-6-yl]imidazo[1,2-a]pyridin-7-yl]cyclopropylnitrile (Compound P3); 6-[3-Ethylsulfonyl-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P2); yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P4); 1-[3-ethylsulfonyl-2-[1-oxo-6-(trifluoromethoxy)isoindolin-2-yl]imidazo[1,2-a]pyridin-7-yl]cyclopropylcarbonitrile (Compound P5); 2-[3-ethylsulfonyl-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-6-(trifluoromethoxy)isoindolin-1-one (Compound P6); 2-[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-6-(trifluoromethoxy)isoindolin-1-one (Compound P7); 6-(3-ethylsulfonyl-6-methoxy-imidazo[ 1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P8); 6-(3-ethylsulfonyl-6-isopropoxy-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P9); 6-[6-(difluoromethoxy)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P10); 6-[3-ethylsulfonyl-6-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P11); )-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P11); 6-[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P12); 6-(3-ethylsulfonyl-7-methoxy-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P13); 1-[3-ethylsulfonyl-2-[1-oxo-6-(trifluoromethoxy)isoindolin-2-yl]imidazo[1,2-a]pyridin-6-yl]cyclopropylcarbonitrile (Compound P14);1-[3-Ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-6-yl]imidazo[1,2-a]pyridin-6-yl]cyclopropylnitrile (Compound P15); 1-[3-Ethylsulfonyl-2-[1-oxo-6-(trifluoromethyl)isoindolin-2-yl]imidazo[1,2-a]pyridin-6-yl]cyclopropylnitrile (Compound P16); 2-[6-(1,1-difluoroethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]-6-(trifluoromethoxy)isoindolin-1-one (Compound P17); 6-[6-(1,1-difluoroethyl)-3-ethylsulfonyl-imidazo[ 1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P18); 6-[6-(2,2-difluoroethoxy)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P19); 2-[3-ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-6-yl]imidazo[1,2-a]pyridin-6-yl]oxy-2-methyl-propionitrile (Compound P20); 6-(6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P21); pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P21); 6-(7-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P22); 6-(3-ethylsulfonyl-7-methyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P23); 6-(7-cyclopropyl-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P24). b]pyridin-5-one (Compound P24); 6-[7-(1,1-difluoroethyl)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P25); 2-[3-ethylsulfonyl-2-[1-oxo-6-(trifluoromethoxy)isoindolin-2-yl]imidazo[1,2-a]pyridin-6-yl]oxy-2-methyl-propionitrile (Compound P26); 6-(6-cyclopropyl-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P27);2-[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]-6-(trifluoromethoxy)isoindolin-1-one (Compound P28); 2-(6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-6-(trifluoromethoxy)isoindolin-1-one (Compound P29); 2-(6-bromo-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl)-6-(trifluoromethylsulfonyl)isoindolin-1-one (Compound P30); 1-[[3 -ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-6-yl]imidazo[1,2-a]pyridin-6-yl]oxymethyl]cyclopropylnitrile (Compound P31); 2-[3-ethylsulfonyl-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-6-(trifluoromethylsulfonyl)isoindolin-1-one (Compound P32); 2-[3-ethylsulfonyl-7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-2-yl]-6-(trifluoromethyl) isoindolin-1-one (Compound P33); 6-(difluoromethoxy)-2-[3-ethylsulfonyl-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]isoindolin-1-one (Compound P34); 2-[3-ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-6-yl]imidazo[1,2-a]pyridin-6-yl]-2-methyl-propionitrile (Compound P35); N-[3-ethylsulfonyl-2-[5-oxo-3-(trifluoromethyl)-7 H-pyrrolo[3,4-b]pyridin-6-yl]imidazo[1,2-a]pyridin-6-yl]acetamide (Compound P36); 2-[3-ethylsulfonyl-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-6-(trifluoromethylsulfonyl)isoindolin-1-one (Compound P37); and 6-[7-(2,2-difluoroethoxy)-3-ethylsulfonyl-imidazo[1,2-a]pyridin-2-yl]-3-(trifluoromethyl)-7H-pyrrolo[3,4-b]pyridin-5-one (Compound P38). ; 14. A composition comprising an insecticidal, acaricidal, nematicidal or molluscicidal effective amount of a compound as defined in any one of claims 1 to 13, or an agrochemically acceptable salt thereof, and optionally, an adjuvant or diluent.

15. A method for combating and controlling insects, mites, nematodes or molluscs for non-therapeutic purposes, the method comprising applying an insecticidal, acaricidal, nematicidal or molluscicidal effective amount of a compound as defined in any one of claims 1 to 13, or an agrochemically acceptable salt thereof, or a composition as defined in claim 14 to the pest, the location of the pest, or a plant susceptible to attack by the pest.

16. A method for protecting plant propagation material from attack by insects, mites, nematodes or molluscs, the method comprising treating the propagation material or the site where the propagation material is planted with a composition according to claim 14.

17. A compound having formula XVII-Qa-1 in R2, G1, G2, R3, R4, R1 and X are as defined in formula (I) according to claim 1; and R a It is hydrogen, C1-C6 alkyl, benzyl or phenyl.

Citation Information

Patent Citations

  • Carbazole carboxamide compounds useful as kinase inhibitors

    US20100160303A1

  • Method and means for increasing efficacy and wash durability of insecticide treated fabric

    US5631072A

  • Bacterial genes

    WO1990013651A1

  • Synthetic DNA sequence having enhanced insecticidal activity in maize

    WO1993007278A1

  • Genes for the synthesis of antipathogenic substances

    WO1995033818A2